CHEBI ONTOLOGY - ANNOTATIONS |
|
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
|
Term: | vitamin E |
|
Accession: | CHEBI:33234
|
browse the term
|
Definition: | A chromanol that is chroman-6-ol which is substituted at position 2 by a methyl group and (also at position 2) either a saturated or a triply-unsaturated hydrocarbon chain consisting of three isoprenoid units. |
Synonyms: | alt_id: | MESH:D014810 |
| xref: | CAS:59-02-9 |
| xref_mesh: | MESH:D024502 |
| xref: | MetaCyc:Vitamin-E; PMID:7898412; PMID:7901680; Wikipedia:Vitamin_E |
|
|
|
G |
Aamp |
angio-associated, migratory cell protein |
increases expression |
ISO |
Vitamin E results in increased expression of AAMP mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:81,560,836...81,566,642
Ensembl chr 9:81,560,842...81,566,642
|
|
G |
Aass |
aminoadipate-semialdehyde synthase |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of AASS mRNA Vitamin E results in decreased expression of AASS mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:50,152,005...50,208,935
Ensembl chr 4:50,152,452...50,200,328
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
multiple interactions |
EXP |
alpha-Tocopherol inhibits the reaction [nickel chloride results in increased expression of ABCB1 protein] |
CTD |
PMID:24448832 |
|
NCBI chr 4:22,339,829...22,517,642
Ensembl chr 4:22,133,521...22,425,515
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
multiple interactions |
EXP |
[Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of ABCC2 mRNA |
CTD |
PMID:11444866 |
|
NCBI chr 1:263,554,426...263,612,556
Ensembl chr 1:263,554,453...263,613,252
|
|
G |
Abcd1 |
ATP binding cassette subfamily D member 1 |
multiple interactions |
ISO |
alpha-Tocopherol inhibits the reaction [7-ketocholesterol results in decreased expression of ABCD1 mRNA] |
CTD |
PMID:29065513 |
|
NCBI chr X:157,073,860...157,095,652
Ensembl chr X:157,072,736...157,095,274
|
|
G |
Abcd3 |
ATP binding cassette subfamily D member 3 |
multiple interactions |
ISO |
alpha-Tocopherol inhibits the reaction [7-ketocholesterol results in decreased expression of ABCD3 mRNA] |
CTD |
PMID:29065513 |
|
NCBI chr 2:225,335,708...225,389,120
Ensembl chr 2:225,335,718...225,389,120
|
|
G |
Abhd14a |
abhydrolase domain containing 14A |
decreases expression |
ISO |
Vitamin E results in decreased expression of ABHD14A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:115,141,575...115,151,222
Ensembl chr 8:115,141,539...115,149,527
|
|
G |
Abhd2 |
abhydrolase domain containing 2, acylglycerol lipase |
decreases expression increases expression |
ISO |
Vitamin E results in decreased expression of ABHD2 mRNA Vitamin E results in increased expression of ABHD2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:140,998,240...141,087,405
Ensembl chr 1:140,998,240...141,087,405
|
|
G |
Abhd4 |
abhydrolase domain containing 4, N-acyl phospholipase B |
increases expression |
ISO |
Vitamin E results in increased expression of ABHD4 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr15:32,888,233...32,906,861
Ensembl chr15:32,894,938...32,906,850
|
|
G |
Acaa2 |
acetyl-CoA acyltransferase 2 |
increases expression |
ISO |
Vitamin E results in increased expression of ACAA2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr18:70,733,872...70,762,395
Ensembl chr18:70,733,872...70,762,395
|
|
G |
Acads |
acyl-CoA dehydrogenase short chain |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of ACADS mRNA Vitamin E results in increased expression of ACADS mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:47,254,503...47,263,747
Ensembl chr12:47,254,484...47,263,747
|
|
G |
Acat1 |
acetyl-CoA acetyltransferase 1 |
multiple interactions |
EXP |
alpha-Tocopherol inhibits the reaction [iron(II)-ascorbic acid complex results in decreased activity of ACAT1 protein] |
CTD |
PMID:10656290 |
|
NCBI chr 8:58,166,990...58,195,884
Ensembl chr 8:58,166,990...58,195,884
|
|
G |
Ache |
acetylcholinesterase |
multiple interactions |
ISO EXP |
[Resveratrol co-treated with Ascorbic Acid co-treated with Thioctic Acid co-treated with Vitamin E] results in increased activity of ACHE protein; Hexachlorocyclohexane inhibits the reaction [[Resveratrol co-treated with Ascorbic Acid co-treated with Thioctic Acid co-treated with Vitamin E] results in increased activity of ACHE protein] [Zinc co-treated with Vitamin E co-treated with Ascorbic Acid] inhibits the reaction [sodium arsenite results in increased activity of ACHE protein]; alpha-Tocopherol inhibits the reaction [Streptozocin results in increased activity of ACHE protein]; Vitamin E inhibits the reaction [Scopolamine results in decreased activity of ACHE protein] |
CTD |
PMID:11814146 PMID:19464315 PMID:20663516 PMID:23619517 |
|
NCBI chr12:22,472,358...22,477,052
Ensembl chr12:22,472,358...22,478,753
|
|
G |
Aco2 |
aconitase 2 |
increases expression |
ISO |
Vitamin E results in increased expression of ACO2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:123,102,493...123,145,608
Ensembl chr 7:123,102,468...123,145,635
|
|
G |
Acot2 |
acyl-CoA thioesterase 2 |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of ACOT2 mRNA Vitamin E results in increased expression of ACOT2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:107,460,596...107,468,324
Ensembl chr 6:107,460,668...107,467,487
|
|
G |
Acp1 |
acid phosphatase 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of ACP1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:49,836,064...49,851,714
Ensembl chr 6:49,836,075...49,851,714
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
decreases expression |
ISO |
Vitamin E results in decreased expression of ACTA2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:252,537,614...252,550,394
Ensembl chr 1:252,537,615...252,550,394
|
|
G |
Actb |
actin, beta |
increases expression |
ISO |
Vitamin E results in increased expression of ACTB mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:13,715,843...13,718,813
Ensembl chr12:13,715,843...13,718,841
|
|
G |
Actn4 |
actinin alpha 4 |
increases expression |
ISO |
Vitamin E results in increased expression of ACTN4 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:87,078,012...87,147,347
Ensembl chr 1:87,078,020...87,147,333
|
|
G |
Actr1a |
actin related protein 1A |
increases expression |
ISO |
Vitamin E results in increased expression of ACTR1A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:266,123,864...266,142,621
Ensembl chr 1:266,123,870...266,142,538
|
|
G |
Actr1b |
actin related protein 1B |
increases expression |
ISO |
Vitamin E results in increased expression of ACTR1B mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:43,267,053...43,276,717
Ensembl chr 9:43,267,057...43,276,685
|
|
G |
Acvr2a |
activin A receptor type 2A |
decreases expression |
ISO |
Vitamin E results in decreased expression of ACVR2A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:32,947,901...33,034,598
Ensembl chr 3:32,947,378...33,034,282
|
|
G |
Acvrl1 |
activin A receptor like type 1 |
increases expression |
EXP |
alpha-Tocopherol results in increased expression of ACVRL1 mRNA |
CTD |
PMID:16908007 |
|
NCBI chr 7:142,769,942...142,787,336
Ensembl chr 7:142,776,252...142,787,335
|
|
G |
Adam17 |
ADAM metallopeptidase domain 17 |
decreases expression |
ISO |
Vitamin E results in decreased expression of ADAM17 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:43,400,525...43,448,280
Ensembl chr 6:43,400,528...43,448,280
|
|
G |
Adamts5 |
ADAM metallopeptidase with thrombospondin type 1 motif, 5 |
decreases expression |
ISO |
Vitamin E results in decreased expression of ADAMTS5 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr11:25,411,174...25,456,639
Ensembl chr11:25,410,975...25,456,836
|
|
G |
Adap1 |
ArfGAP with dual PH domains 1 |
increases expression |
ISO |
Vitamin E results in increased expression of ADAP1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:17,416,327...17,468,212
Ensembl chr12:17,416,327...17,468,212
|
|
G |
Adarb1 |
adenosine deaminase, RNA-specific, B1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of ADARB1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:11,972,352...12,101,022
Ensembl chr20:11,972,381...12,101,047
|
|
G |
Adcy2 |
adenylate cyclase 2 |
multiple interactions |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of ADCY2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:37,043,071...37,698,390
Ensembl chr 1:37,507,276...37,698,390
|
|
G |
Adcy6 |
adenylate cyclase 6 |
increases expression |
ISO |
Vitamin E results in increased expression of ADCY6 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:140,270,678...140,291,722
Ensembl chr 7:140,270,692...140,291,620
|
|
G |
Add1 |
adducin 1 |
increases expression |
ISO |
Vitamin E results in increased expression of ADD1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:81,367,466...81,426,610
Ensembl chr14:81,367,468...81,426,496
|
|
G |
Add3 |
adducin 3 |
decreases expression |
ISO |
Vitamin E results in decreased expression of ADD3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:273,854,195...273,961,982
Ensembl chr 1:273,854,248...273,961,982
|
|
G |
Adgrb1 |
adhesion G protein-coupled receptor B1 |
increases expression |
ISO |
Vitamin E results in increased expression of ADGRB1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:115,766,484...115,828,514
|
|
G |
Adh7 |
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide |
decreases expression |
ISO |
Vitamin E results in decreased expression of ADH7 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 2:243,500,540...243,516,865
Ensembl chr 2:243,502,073...243,516,532
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
multiple interactions |
EXP |
Vitamin E inhibits the reaction [Dietary Fats results in decreased expression of ADIPOQ mRNA]; Vitamin E inhibits the reaction [Dietary Fats results in decreased expression of ADIPOQ protein] |
CTD |
PMID:20404018 |
|
NCBI chr11:81,330,845...81,344,488
Ensembl chr11:81,330,293...81,344,488
|
|
G |
Adra2c |
adrenoceptor alpha 2C |
increases expression |
ISO |
Vitamin E results in increased expression of ADRA2C mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:80,730,307...80,732,010
Ensembl chr14:80,730,307...80,732,010
|
|
G |
Adrm1 |
adhesion regulating molecule 1 |
increases expression |
ISO |
Vitamin E results in increased expression of ADRM1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:175,548,181...175,552,943
Ensembl chr 3:175,548,174...175,552,947
|
|
G |
Aebp1 |
AE binding protein 1 |
increases expression |
ISO |
Vitamin E results in increased expression of AEBP1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:86,101,253...86,111,323
Ensembl chr14:86,101,277...86,111,306
|
|
G |
Aen |
apoptosis enhancing nuclease |
increases expression |
ISO |
Vitamin E results in increased expression of AEN mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:140,584,328...140,593,749
Ensembl chr 1:140,584,380...140,593,745
|
|
G |
Agpat2 |
1-acylglycerol-3-phosphate O-acyltransferase 2 |
multiple interactions |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of AGPAT2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:4,044,741...4,055,384
Ensembl chr 3:4,044,542...4,055,806
|
|
G |
Agrn |
agrin |
decreases expression |
ISO |
Vitamin E results in decreased expression of AGRN mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:173,589,910...173,622,813
Ensembl chr 5:173,589,819...173,622,645
|
|
G |
Agt |
angiotensinogen |
multiple interactions |
ISO |
alpha-Tocopherol inhibits the reaction [AGT protein results in increased expression of PSMC6 protein]; alpha-Tocopherol inhibits the reaction [AGT protein results in increased phosphorylation of NFKBIA protein] |
CTD |
PMID:17532611 |
|
NCBI chr19:57,321,594...57,333,460
Ensembl chr19:57,321,640...57,333,433
|
|
G |
Agtpbp1 |
ATP/GTP binding carboxypeptidase 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of AGTPBP1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr17:5,510,009...5,614,416
Ensembl chr17:5,511,385...5,614,435
|
|
G |
Ahnak |
AHNAK nucleoprotein |
increases expression |
ISO |
Vitamin E results in increased expression of AHNAK mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:225,184,883...225,429,638
Ensembl chr 1:225,184,939...225,215,015
|
|
G |
Ahnak2 |
AHNAK nucleoprotein 2 |
increases expression |
ISO |
Vitamin E results in increased expression of AHNAK2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:137,335,273...137,380,219
|
|
G |
Ahr |
aryl hydrocarbon receptor |
decreases expression |
ISO |
Vitamin E results in decreased expression of AHR mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:54,963,990...55,001,806
Ensembl chr 6:54,963,990...55,001,464
|
|
G |
Aimp1 |
aminoacyl tRNA synthetase complex-interacting multifunctional protein 1 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of AIMP1 mRNA Vitamin E results in decreased expression of AIMP1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 2:237,727,782...237,751,327
Ensembl chr 2:237,727,764...237,751,378
|
|
G |
Ak1 |
adenylate kinase 1 |
increases expression |
ISO |
Vitamin E results in increased expression of AK1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:11,652,143...11,659,135
|
|
G |
Ak3 |
adenylate kinase 3 |
multiple interactions |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of AK3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:247,144,486...247,169,690
Ensembl chr 1:247,144,491...247,169,693
|
|
G |
Akap13 |
A-kinase anchoring protein 13 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of AKAP13 mRNA Vitamin E results in decreased expression of AKAP13 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:137,089,558...137,315,272
Ensembl chr 1:137,014,272...137,315,272
|
|
G |
Akap2 |
A-kinase anchoring protein 2 |
increases expression decreases expression |
ISO |
Vitamin E results in increased expression of PALM2AKAP2 mRNA Vitamin E results in decreased expression of PALM2AKAP2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:74,874,245...74,985,789
Ensembl chr 5:74,874,306...74,982,401
|
|
G |
Akr1b1 |
aldo-keto reductase family 1 member B |
increases expression |
EXP ISO |
alpha-Tocopherol results in increased expression of AKR1B1 mRNA Vitamin E results in increased expression of AKR1B1 mRNA |
CTD |
PMID:16908007 PMID:19244175 |
|
NCBI chr 4:61,706,866...61,720,959
Ensembl chr 4:61,706,864...61,720,956
|
|
G |
Akr1c2 |
aldo-keto reductase family 1, member C2 |
increases expression |
ISO |
Vitamin E results in increased expression of AKR1C2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr17:69,388,337...69,435,160
Ensembl chr17:69,388,335...69,404,341
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions increases expression |
ISO EXP |
alpha-Tocopherol inhibits the reaction [28-O-acetylbetulin-3-ylglucopyranoside results in decreased phosphorylation of AKT1 protein] [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Diethylhexyl Phthalate results in decreased phosphorylation of AKT1 protein]; alpha-Tocopherol inhibits the reaction [7-ketocholesterol results in decreased phosphorylation of and results in decreased activity of AKT1 protein] Vitamin E results in increased expression of AKT1 mRNA |
CTD |
PMID:19244175 PMID:19351882 PMID:21911000 PMID:22343715 |
|
NCBI chr 6:137,218,398...137,239,970
Ensembl chr 6:137,218,376...137,236,258
|
|
G |
Alad |
aminolevulinate dehydratase |
multiple interactions |
ISO EXP |
alpha-Tocopherol inhibits the reaction [[Streptozocin results in increased abundance of Blood Glucose] which results in decreased expression of ALAD protein] Vitamin E inhibits the reaction [lead acetate results in decreased activity of ALAD protein] |
CTD |
PMID:2604901 PMID:7728901 |
|
NCBI chr 5:78,368,867...78,379,206
Ensembl chr 5:78,368,867...78,379,346
|
|
G |
Alas1 |
5'-aminolevulinate synthase 1 |
multiple interactions |
EXP |
alpha-Tocopherol inhibits the reaction [Paraquat results in increased activity of ALAS1 protein] |
CTD |
PMID:12180188 |
|
NCBI chr 8:114,927,704...114,941,038
Ensembl chr 8:114,927,722...114,940,177
|
|
G |
Alb |
albumin |
multiple interactions |
ISO EXP |
Vitamin E inhibits the reaction [Ethanol results in decreased expression of ALB protein] [Quercetin co-treated with Vitamin E] inhibits the reaction [Cyclosporine results in decreased expression of ALB protein]; alpha-Tocopherol inhibits the reaction [beryllium nitrate results in decreased expression of ALB protein]; sodium-4,5-dihydroxy-1,3-benzene disulfonate promotes the reaction [alpha-Tocopherol inhibits the reaction [beryllium nitrate results in decreased expression of ALB protein]]; Vitamin E inhibits the reaction [Cyclosporine results in decreased expression of ALB protein] Vitamin E inhibits the reaction [Oleic Acid results in decreased secretion of ALB protein] |
CTD |
PMID:17429802 PMID:17927767 PMID:21086752 PMID:23348005 |
|
NCBI chr14:19,176,275...19,191,793
Ensembl chr14:19,176,277...19,191,863
|
|
G |
Aldh6a1 |
aldehyde dehydrogenase 6 family, member A1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of ALDH6A1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:108,146,552...108,167,185
Ensembl chr 6:108,146,582...108,167,185
|
|
G |
Aldoa |
aldolase, fructose-bisphosphate A |
increases expression |
ISO |
Vitamin E results in increased expression of ALDOA mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:198,228,387...198,233,988
Ensembl chr 1:198,228,387...198,233,588
|
|
G |
Alg3 |
ALG3, alpha-1,3- mannosyltransferase |
increases expression |
ISO |
Vitamin E results in increased expression of ALG3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr11:83,985,484...83,991,706
Ensembl chr11:83,986,230...83,991,706
|
|
G |
Alg9 |
ALG9, alpha-1,2-mannosyltransferase |
multiple interactions |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of ALG9 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:55,202,140...55,265,478
Ensembl chr 8:55,202,725...55,265,478
|
|
G |
Alkbh1 |
alkB homolog 1, histone H2A dioxygenase |
decreases expression |
ISO |
Vitamin E results in decreased expression of ALKBH1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:111,456,096...111,476,829
Ensembl chr 6:111,456,187...111,477,090
|
|
G |
Alox5 |
arachidonate 5-lipoxygenase |
decreases activity multiple interactions |
ISO EXP |
Vitamin E results in decreased activity of ALOX5 protein [Vitamin E co-treated with Selenium] results in decreased expression of ALOX5 mRNA; [Vitamin E co-treated with Selenium] results in decreased expression of ALOX5 protein |
CTD |
PMID:11325678 PMID:12200813 PMID:22223226 |
|
NCBI chr 4:148,398,004...148,446,308
Ensembl chr 4:148,398,892...148,446,303
|
|
G |
Ambra1 |
autophagy and beclin 1 regulator 1 |
increases expression |
ISO |
Vitamin E results in increased expression of AMBRA1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:80,634,470...80,830,068
Ensembl chr 3:80,634,470...80,830,068
|
|
G |
Anapc15 |
anaphase promoting complex subunit 15 |
increases expression |
ISO |
Vitamin E results in increased expression of ANAPC15 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:166,981,738...166,985,363
Ensembl chr 1:166,983,175...166,985,054
|
|
G |
Andpro |
androgen regulated protein |
decreases expression |
EXP |
Vitamin E results in decreased expression of ANDPRO mRNA |
CTD |
PMID:15084515 |
|
NCBI chr 3:143,893,005...143,899,609
Ensembl chr 3:143,893,006...143,899,370
|
|
G |
Angpt1 |
angiopoietin 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of ANGPT1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:81,338,327...81,592,459
Ensembl chr 7:81,342,280...81,592,206
|
|
G |
Ank3 |
ankyrin 3 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of ANK3 mRNA Vitamin E results in decreased expression of ANK3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:19,948,767...20,480,628
Ensembl chr20:20,105,047...20,480,623
|
|
G |
Ankrd12 |
ankyrin repeat domain 12 |
decreases expression |
ISO |
Vitamin E results in decreased expression of ANKRD12 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:113,605,683...113,682,482
Ensembl chr 9:113,605,657...113,682,482
|
|
G |
Ano6 |
anoctamin 6 |
multiple interactions |
ISO |
alpha-Tocopherol inhibits the reaction [Ozone results in increased expression of ANO6 mRNA] |
CTD |
PMID:27886375 |
|
NCBI chr 7:137,142,063...137,335,208
Ensembl chr 7:137,142,170...137,335,208
|
|
G |
Anp32b |
acidic nuclear phosphoprotein 32 family member B |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of ANP32B mRNA Vitamin E results in decreased expression of ANP32B mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:62,070,709...62,094,633
Ensembl chr 5:62,071,346...62,094,633
|
|
G |
Anxa6 |
annexin A6 |
increases expression |
ISO |
Vitamin E results in increased expression of ANXA6 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:40,320,581...40,375,605
Ensembl chr10:40,320,581...40,375,605
|
|
G |
Ap1m2 |
adaptor related protein complex 1 subunit mu 2 |
increases expression |
ISO |
Vitamin E results in increased expression of AP1M2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:22,318,941...22,336,827
Ensembl chr 8:22,319,331...22,336,794
|
|
G |
Ap2a2 |
adaptor related protein complex 2 subunit alpha 2 |
increases expression |
ISO |
Vitamin E results in increased expression of AP2A2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:214,534,217...214,607,497
Ensembl chr 1:214,534,284...214,606,169
|
|
G |
Ap2m1 |
adaptor related protein complex 2 subunit mu 1 |
increases expression |
ISO |
Vitamin E results in increased expression of AP2M1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr11:84,041,184...84,047,542
Ensembl chr11:84,041,184...84,047,546
|
|
G |
Ap2s1 |
adaptor related protein complex 2 subunit sigma 1 |
increases expression |
ISO |
Vitamin E results in increased expression of AP2S1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:78,671,238...78,682,847
Ensembl chr 1:78,671,121...78,682,871
|
|
G |
Ap3s2 |
adaptor related protein complex 3 subunit sigma 2 |
increases expression |
ISO |
Vitamin E results in increased expression of AP3S2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:141,612,961...141,655,417
Ensembl chr 1:141,612,963...141,655,894
|
|
G |
Apbb2 |
amyloid beta precursor protein binding family B member 2 |
decreases expression |
ISO |
Vitamin E results in decreased expression of APBB2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:43,205,047...43,526,968
Ensembl chr14:43,512,901...43,523,080
|
|
G |
Apex1 |
apurinic/apyrimidinic endodeoxyribonuclease 1 |
increases expression |
ISO |
Vitamin E results in increased expression of APEX1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr15:27,849,943...27,852,083
Ensembl chr15:27,849,979...27,852,082
|
|
G |
Apex2 |
apurinic/apyrimidinic endodeoxyribonuclease 2 |
multiple interactions decreases expression |
EXP |
alpha-Tocopherol inhibits the reaction [Acrylonitrile results in increased expression of APEX2 mRNA] alpha-Tocopherol results in decreased expression of APEX2 mRNA |
CTD |
PMID:26332274 |
|
NCBI chr X:23,146,085...23,166,676
Ensembl chr X:23,146,085...23,166,675
|
|
G |
Aplp2 |
amyloid beta precursor like protein 2 |
increases expression |
ISO |
Vitamin E results in increased expression of APLP2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:32,298,526...32,328,821
Ensembl chr 8:32,298,532...32,328,839
|
|
G |
Apoa1 |
apolipoprotein A1 |
decreases expression increases expression decreases activity |
ISO EXP |
alpha-Tocopherol results in decreased expression of APOA1 mRNA; alpha-Tocopherol results in decreased expression of APOA1 protein Vitamin E results in increased expression of APOA1 protein alpha-Tocopherol results in decreased activity of APOA1 promoter |
CTD |
PMID:16423621 PMID:18458655 |
|
NCBI chr 8:50,525,091...50,526,875
Ensembl chr 8:50,525,091...50,526,875
|
|
G |
Apob |
apolipoprotein B |
multiple interactions |
ISO |
[Eicosapentaenoic Acid co-treated with Docosahexaenoic Acids co-treated with Oleic Acid co-treated with Folic Acid co-treated with Vitamin B 6 co-treated with Vitamin E] results in decreased expression of APOB protein; alpha-Tocopherol promotes the reaction [APOB protein results in increased reduction of Copper]; Vitamin E promotes the reaction [Flavonoids inhibits the reaction [Copper results in increased oxidation of APOB protein]]; Vitamin E promotes the reaction [Quercetin inhibits the reaction [Copper results in increased oxidation of APOB protein]] |
CTD |
PMID:11368321 PMID:17237316 PMID:17475462 |
|
NCBI chr 6:33,176,826...33,216,381
Ensembl chr 6:33,176,778...33,224,997
|
|
G |
Apoe |
apolipoprotein E |
multiple interactions |
ISO |
Vitamin E inhibits the reaction [APOE mutant form results in increased abundance of 8,12-iso-isoprostane F2alpha-VI] |
CTD |
PMID:16303615 |
|
NCBI chr 1:80,612,894...80,616,820
Ensembl chr 1:80,612,895...80,617,057
|
|
G |
Apol3 |
apolipoprotein L, 3 |
increases expression |
ISO |
Vitamin E results in increased expression of APOL3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:118,685,022...118,694,016
Ensembl chr 7:118,685,022...118,694,015
|
|
G |
Apom |
apolipoprotein M |
increases expression |
ISO |
Vitamin E results in increased expression of APOM mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:5,120,473...5,123,073
Ensembl chr20:5,120,474...5,123,073
|
|
G |
App |
amyloid beta precursor protein |
multiple interactions decreases expression |
ISO EXP |
alpha-Tocopherol inhibits the reaction [APP protein results in increased activity of MAPK14 protein]; alpha-Tocopherol inhibits the reaction [APP protein results in increased activity of MAPK8 protein] Vitamin E inhibits the reaction [APP protein modified form promotes the reaction [[IFNG protein co-treated with Lipopolysaccharides] results in increased expression of NOS2 protein]]; Vitamin E inhibits the reaction [APP protein results in increased activity of CASP3] Vitamin E inhibits the reaction [Aluminum results in increased cleavage of APP protein] Vitamin E results in decreased expression of APP mRNA |
CTD |
PMID:12039845 PMID:12117551 PMID:12684028 PMID:15223066 PMID:19244175 |
|
NCBI chr11:24,425,013...24,641,872
Ensembl chr11:24,425,005...24,641,858
|
|
G |
Appbp2 |
amyloid beta precursor protein binding protein 2 |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of APPBP2 mRNA Vitamin E results in increased expression of APPBP2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:72,503,347...72,545,141
Ensembl chr10:72,503,347...72,545,141
|
|
G |
Aqp1 |
aquaporin 1 |
increases expression |
ISO |
Vitamin E results in increased expression of AQP1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:85,551,503...85,563,683
Ensembl chr 4:85,551,502...85,569,360
|
|
G |
Aqp3 |
aquaporin 3 (Gill blood group) |
increases expression multiple interactions |
ISO |
Vitamin E results in increased expression of AQP3 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of AQP3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:57,423,735...57,429,252
Ensembl chr 5:57,423,734...57,429,245
|
|
G |
Aqp4 |
aquaporin 4 |
multiple interactions |
EXP ISO |
Vitamin E inhibits the reaction [manganese(III) acetate dihydrate results in increased expression of AQP4 protein] Vitamin E inhibits the reaction [[ferrous chloride results in increased abundance of Iron] which results in increased expression of AQP4 protein] |
CTD |
PMID:20648640 PMID:30914277 |
|
NCBI chr18:6,766,009...6,782,757
Ensembl chr18:6,765,945...6,782,996
|
|
G |
Araf |
A-Raf proto-oncogene, serine/threonine kinase |
multiple interactions |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of ARAF mRNA |
CTD |
PMID:19244175 |
|
NCBI chr X:1,369,534...1,391,603
Ensembl chr X:1,379,194...1,390,873
|
|
G |
Arf3 |
ADP-ribosylation factor 3 |
increases expression |
ISO |
Vitamin E results in increased expression of ARF3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:140,412,463...140,438,751
Ensembl chr 7:140,398,199...140,437,467
|
|
G |
Arf5 |
ADP-ribosylation factor 5 |
increases expression |
ISO |
Vitamin E results in increased expression of ARF5 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:55,715,744...55,718,670
Ensembl chr 4:55,715,744...55,718,670
|
|
G |
Arhgap10 |
Rho GTPase activating protein 10 |
increases expression |
ISO |
Vitamin E results in increased expression of ARHGAP10 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:34,138,978...34,406,593
Ensembl chr19:34,139,997...34,402,436
|
|
G |
Arhgap8 |
Rho GTPase activating protein 8 |
increases expression |
ISO |
Vitamin E results in increased expression of ARHGAP8 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:125,732,300...125,797,149
Ensembl chr 7:125,731,275...125,795,980
|
|
G |
Arhgdia |
Rho GDP dissociation inhibitor alpha |
increases expression |
ISO |
Vitamin E results in increased expression of ARHGDIA mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:109,754,012...109,757,506
Ensembl chr10:109,754,004...109,757,550
|
|
G |
Arih1 |
ariadne RBR E3 ubiquitin protein ligase 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of ARIH1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:64,166,359...64,268,555
Ensembl chr 8:64,166,360...64,268,555
|
|
G |
Arl4d |
ADP-ribosylation factor like GTPase 4D |
increases expression |
ISO |
Vitamin E results in increased expression of ARL4D mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:89,577,556...89,580,368
Ensembl chr10:89,578,212...89,580,368
|
|
G |
Arl6ip4 |
ADP-ribosylation factor like GTPase 6 interacting protein 4 |
increases expression |
ISO |
Vitamin E results in increased expression of ARL6IP4 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:37,904,376...37,906,521
Ensembl chr12:37,904,379...37,906,521
|
|
G |
Arpc1a |
actin related protein 2/3 complex, subunit 1A |
increases expression |
ISO |
Vitamin E results in increased expression of ARPC1A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:11,272,609...11,294,084
Ensembl chr12:11,272,609...11,294,058
|
|
G |
Arpc4 |
actin related protein 2/3 complex, subunit 4 |
increases expression |
ISO |
Vitamin E results in increased expression of ARPC4 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:145,330,457...145,340,985
Ensembl chr 4:145,330,457...145,340,984
|
|
G |
Asap3 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain 3 |
increases expression |
ISO |
Vitamin E results in increased expression of ASAP3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:154,551,901...154,596,125
Ensembl chr 5:154,552,195...154,594,785
|
|
G |
Asb1 |
ankyrin repeat and SOCS box-containing 1 |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of ASB1 mRNA Vitamin E results in increased expression of ASB1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:98,668,231...98,689,471
Ensembl chr 9:98,668,231...98,684,900
|
|
G |
Asxl1 |
ASXL transcriptional regulator 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of ASXL1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:148,832,231...148,902,356
Ensembl chr 3:148,837,814...148,900,452
|
|
G |
Atf2 |
activating transcription factor 2 |
multiple interactions increases phosphorylation |
ISO |
alpha-Tocopherol inhibits the reaction [Tamoxifen results in increased phosphorylation of ATF2 protein] Vitamin E results in increased phosphorylation of ATF2 protein |
CTD |
PMID:11522656 PMID:14645110 |
|
NCBI chr 3:60,721,137...60,795,951
Ensembl chr 3:60,721,135...60,795,951
|
|
G |
Atf3 |
activating transcription factor 3 |
decreases expression |
ISO |
Vitamin E results in decreased expression of ATF3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr13:109,817,892...109,849,632
Ensembl chr13:109,817,728...109,849,632
|
|
G |
Atf5 |
activating transcription factor 5 |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of ATF5 mRNA Vitamin E results in increased expression of ATF5 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:100,807,821...100,812,410
Ensembl chr 1:100,808,241...100,810,522
|
|
G |
Atg12 |
autophagy related 12 |
decreases expression |
ISO |
Vitamin E results in decreased expression of ATG12 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr18:40,721,799...40,732,143
Ensembl chr18:40,721,800...40,732,126
|
|
G |
Atmin |
ATM interactor |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of ATMIN mRNA Vitamin E results in decreased expression of ATMIN mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:49,482,482...49,499,682
|
|
G |
Atox1 |
antioxidant 1 copper chaperone |
increases expression |
ISO |
Vitamin E results in increased expression of ATOX1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:40,790,850...40,805,886
Ensembl chr10:40,790,845...40,805,941
|
|
G |
Atp5f1b |
ATP synthase F1 subunit beta |
increases expression |
ISO |
Vitamin E results in increased expression of ATP5F1B mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:2,504,708...2,511,748
Ensembl chr 7:2,504,695...2,511,749
|
|
G |
Atp5f1c |
ATP synthase F1 subunit gamma |
decreases expression |
ISO |
Vitamin E results in decreased expression of ATP5F1C mRNA |
CTD |
PMID:19244175 |
|
NCBI chr17:72,209,321...72,231,562
Ensembl chr17:72,209,373...72,394,271
|
|
G |
Atp5me |
ATP synthase membrane subunit e |
decreases expression |
ISO |
Vitamin E results in decreased expression of ATP5ME mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:2,325,308...2,326,436
Ensembl chr14:2,325,308...2,326,436
|
|
G |
Atp6ap2 |
ATPase H+ transporting accessory protein 2 |
decreases expression |
ISO |
Vitamin E results in decreased expression of ATP6AP2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr X:11,137,889...11,164,854
Ensembl chr X:11,136,939...11,164,915
|
|
G |
Atp6v0d1 |
ATPase H+ transporting V0 subunit D1 |
increases expression |
ISO |
Vitamin E results in increased expression of ATP6V0D1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:37,481,782...37,525,762
Ensembl chr19:37,481,782...37,525,762
|
|
G |
Atp6v1c1 |
ATPase H+ transporting V1 subunit C1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of ATP6V1C1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:77,678,853...77,716,658
Ensembl chr 7:77,678,968...77,716,408
|
|
G |
Atp8b1 |
ATPase phospholipid transporting 8B1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of ATP8B1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr18:60,013,388...60,152,920
Ensembl chr18:60,013,382...60,095,354
|
|
G |
Atrx |
ATRX, chromatin remodeler |
decreases expression multiple interactions |
ISO |
Vitamin E results in decreased expression of ATRX mRNA [Selenium co-treated with Vitamin E] results in decreased expression of ATRX mRNA |
CTD |
PMID:19244175 |
|
NCBI chr X:76,820,110...76,979,155
Ensembl chr X:76,692,970...76,708,878 Ensembl chr X:76,692,970...76,708,878
|
|
G |
Atxn3 |
ataxin 3 |
decreases expression |
ISO |
Vitamin E results in decreased expression of ATXN3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:125,817,420...125,853,461
Ensembl chr 6:125,819,640...125,853,461
|
|
G |
Atxn7 |
ataxin 7 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of ATXN7 mRNA Vitamin E results in decreased expression of ATXN7 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr15:12,421,432...12,569,649
Ensembl chr15:12,425,175...12,513,931
|
|
G |
Auts2 |
activator of transcription and developmental regulator AUTS2 |
decreases expression |
ISO |
Vitamin E results in decreased expression of AUTS2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:27,155,362...28,252,752
Ensembl chr12:28,212,333...28,251,816
|
|
G |
Axl |
Axl receptor tyrosine kinase |
decreases expression |
ISO |
Vitamin E results in decreased expression of AXL mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:82,550,892...82,580,761
Ensembl chr 1:82,549,420...82,580,761
|
|
G |
Baat |
bile acid CoA:amino acid N-acyltransferase |
increases expression |
EXP |
Vitamin E results in increased expression of BAAT mRNA |
CTD |
PMID:28923436 |
|
NCBI chr 5:64,768,397...64,777,368
Ensembl chr 5:64,768,401...64,777,368
|
|
G |
Babam1 |
BRISC and BRCA1 A complex member 1 |
increases expression |
ISO |
Vitamin E results in increased expression of BABAM1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr16:19,792,720...19,798,886
Ensembl chr16:19,792,838...19,798,894
|
|
G |
Babam2 |
BRISC and BRCA1 A complex member 2 |
increases expression |
ISO |
Vitamin E results in increased expression of BABAM2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:25,666,654...26,135,888
Ensembl chr 6:25,666,655...26,051,229
|
|
G |
Bace1 |
beta-secretase 1 |
multiple interactions |
ISO |
alpha-Tocopherol inhibits the reaction [Oxygen deficiency results in increased expression of BACE1 mRNA] |
CTD |
PMID:19196431 |
|
NCBI chr 8:50,140,092...50,162,388
Ensembl chr 8:50,139,997...50,162,361
|
|
G |
Bad |
BCL2-associated agonist of cell death |
increases expression |
EXP |
alpha-Tocopherol results in increased expression of BAD mRNA |
CTD |
PMID:26332274 |
|
NCBI chr 1:222,198,516...222,207,459
Ensembl chr 1:222,198,534...222,207,453
|
|
G |
Bag5 |
BAG cochaperone 5 |
decreases expression |
ISO |
Vitamin E results in decreased expression of BAG5 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:136,180,640...136,185,651
Ensembl chr 6:136,182,006...136,185,651
|
|
G |
Bag6 |
BAG cochaperone 6 |
increases expression |
ISO |
Vitamin E results in increased expression of BAG6 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:5,124,512...5,138,084
Ensembl chr20:5,125,349...5,138,084
|
|
G |
Banf1 |
BAF nuclear assembly factor 1 |
increases expression |
ISO |
Vitamin E results in increased expression of BANF1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:220,744,195...220,746,224
Ensembl chr 1:220,744,195...220,746,224
|
|
G |
Bap1 |
Brca1 associated protein 1 |
increases expression |
ISO |
Vitamin E results in increased expression of BAP1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr16:7,336,685...7,345,511
Ensembl chr16:7,336,685...7,345,511
|
|
G |
Bard1 |
BRCA1 associated RING domain 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of BARD1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:78,297,723...78,368,777
Ensembl chr 9:78,294,834...78,369,031
|
|
G |
Batf |
basic leucine zipper ATF-like transcription factor |
increases expression |
ISO |
Vitamin E results in increased expression of BATF mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:109,562,415...109,584,541
Ensembl chr 6:109,562,587...109,584,545
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression multiple interactions affects expression |
EXP ISO |
alpha-Tocopherol results in increased expression of BAX mRNA [Vitamin E co-treated with Folic Acid] affects the expression of BAX protein; alpha-Tocopherol inhibits the reaction [Mercuric Chloride results in increased expression of BAX protein]; Vitamin E inhibits the reaction [Diazinon results in increased expression of BAX mRNA]; Vitamin E inhibits the reaction [Diazinon results in increased expression of BAX protein]; Vitamin E inhibits the reaction [Nanotubes, Carbon results in increased expression of BAX protein] Vitamin E affects the expression of BAX protein Vitamin E results in increased expression of BAX protein alpha-Tocopherol affects the reaction [Lipopolysaccharides results in increased expression of BAX protein]; Vitamin E inhibits the reaction [cinnamic aldehyde results in increased expression of BAX protein]; Vitamin E inhibits the reaction [Curcumin results in decreased expression of BAX protein]; Vitamin E inhibits the reaction [phenethyl isothiocyanate results in increased expression of BAX protein] |
CTD |
PMID:11166918 PMID:11805214 PMID:15566391 PMID:16054126 PMID:16933212 PMID:22020378 PMID:23523949 PMID:26332274 PMID:27353299 PMID:30935902 PMID:32134168 |
|
NCBI chr 1:101,451,801...101,457,207
Ensembl chr 1:101,451,802...101,457,207
|
|
G |
Baz1a |
bromodomain adjacent to zinc finger domain, 1A |
decreases expression |
ISO |
Vitamin E results in decreased expression of BAZ1A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:75,793,223...75,873,854
Ensembl chr 6:75,793,960...75,874,235
|
|
G |
Baz1b |
bromodomain adjacent to zinc finger domain, 1B |
increases expression |
ISO |
Vitamin E results in increased expression of BAZ1B mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:24,478,882...24,536,851
Ensembl chr12:24,478,898...24,537,313
|
|
G |
Bbx |
BBX high mobility group box domain containing |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of BBX mRNA Vitamin E results in decreased expression of BBX mRNA |
CTD |
PMID:19244175 |
|
NCBI chr11:52,983,286...53,228,557
Ensembl chr11:53,081,025...53,228,716
|
|
G |
Bcap31 |
B-cell receptor-associated protein 31 |
increases expression |
ISO |
Vitamin E results in increased expression of BCAP31 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr X:157,094,365...157,126,397
Ensembl chr X:157,095,937...157,126,393
|
|
G |
Bche |
butyrylcholinesterase |
multiple interactions |
ISO |
[Resveratrol co-treated with Ascorbic Acid co-treated with Thioctic Acid co-treated with Vitamin E] results in increased activity of BCHE protein; alpha-Tocopherol inhibits the reaction [Endosulfan results in decreased activity of BCHE protein]; Hexachlorocyclohexane inhibits the reaction [[Resveratrol co-treated with Ascorbic Acid co-treated with Thioctic Acid co-treated with Vitamin E] results in increased activity of BCHE protein] |
CTD |
PMID:20663516 PMID:24299906 |
|
NCBI chr 2:171,104,476...171,196,186
Ensembl chr 2:171,100,140...171,196,395
|
|
G |
Bcl11a |
BAF chromatin remodeling complex subunit BCL11A |
decreases expression |
ISO |
Vitamin E results in decreased expression of BCL11A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:108,826,717...108,921,197
Ensembl chr14:108,826,831...108,921,669
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression increases expression multiple interactions |
ISO EXP |
alpha-Tocopherol analog results in decreased expression of BCL2 mRNA; alpha-Tocopherol analog results in decreased expression of BCL2 protein Vitamin E results in increased expression of BCL2 mRNA [Vitamin E co-treated with Folic Acid] affects the expression of BCL2 protein; alpha-Tocopherol inhibits the reaction [mancozeb results in decreased expression of BCL2 protein]; alpha-Tocopherol inhibits the reaction [Triiodothyronine, Reverse results in increased activity of BCL2 protein]; Vitamin E inhibits the reaction [Nanotubes, Carbon results in decreased expression of BCL2 protein] [Vitamin E co-treated with Curcumin] results in decreased expression of BCL2 protein; alpha-Tocopherol affects the reaction [Lipopolysaccharides results in decreased expression of BCL2 protein]; benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [alpha-Tocopherol analog results in decreased expression of BCL2 protein]; DDIT3 mRNA affects the reaction [alpha-Tocopherol analog results in decreased expression of BCL2 protein]; salubrinal inhibits the reaction [alpha-Tocopherol analog results in decreased expression of BCL2 protein]; TNFRSF10B mRNA affects the reaction [alpha-Tocopherol analog results in decreased expression of BCL2 protein]; Vitamin E inhibits the reaction [cinnamic aldehyde results in decreased expression of BCL2 protein] |
CTD |
PMID:11805214 PMID:15566391 PMID:16005924 PMID:16135673 PMID:16933212 PMID:20686688 PMID:22020378 PMID:27353299 PMID:30935902 |
|
NCBI chr13:26,605,426...26,769,374
Ensembl chr13:26,605,426...26,769,374
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
decreases expression increases expression multiple interactions |
EXP ISO |
alpha-Tocopherol results in decreased expression of BCL2L1 protein Vitamin E results in increased expression of BCL2L1 mRNA [Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of BCL2L1 mRNA |
CTD |
PMID:11444866 PMID:18942769 PMID:19244175 |
|
NCBI chr 3:148,259,594...148,314,191
Ensembl chr 3:148,259,596...148,313,810
|
|
G |
Bcl6 |
BCL6, transcription repressor |
decreases expression |
ISO |
Vitamin E results in decreased expression of BCL6 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr11:80,255,790...80,279,075
Ensembl chr11:80,255,790...80,279,075
|
|
G |
Bclaf1 |
BCL2-associated transcription factor 1 |
decreases expression multiple interactions |
ISO |
Vitamin E results in decreased expression of BCLAF1 mRNA [Selenium co-treated with Vitamin E] results in increased expression of BCLAF1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:15,799,753...15,828,838
Ensembl chr 1:15,782,477...15,860,624
|
|
G |
Bco1 |
beta-carotene oxygenase 1 |
multiple interactions |
EXP |
Vitamin E inhibits the reaction [Oxidants inhibits the reaction [BCO1 protein results in increased oxidation of beta Carotene]] |
CTD |
PMID:9526112 |
|
NCBI chr19:49,637,059...49,673,577
Ensembl chr19:49,637,016...49,673,808
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
multiple interactions |
ISO |
[alpha-Tocopherol co-treated with Nimodipine] inhibits the reaction [Dibutyl Phthalate results in decreased expression of BDNF protein] |
CTD |
PMID:30776390 |
|
NCBI chr 3:100,768,637...100,819,216
Ensembl chr 3:100,768,637...100,819,210
|
|
G |
Becn1 |
beclin 1 |
multiple interactions decreases expression |
EXP |
Vitamin E inhibits the reaction [Pilocarpine results in increased expression of BECN1 mRNA]; Vitamin E inhibits the reaction [Pilocarpine results in increased expression of BECN1 protein] Vitamin E results in decreased expression of BECN1 protein |
CTD |
PMID:19138675 |
|
NCBI chr10:89,209,944...89,225,297
Ensembl chr10:89,209,940...89,225,297
|
|
G |
Bicd1 |
BICD cargo adaptor 1 |
decreases expression multiple interactions |
ISO |
Vitamin E results in decreased expression of BICD1 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of BICD1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:184,018,845...184,167,628
Ensembl chr 4:184,019,087...184,165,540
|
|
G |
Bicd2 |
BICD cargo adaptor 2 |
decreases expression |
ISO |
Vitamin E results in decreased expression of BICD2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr17:15,673,649...15,718,035
Ensembl chr17:15,673,650...15,718,035
|
|
G |
Bin1 |
bridging integrator 1 |
increases expression |
ISO |
Vitamin E results in increased expression of BIN1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr18:25,163,575...25,222,139
Ensembl chr18:25,163,561...25,222,135
|
|
G |
Birc2 |
baculoviral IAP repeat-containing 2 |
multiple interactions |
EXP ISO |
[Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of BIRC2 mRNA Vitamin E inhibits the reaction [cinnamic aldehyde results in decreased expression of BIRC2 protein] |
CTD |
PMID:11444866 PMID:15566391 |
|
NCBI chr 8:6,014,014...6,036,668
Ensembl chr 8:6,013,207...6,034,142
|
|
G |
Birc3 |
baculoviral IAP repeat-containing 3 |
multiple interactions |
ISO |
Vitamin E inhibits the reaction [cinnamic aldehyde results in decreased expression of BIRC3 protein] |
CTD |
PMID:15566391 |
|
NCBI chr 8:6,048,590...6,076,828
Ensembl chr 8:6,048,969...6,076,598
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
multiple interactions |
ISO |
Vitamin E inhibits the reaction [Benzo(a)pyrene results in decreased expression of BIRC5 protein] |
CTD |
PMID:24664296 |
|
NCBI chr10:106,856,097...106,864,419
Ensembl chr10:106,856,097...106,864,413
|
|
G |
Bles03 |
basophilic leukemia expressed protein BLES03 |
increases expression |
ISO |
Vitamin E results in increased expression of C11ORF68 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:220,806,563...220,808,817
Ensembl chr 1:220,806,473...220,808,804
|
|
G |
Blvra |
biliverdin reductase A |
increases expression |
ISO |
Vitamin E results in increased expression of BLVRA mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:119,552,550...119,577,796
Ensembl chr 3:119,561,290...119,577,806
|
|
G |
Bmp2k |
BMP-2 inducible kinase |
decreases expression |
ISO |
Vitamin E results in decreased expression of BMP2K mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:14,126,086...14,226,823
Ensembl chr14:14,129,725...14,192,048
|
|
G |
Bmp4 |
bone morphogenetic protein 4 |
increases expression |
ISO |
Vitamin E results in increased expression of BMP4 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr15:20,776,060...20,791,013
Ensembl chr15:20,776,054...20,822,740
|
|
G |
Bptf |
bromodomain PHD finger transcription factor |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of BPTF mRNA Vitamin E results in decreased expression of BPTF mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:95,248,573...95,350,162
Ensembl chr10:95,250,294...95,349,789
|
|
G |
Brd2 |
bromodomain containing 2 |
multiple interactions decreases expression increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of BRD2 mRNA Vitamin E results in decreased expression of BRD2 mRNA Vitamin E results in increased expression of BRD2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:3,910,555...3,921,074
Ensembl chr20:3,910,555...3,917,426 Ensembl chr20:3,910,555...3,917,426
|
|
G |
Brf2 |
BRF2, RNA polymerase III transcription initiation factor subunit |
increases expression |
ISO |
Vitamin E results in increased expression of BRF2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr16:69,089,955...69,094,678
Ensembl chr16:69,089,955...69,094,680
|
|
G |
Brms1 |
BRMS1, transcriptional repressor and anoikis regulator |
increases expression |
ISO |
Vitamin E results in increased expression of BRMS1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:220,325,352...220,334,616
|
|
G |
Bscl2 |
BSCL2 lipid droplet biogenesis associated, seipin |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of BSCL2 mRNA Vitamin E results in increased expression of BSCL2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:225,035,956...225,046,137
Ensembl chr 1:225,037,737...225,046,040
|
|
G |
Bst2 |
bone marrow stromal cell antigen 2 |
increases expression |
ISO |
Vitamin E results in increased expression of BST2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr16:19,938,781...19,942,353
Ensembl chr16:19,938,784...19,942,353
|
|
G |
C1s |
complement C1s |
increases expression |
ISO |
Vitamin E results in increased expression of C1S mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:157,143,592...157,155,592
Ensembl chr 4:157,143,592...157,155,609
|
|
G |
Ca3 |
carbonic anhydrase 3 |
multiple interactions |
EXP |
[Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of CA3 mRNA |
CTD |
PMID:11444866 |
|
NCBI chr 2:88,126,519...88,136,063
Ensembl chr 2:88,126,667...88,135,410
|
|
G |
Caap1 |
caspase activity and apoptosis inhibitor 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of CAAP1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:113,479,416...113,532,961
Ensembl chr 5:113,480,547...113,532,878
|
|
G |
Cab39 |
calcium binding protein 39 |
increases expression |
ISO |
Vitamin E results in increased expression of MO25 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:92,834,327...92,895,778
Ensembl chr 9:92,834,357...92,895,778
|
|
G |
Cald1 |
caldesmon 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of CALD1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:62,103,948...62,291,375
Ensembl chr 4:62,220,736...62,291,489
|
|
G |
Calm3 |
calmodulin 3 |
increases expression |
ISO |
Vitamin E results in increased expression of CALM3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:78,844,520...78,851,628
Ensembl chr 1:78,843,080...78,851,719
|
|
G |
Calr |
calreticulin |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of CALR mRNA Vitamin E results in decreased expression of CALR mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:25,956,771...25,961,666
Ensembl chr19:25,956,771...25,961,666
|
|
G |
Calu |
calumenin |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of CALU mRNA Vitamin E results in increased expression of CALU mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:56,625,611...56,653,112
Ensembl chr 4:56,625,561...56,653,111
|
|
G |
Camk2b |
calcium/calmodulin-dependent protein kinase II beta |
increases expression |
ISO |
Vitamin E results in increased expression of CAMK2B mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:86,208,876...86,297,727
Ensembl chr14:86,208,901...86,297,652
|
|
G |
Camk2g |
calcium/calmodulin-dependent protein kinase II gamma |
decreases expression |
ISO |
Vitamin E results in decreased expression of CAMK2G mRNA |
CTD |
PMID:19244175 |
|
NCBI chr15:3,936,721...3,995,740
Ensembl chr15:3,936,786...3,995,915
|
|
G |
Canx |
calnexin |
affects localization increases expression |
EXP |
alpha-Tocopherol affects the localization of CANX protein alpha-Tocopherol results in increased expression of CANX mRNA; alpha-Tocopherol results in increased expression of CANX protein |
CTD |
PMID:16908007 |
|
NCBI chr10:35,800,942...35,833,939
Ensembl chr10:35,800,942...35,833,861
|
|
G |
Cap1 |
cyclase associated actin cytoskeleton regulatory protein 1 |
increases expression |
ISO |
Vitamin E results in increased expression of CAP1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:140,559,195...140,585,494
Ensembl chr 5:140,559,206...140,585,408
|
|
G |
Capg |
capping actin protein, gelsolin like |
increases expression |
ISO |
Vitamin E results in increased expression of CAPG mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:100,395,693...100,419,447
Ensembl chr 4:100,407,658...100,419,446
|
|
G |
Capn7 |
calpain 7 |
decreases expression |
ISO |
Vitamin E results in decreased expression of CAPN7 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr16:7,435,541...7,472,483
Ensembl chr16:7,435,634...7,471,807
|
|
G |
Capns1 |
calpain, small subunit 1 |
increases expression |
ISO |
Vitamin E results in increased expression of CAPNS1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:91,058,528...91,064,880
|
|
G |
Caprin2 |
caprin family member 2 |
decreases expression |
ISO |
Vitamin E results in decreased expression of CAPRIN2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:183,304,993...183,374,195
Ensembl chr 4:183,305,813...183,374,195
|
|
G |
Capzb |
capping actin protein of muscle Z-line subunit beta |
increases expression |
ISO |
Vitamin E results in increased expression of CAPZB mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:157,642,742...157,742,487
Ensembl chr 5:157,642,751...157,742,478
|
|
G |
Casc3 |
CASC3 exon junction complex subunit |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of MLN51 mRNA Vitamin E results in increased expression of MLN51 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:86,724,534...86,744,485
Ensembl chr10:86,724,427...86,745,927
|
|
G |
Casp3 |
caspase 3 |
decreases activity multiple interactions |
ISO EXP |
alpha-Tocopherol results in decreased activity of CASP3 protein [alpha-Tocopherol co-treated with Nimodipine] inhibits the reaction [Dibutyl Phthalate results in increased expression of CASP3 protein]; alpha-Tocopherol inhibits the reaction [7-ketocholesterol results in increased cleavage of CASP3 protein]; alpha-Tocopherol inhibits the reaction [Dibutyl Phthalate results in increased expression of CASP3 protein]; Vitamin E inhibits the reaction [titanium dioxide results in increased activity of CASP3 protein] [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of CASP3 protein]; [Vitamin E co-treated with Ascorbic Acid] inhibits the reaction [Dichlorvos results in increased activity of CASP3 protein]; [Vitamin E co-treated with Selenium] inhibits the reaction [Malathion results in increased expression of CASP3 mRNA]; alpha-Tocopherol inhibits the reaction [Diclofenac results in increased activity of CASP3 protein]; alpha-Tocopherol inhibits the reaction [Mercuric Chloride results in increased expression of CASP3 protein]; Vitamin E inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased cleavage of CASP3 protein]; Vitamin E inhibits the reaction [APP protein results in increased activity of CASP3]; Vitamin E inhibits the reaction [Diazinon results in increased activity of CASP3 protein]; Vitamin E inhibits the reaction [Diazinon results in increased cleavage of CASP3 protein]; Vitamin E inhibits the reaction [Diazinon results in increased expression of CASP3 protein modified form]; Vitamin E inhibits the reaction [Nanotubes, Carbon results in increased activity of CASP3 protein] [alpha-Tocopherol co-treated with beta-ionone] results in increased activity of CASP3 protein; [alpha-Tocopherol co-treated with Tretinoin] results in increased activity of CASP3 protein; alpha-Tocopherol inhibits the reaction [7-ketocholesterol results in increased activity of CASP3 protein]; alpha-Tocopherol inhibits the reaction [Acetaldehyde results in increased activity of CASP3 protein]; alpha-Tocopherol inhibits the reaction [cholest-5-en-3 beta,7 alpha-diol results in increased activity of CASP3 protein]; alpha-Tocopherol inhibits the reaction [Galactosamine results in increased cleavage of and results in increased activity of CASP3 protein]; alpha-Tocopherol inhibits the reaction [S-(1,2-dichlorovinyl)cysteine results in increased activity of CASP3 protein]; alpha-Tocopherol inhibits the reaction [Vitamin A results in increased activity of CASP3 protein]; alpha-Tocopherol promotes the reaction [Amiodarone results in increased activity of CASP3 protein]; alpha-Tocopherol promotes the reaction [beta Carotene metabolite results in decreased activity of CASP3 protein]; alpha-Tocopherol promotes the reaction [TNF protein promotes the reaction [Amiodarone results in increased activity of CASP3 protein]]; alpha-Tocopherol results in increased cleavage of and results in increased activity of CASP3 protein; Vitamin E inhibits the reaction [cinnamic aldehyde results in increased activity of CASP3 protein]; Vitamin E inhibits the reaction [Curcumin results in decreased expression of CASP3 protein]; Vitamin E inhibits the reaction [osimertinib results in increased expression of CASP3 protein modified form]; Vitamin E inhibits the reaction [phenethyl isothiocyanate results in increased activity of CASP3 protein] |
CTD |
PMID:12117551 PMID:12450566 PMID:14599462 PMID:14722101 PMID:15095415 PMID:15566391 PMID:16054126 PMID:16973328 PMID:17618090 PMID:17874176 PMID:17936189 PMID:21628957 PMID:21869839 PMID:21873648 PMID:22020378 PMID:22389237 PMID:23042730 PMID:23523949 PMID:27353299 PMID:28237877 PMID:29065513 PMID:29129777 PMID:30626778 PMID:30776390 PMID:30935902 PMID:31712109 PMID:32134168 |
|
NCBI chr16:48,845,011...48,863,249
Ensembl chr16:48,845,012...48,863,204
|
|
G |
Casp7 |
caspase 7 |
multiple interactions |
ISO |
alpha-Tocopherol inhibits the reaction [S-(1,2-dichlorovinyl)cysteine results in increased activity of CASP7 protein]; alpha-Tocopherol promotes the reaction [Amiodarone results in increased activity of CASP7 protein]; alpha-Tocopherol promotes the reaction [TNF protein promotes the reaction [Amiodarone results in increased activity of CASP7 protein]] |
CTD |
PMID:23042730 PMID:29129777 |
|
NCBI chr 1:277,190,557...277,242,779
Ensembl chr 1:277,190,964...277,242,774
|
|
G |
Casp8 |
caspase 8 |
increases cleavage |
ISO |
alpha-Tocopherol analog results in increased cleavage of CASP8 protein |
CTD |
PMID:20686688 |
|
NCBI chr 9:65,614,142...65,662,624
Ensembl chr 9:65,614,142...65,662,106
|
|
G |
Casp9 |
caspase 9 |
increases cleavage multiple interactions increases expression |
ISO EXP |
alpha-Tocopherol analog results in increased cleavage of CASP9 protein alpha-Tocopherol inhibits the reaction [Dibutyl Phthalate results in increased expression of CASP9 protein] [Vitamin E co-treated with Ascorbic Acid] inhibits the reaction [Dichlorvos results in increased activity of CASP9 protein]; [Vitamin E co-treated with Selenium] inhibits the reaction [Malathion results in increased expression of CASP9 mRNA]; Vitamin E inhibits the reaction [Diazinon results in increased cleavage of CASP9 protein] Vitamin E results in increased expression of CASP9 mRNA alpha-Tocopherol results in increased cleavage of and results in increased activity of CASP9 protein |
CTD |
PMID:16973328 PMID:19244175 PMID:20686688 PMID:21628957 PMID:21869839 PMID:27353299 PMID:31712109 |
|
NCBI chr 5:160,356,211...160,373,774
Ensembl chr 5:160,355,833...160,373,778
|
|
G |
Cat |
catalase |
increases expression multiple interactions decreases activity affects expression increases activity |
ISO EXP |
alpha-Tocopherol results in increased expression of CAT mRNA; alpha-Tocopherol results in increased expression of CAT protein alpha-Tocopherol results in increased expression of CAT protein; Vitamin E results in increased expression of CAT protein [Ascorbic Acid co-treated with beta Carotene co-treated with alpha-Tocopherol co-treated with Sodium Selenite] inhibits the reaction [Galactosamine results in increased activity of CAT protein]; [Curcumin co-treated with Vitamin E] inhibits the reaction [Thyroxine results in decreased expression of CAT mRNA]; [Quercetin co-treated with alpha-Tocopherol] inhibits the reaction [Isoproterenol results in decreased activity of CAT protein]; [Selenium co-treated with Vitamin E] inhibits the reaction [Malathion results in decreased activity of CAT protein]; [Sodium Selenite co-treated with alpha-Tocopherol] inhibits the reaction [bisphenol A results in decreased activity of CAT protein]; [Vitamin E co-treated with coenzyme Q10] inhibits the reaction [Cadmium Chloride results in decreased activity of CAT protein]; [Vitamin E co-treated with coenzyme Q10] results in increased activity of CAT protein; [Vitamin E co-treated with Curcumin] inhibits the reaction [Thyroxine results in decreased activity of CAT protein]; [Vitamin E co-treated with Quercetin] inhibits the reaction [Cyclosporine results in decreased activity of CAT protein]; [Vitamin E co-treated with Sodium Selenite] inhibits the reaction [Mercuric Chloride results in decreased activity of CAT protein]; [Vitamin E inhibits the reaction [Nanotubes, Carbon results in decreased activity of CAT protein]] which affects the abundance of Reactive Oxygen Species; [Zinc co-treated with Vitamin E co-treated with Ascorbic Acid co-treated with sodium arsenite] results in increased activity of CAT protein; alpha-Tocopherol affects the reaction [Copper Sulfate results in decreased activity of CAT protein]; alpha-Tocopherol affects the reaction [flubendiamide results in decreased activity of CAT protein]; alpha-Tocopherol inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased activity of CAT protein]; alpha-Tocopherol inhibits the reaction [cholestane-3,5,6-triol results in decreased activity of CAT protein]; alpha-Tocopherol inhibits the reaction [Malathion results in increased activity of CAT protein]; alpha-Tocopherol inhibits the reaction [Streptozocin results in decreased expression of CAT protein]; Ginkgo biloba extract promotes the reaction [Vitamin E inhibits the reaction [endotoxin, Escherichia coli results in decreased activity of CAT protein]]; Vitamin E inhibits the reaction [Cadmium Chloride results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Cadmium results in increased activity of CAT protein]; Vitamin E inhibits the reaction [Carbofuran results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [chromium hexavalent ion results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Cyclosporine results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Diethylnitrosamine results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Dimethoate results in increased activity of CAT protein]; Vitamin E inhibits the reaction [endotoxin, Escherichia coli results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Food Additives affects the activity of CAT protein]; Vitamin E inhibits the reaction [Formaldehyde results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Malathion results in increased activity of CAT protein]; Vitamin E inhibits the reaction [Mercuric Chloride results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Methoxychlor results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Nanotubes, Carbon results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Petroleum results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Potassium Dichromate results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Tetrachlorodibenzodioxin results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Thyroxine results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Thyroxine results in decreased expression of CAT protein]; Vitamin E promotes the reaction [Ginkgo biloba extract inhibits the reaction [endotoxin, Escherichia coli results in decreased activity of CAT protein]] Vitamin E results in decreased activity of CAT protein [Vitamin E co-treated with coenzyme Q10] inhibits the reaction [sodium arsenite results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Cadmium Chloride results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Ethanol results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [fipronil results in decreased activity of CAT protein] Vitamin E affects the expression of CAT protein [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Air Pollutants, Occupational affects the expression of CAT protein]; [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Malathion results in increased activity of CAT protein]; [Ascorbic Acid co-treated with Vitamin E] results in increased expression of CAT mRNA; Vitamin E inhibits the reaction [Aluminum results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Dimethoate results in increased activity of CAT protein]; Vitamin E inhibits the reaction [Malathion results in increased activity of CAT protein]; Vitamin E inhibits the reaction [Oleic Acid results in decreased activity of CAT protein] alpha-Tocopherol results in increased activity of CAT protein |
CTD |
PMID:9306888 PMID:11597945 PMID:11834209 PMID:11955947 PMID:12355564 PMID:14535831 PMID:15669049 PMID:15820619 PMID:16144695 PMID:16298753 PMID:16758767 PMID:16937016 PMID:16979807 PMID:17262218 PMID:17383094 PMID:17709913 PMID:17927767 PMID:18547560 PMID:18655177 PMID:19083475 PMID:19464315 PMID:19914224 PMID:19941068 PMID:19958828 PMID:20077558 PMID:20079796 PMID:20194575 PMID:20535553 PMID:21086752 PMID:21322096 PMID:21628957 PMID:21736874 PMID:21787585 PMID:22020378 PMID:22207723 PMID:22732938 PMID:23348005 PMID:23369933 PMID:23619517 PMID:24865641 PMID:25046308 PMID:25721553 PMID:27823922 PMID:29948670 PMID:30057697 PMID:31022331 |
|
NCBI chr 3:93,379,872...93,412,058
Ensembl chr 3:93,379,874...93,412,058
|
|
G |
Cav1 |
caveolin 1 |
multiple interactions |
ISO |
alpha-Tocopherol inhibits the reaction [Lysophosphatidylcholines results in increased expression of CAV1 mRNA] Vitamin E inhibits the reaction [Hydrogen Peroxide results in increased expression of CAV1 protein] |
CTD |
PMID:12134086 PMID:27257344 |
|
NCBI chr 4:44,597,123...44,630,206
Ensembl chr 4:44,597,123...44,630,200
|
|
G |
Cavin1 |
caveolae associated protein 1 |
multiple interactions increases expression |
ISO |
Vitamin E inhibits the reaction [Hydrogen Peroxide results in increased expression of CAVIN1 protein] Vitamin E results in increased expression of CAVIN1 mRNA |
CTD |
PMID:19244175 PMID:21705337 |
|
NCBI chr10:88,862,513...88,874,495
Ensembl chr10:88,860,733...88,874,528
|
|
G |
Cavin3 |
caveolae associated protein 3 |
increases expression |
ISO |
Vitamin E results in increased expression of CAVIN3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:170,317,099...170,318,688
Ensembl chr 1:170,317,113...170,318,935
|
|
G |
Cblb |
Cbl proto-oncogene B |
decreases expression |
ISO |
Vitamin E results in decreased expression of CBLB mRNA |
CTD |
PMID:19244175 |
|
NCBI chr11:51,037,383...51,202,761
Ensembl chr11:51,037,393...51,202,820
|
|
G |
Cbx5 |
chromobox 5 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of CBX5 mRNA Vitamin E results in decreased expression of CBX5 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:144,819,673...144,865,014
Ensembl chr 7:144,819,420...144,837,583
|
|
G |
Cbx6 |
chromobox 6 |
increases expression |
ISO |
Vitamin E results in increased expression of CBX6 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:121,047,996...121,058,109
Ensembl chr 7:121,050,302...121,058,029
|
|
G |
Cbx7 |
chromobox 7 |
increases expression |
ISO |
Vitamin E results in increased expression of CBX7 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:121,136,067...121,153,503
Ensembl chr 7:121,136,058...121,153,383
|
|
G |
Cby1 |
chibby family member 1, beta catenin antagonist |
increases expression |
ISO |
Vitamin E results in increased expression of CBY1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:120,891,930...120,898,318
Ensembl chr 7:120,891,940...120,897,687
|
|
G |
Ccdc85b |
coiled-coil domain containing 85B |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of DIPA mRNA Vitamin E results in increased expression of DIPA mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:220,835,647...220,837,220
|
|
G |
Cchcr1 |
coiled-coil alpha-helical rod protein 1 |
increases expression |
ISO |
Vitamin E results in increased expression of CCHCR1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:3,730,968...3,745,721
Ensembl chr20:3,730,955...3,740,009
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
multiple interactions increases expression |
ISO EXP |
alpha-Tocopherol inhibits the reaction [Vitamin E deficiency results in increased expression of CCL2 protein]; Quercetin inhibits the reaction [Vitamin E deficiency results in increased expression of CCL2 protein] alpha-Tocopherol inhibits the reaction [Acrylonitrile results in increased expression of CCL2 mRNA]; alpha-Tocopherol inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] |
CTD |
PMID:19735175 PMID:24333275 PMID:26332274 |
|
NCBI chr10:69,412,065...69,413,863
Ensembl chr10:69,412,017...69,413,870
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
multiple interactions |
ISO |
[Vitamin E co-treated with Quercetin co-treated with kaempferol co-treated with 3,4-dihydroxyphenylethanol] results in decreased expression of CCL5 mRNA |
CTD |
PMID:16797527 |
|
NCBI chr10:70,739,764...70,744,303
Ensembl chr10:70,739,800...70,744,315
|
|
G |
Ccnd1 |
cyclin D1 |
increases expression multiple interactions affects expression |
ISO EXP |
Vitamin E results in increased expression of CCND1 mRNA Vitamin E inhibits the reaction [Curcumin results in decreased expression of CCND1 protein] Vitamin E affects the expression of CCND1 mRNA; Vitamin E affects the expression of CCND1 protein [Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of CCND1 mRNA; alpha-Tocopherol inhibits the reaction [Acrylonitrile results in increased expression of CCND1 mRNA] |
CTD |
PMID:11444866 PMID:16298738 PMID:19244175 PMID:26332274 PMID:30935902 |
|
NCBI chr 1:218,090,750...218,100,447
Ensembl chr 1:218,090,750...218,100,325
|
|
G |
Ccnd2 |
cyclin D2 |
multiple interactions increases expression |
EXP ISO |
alpha-Tocopherol inhibits the reaction [Acrylonitrile results in increased expression of CCND2 mRNA] Vitamin E results in increased expression of CCND2 mRNA |
CTD |
PMID:19244175 PMID:26332274 |
|
NCBI chr 4:159,674,885...159,697,207
Ensembl chr 4:159,674,885...159,697,207
|
|
G |
Ccnd3 |
cyclin D3 |
affects expression |
EXP |
Vitamin E affects the expression of CCND3 mRNA |
CTD |
PMID:15370891 |
|
NCBI chr 9:15,404,816...15,410,905
Ensembl chr 9:15,404,822...15,410,943
|
|
G |
Ccne1 |
cyclin E1 |
affects expression |
EXP |
Vitamin E affects the expression of CCNE1 mRNA |
CTD |
PMID:16298738 |
|
NCBI chr 1:94,485,830...94,495,112
Ensembl chr 1:94,485,832...94,494,980
|
|
G |
Ccnl1 |
cyclin L1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of CCNL1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 2:157,747,295...157,759,838
Ensembl chr 2:157,747,542...157,759,838
|
|
G |
Ccpg1 |
cell cycle progression 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of CPR8 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:79,660,634...79,692,044
Ensembl chr 8:79,660,657...79,692,039
|
|
G |
Ccs |
copper chaperone for superoxide dismutase |
increases expression |
ISO |
Vitamin E results in increased expression of CCS mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:220,075,251...220,096,319
Ensembl chr 1:220,075,247...220,096,404
|
|
G |
Cd2bp2 |
Cd2 (cytoplasmic tail) binding protein 2 |
increases expression |
ISO |
Vitamin E results in increased expression of CD2BP2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:198,635,445...198,641,195
Ensembl chr 1:198,635,447...198,638,944
|
|
G |
Cd36 |
CD36 molecule |
affects expression multiple interactions |
EXP |
alpha-Tocopherol affects the expression of CD36 mRNA alpha-Tocopherol inhibits the reaction [[troglitazone co-treated with Ethanol] results in increased expression of CD36 protein] |
CTD |
PMID:16407258 |
|
NCBI chr 4:14,150,309...14,191,498
Ensembl chr 4:14,001,761...14,249,749
|
|
G |
Cd44 |
CD44 molecule (Indian blood group) |
decreases expression |
ISO |
Vitamin E results in decreased expression of CD44 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:92,695,083...92,783,820
Ensembl chr 3:92,696,313...92,783,658
|
|
G |
Cd63 |
Cd63 molecule |
increases expression |
ISO |
Vitamin E results in increased expression of CD63 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:3,320,250...3,335,583
Ensembl chr 7:3,320,103...3,335,582
|
|
G |
Cd86 |
CD86 molecule |
multiple interactions |
ISO |
Vitamin E inhibits the reaction [Dinitrochlorobenzene results in increased expression of CD86 protein]; Vitamin E inhibits the reaction [Ethylmercuric Chloride results in increased expression of CD86 protein]; Vitamin E inhibits the reaction [Thimerosal results in increased expression of CD86 protein] |
CTD |
PMID:20457211 |
|
NCBI chr11:67,060,305...67,117,990
Ensembl chr11:67,082,193...67,118,795
|
|
G |
Cd99 |
CD99 molecule (Xg blood group) |
increases expression |
ISO |
Vitamin E results in increased expression of CD99 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:56,192,426...56,196,961
Ensembl chr20:56,192,390...56,197,025
|
|
G |
Cdc14b |
cell division cycle 14B |
decreases expression |
ISO |
Vitamin E results in decreased expression of CDC14B mRNA |
CTD |
PMID:19244175 |
|
NCBI chr17:1,709,703...1,797,732
Ensembl chr17:1,703,943...1,797,750
|
|
G |
Cdc16 |
cell division cycle 16 |
decreases expression |
ISO |
Vitamin E results in decreased expression of CDC16 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr16:81,493,355...81,516,493
Ensembl chr16:81,493,355...81,516,493
|
|
G |
Cdc25b |
cell division cycle 25B |
increases expression |
ISO |
Vitamin E results in increased expression of CDC25B mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:123,731,539...123,741,696
Ensembl chr 3:123,731,539...123,741,339
|
|
G |
Cdc27 |
cell division cycle 27 |
decreases expression |
ISO |
Vitamin E results in decreased expression of CDC27 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:92,551,754...92,602,214
Ensembl chr10:92,554,081...92,602,082
|
|
G |
Cdc42bpa |
CDC42 binding protein kinase alpha |
multiple interactions increases expression decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of CDC42BPA mRNA Vitamin E results in increased expression of CDC42BPA mRNA Vitamin E results in decreased expression of CDC42BPA mRNA |
CTD |
PMID:19244175 |
|
NCBI chr13:98,231,326...98,447,762
Ensembl chr13:98,231,326...98,447,762
|
|
G |
Cdh2 |
cadherin 2 |
multiple interactions |
EXP |
[Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [mono-(2-ethylhexyl)phthalate affects the localization of CDH2 protein] |
CTD |
PMID:29940330 |
|
NCBI chr18:8,146,971...8,366,037
Ensembl chr18:8,146,971...8,360,684
|
|
G |
Cdh3 |
cadherin 3 |
increases expression |
ISO |
Vitamin E results in increased expression of CDH3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:38,668,957...38,719,801
Ensembl chr19:38,669,230...38,719,677
|
|
G |
Cdk10 |
cyclin-dependent kinase 10 |
multiple interactions |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of CDK10 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:56,024,903...56,032,610
Ensembl chr19:56,024,903...56,032,605
|
|
G |
Cdk13 |
cyclin-dependent kinase 13 |
decreases expression |
ISO |
Vitamin E results in decreased expression of CDK13 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr17:49,833,194...49,922,932
Ensembl chr17:49,833,400...49,921,550
|
|
G |
Cdk4 |
cyclin-dependent kinase 4 |
increases expression |
ISO |
Vitamin E results in increased expression of CDK4 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:70,345,971...70,352,689
Ensembl chr 7:70,349,863...70,352,418
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
multiple interactions affects expression decreases expression |
EXP ISO |
alpha-Tocopherol inhibits the reaction [Acrylonitrile results in increased expression of CDKN1A mRNA] Vitamin E inhibits the reaction [Curcumin results in decreased expression of CDKN1A protein] Vitamin E affects the expression of CDKN1A mRNA alpha-Tocopherol results in decreased expression of CDKN1A mRNA |
CTD |
PMID:16298738 PMID:26332274 PMID:30935902 |
|
NCBI chr20:6,348,422...6,358,864
Ensembl chr20:6,351,458...6,358,864
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
increases expression |
ISO |
Vitamin E results in increased expression of CDKN1B protein |
CTD |
PMID:12352461 |
|
NCBI chr 4:168,689,043...168,694,159
Ensembl chr 4:168,689,163...168,693,964
|
|
G |
Cds1 |
CDP-diacylglycerol synthase 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of CDS1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:9,396,511...9,456,964
Ensembl chr14:9,396,512...9,456,990
|
|
G |
Cebpa |
CCAAT/enhancer binding protein alpha |
multiple interactions |
ISO |
Vitamin E inhibits the reaction [Ethanol results in decreased activity of CEBPA protein]; Vitamin E inhibits the reaction [Ethanol results in decreased expression of CEBPA protein] |
CTD |
PMID:16737972 |
|
NCBI chr 1:91,363,492...91,366,164
Ensembl chr 1:91,363,492...91,366,164
|
|
G |
Cebpb |
CCAAT/enhancer binding protein beta |
increases response to substance |
ISO |
CEBPB results in increased susceptibility to Vitamin E |
CTD |
PMID:9359698 |
|
NCBI chr 3:164,424,502...164,425,933
Ensembl chr 3:164,424,515...164,425,910
|
|
G |
Cep164 |
centrosomal protein 164 |
increases expression |
ISO |
Vitamin E results in increased expression of CEP164 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:50,069,282...50,132,477
Ensembl chr 8:50,070,579...50,126,413
|
|
G |
Cep170 |
centrosomal protein 170 |
decreases expression |
ISO |
Vitamin E results in decreased expression of CEP170 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr13:94,807,090...94,887,448
Ensembl chr13:94,807,756...94,859,436
|
|
G |
Cep290 |
centrosomal protein 290 |
decreases expression |
ISO |
Vitamin E results in decreased expression of CEP290 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:40,217,269...40,306,327
Ensembl chr 7:40,217,269...40,306,327
|
|
G |
Cep350 |
centrosomal protein 350 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of CEP350 mRNA Vitamin E results in decreased expression of CEP350 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr13:73,499,715...73,637,707
Ensembl chr13:73,499,229...73,638,073
|
|
G |
Cep57 |
centrosomal protein 57 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of CEP57 mRNA Vitamin E results in decreased expression of CEP57 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:12,335,430...12,355,425
Ensembl chr 8:12,335,432...12,355,091
|
|
G |
Cep97 |
centrosomal protein 97 |
decreases expression |
ISO |
Vitamin E results in decreased expression of CEP97 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr11:47,146,409...47,174,460
Ensembl chr11:47,146,308...47,174,713
|
|
G |
Cerk |
ceramide kinase |
increases expression |
ISO |
Vitamin E results in increased expression of CERK mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:127,015,162...127,058,056
Ensembl chr 7:127,015,162...127,058,056
|
|
G |
Cert1 |
ceramide transporter 1 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of CERT1 mRNA Vitamin E results in decreased expression of CERT1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 2:27,365,145...27,469,797
Ensembl chr 2:27,365,148...27,469,779
|
|
G |
Ces1d |
carboxylesterase 1D |
increases expression |
ISO |
Vitamin E results in increased expression of CES1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:15,195,514...15,239,827
Ensembl chr19:15,033,108...15,239,821
|
|
G |
Cflar |
CASP8 and FADD-like apoptosis regulator |
increases expression |
ISO |
Vitamin E results in increased expression of CFLAR mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:65,534,608...65,586,395
Ensembl chr 9:65,534,704...65,587,251
|
|
G |
Cftr |
CF transmembrane conductance regulator |
multiple interactions |
ISO |
alpha-Tocopherol inhibits the reaction [Cadmium results in decreased expression of CFTR protein] |
CTD |
PMID:20363832 |
|
NCBI chr 4:42,693,263...42,860,679
Ensembl chr 4:42,692,836...42,860,676
|
|
G |
Chat |
choline O-acetyltransferase |
multiple interactions |
EXP |
[Ascorbic Acid co-treated with alpha-Tocopherol co-treated with Acetylcysteine] results in increased expression of CHAT protein; Tobacco Smoke Pollution inhibits the reaction [[Ascorbic Acid co-treated with alpha-Tocopherol co-treated with Acetylcysteine] results in increased expression of CHAT protein] |
CTD |
PMID:25891525 |
|
NCBI chr16:8,576,858...8,686,131
Ensembl chr16:8,577,840...8,686,131
|
|
G |
Chd1 |
chromodomain helicase DNA binding protein 1 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of CHD1 mRNA Vitamin E results in decreased expression of CHD1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:57,692,828...57,756,762
Ensembl chr 1:57,692,836...57,755,485
|
|
G |
Chordc1 |
cysteine and histidine rich domain containing 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of CHORDC1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:17,421,552...17,445,513
Ensembl chr 8:17,421,557...17,446,165
|
|
G |
Chpf |
chondroitin polymerizing factor |
multiple interactions |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of CHPF mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:82,669,199...82,673,898
Ensembl chr 9:82,669,204...82,673,898
|
|
G |
Chst3 |
carbohydrate sulfotransferase 3 |
increases expression |
ISO |
Vitamin E results in increased expression of CHST3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:29,731,828...29,768,656
Ensembl chr20:29,731,816...29,738,506
|
|
G |
Chst5 |
carbohydrate sulfotransferase 5 |
increases expression |
ISO |
Vitamin E results in increased expression of CHST6 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:44,115,065...44,136,092
Ensembl chr19:44,115,120...44,135,387
|
|
G |
Ciao2b |
cytosolic iron-sulfur assembly component 2B |
increases expression |
ISO |
Vitamin E results in increased expression of CIAO2B mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:551,708...553,573
Ensembl chr19:551,708...553,573
|
|
G |
Cib2 |
calcium and integrin binding family member 2 |
increases expression |
ISO |
Vitamin E results in increased expression of CIB2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:59,123,078...59,139,946
Ensembl chr 8:59,123,079...59,139,946
|
|
G |
Cirbp |
cold inducible RNA binding protein |
increases expression |
ISO |
Vitamin E results in increased expression of CIRBP mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:12,400,066...12,405,054
Ensembl chr 7:12,401,207...12,405,022
|
|
G |
Ckap2 |
cytoskeleton associated protein 2 |
decreases expression |
ISO |
Vitamin E results in decreased expression of CKAP2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr16:74,752,655...74,779,184
Ensembl chr16:74,752,655...74,779,184
|
|
G |
Ckb |
creatine kinase B |
increases expression |
ISO |
Vitamin E results in increased expression of CKB mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:136,142,956...136,145,838
Ensembl chr 6:136,142,956...136,145,837
|
|
G |
Ckm |
creatine kinase, M-type |
multiple interactions |
EXP |
Vitamin E inhibits the reaction [Diazinon results in increased activity of CKM protein] |
CTD |
PMID:23523949 |
|
NCBI chr 1:80,321,507...80,331,841
Ensembl chr 1:80,321,585...80,331,841
|
|
G |
Clcc1 |
chloride channel CLIC-like 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of CLCC1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 2:211,450,426...211,479,885
Ensembl chr 2:211,450,484...211,479,884
|
|
G |
Clcn3 |
chloride voltage-gated channel 3 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of CLCN3 mRNA; alpha-Tocopherol inhibits the reaction [Ozone results in increased expression of CLCN3 mRNA] Vitamin E results in decreased expression of CLCN3 mRNA |
CTD |
PMID:19244175 PMID:27886375 |
|
NCBI chr16:32,448,821...32,520,649
Ensembl chr16:32,449,116...32,519,148
|
|
G |
Cldn2 |
claudin 2 |
multiple interactions |
EXP |
alpha-Tocopherol inhibits the reaction [Potassium Dichromate affects the localization of CLDN2 protein] |
CTD |
PMID:19766176 |
|
NCBI chr X:111,122,552...111,133,188
Ensembl chr X:111,122,552...111,137,769
|
|
G |
Cldn4 |
claudin 4 |
multiple interactions |
EXP |
Vitamin E inhibits the reaction [phoxim results in decreased expression of CLDN4 mRNA] |
CTD |
PMID:30003487 |
|
NCBI chr12:24,761,210...24,763,008
Ensembl chr12:24,761,210...24,763,005
|
|
G |
Clec3b |
C-type lectin domain family 3, member B |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of TNA mRNA Vitamin E results in increased expression of TNA mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:132,241,016...132,248,066
Ensembl chr 8:132,241,134...132,246,694
|
|
G |
Clic1 |
chloride intracellular channel 1 |
increases expression |
ISO |
Vitamin E results in increased expression of CLIC1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:5,040,314...5,049,166
Ensembl chr20:5,040,337...5,049,166
|
|
G |
Clip1 |
CAP-GLY domain containing linker protein 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of CLIP1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:38,345,203...38,452,650
Ensembl chr12:38,345,456...38,452,652
|
|
G |
Cln3 |
CLN3 lysosomal/endosomal transmembrane protein, battenin |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of CLN3 mRNA Vitamin E results in increased expression of CLN3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:197,986,384...197,999,726
Ensembl chr 1:197,986,385...197,997,664
|
|
G |
Cltb |
clathrin, light chain B |
increases expression |
ISO |
Vitamin E results in increased expression of CLTB mRNA |
CTD |
PMID:19244175 |
|
NCBI chr17:10,537,348...10,554,999
Ensembl chr17:10,537,365...10,554,989
|
|
G |
Clu |
clusterin |
multiple interactions increases expression |
EXP ISO |
Vitamin E inhibits the reaction [Estradiol results in increased expression of CLU protein] Vitamin E results in increased expression of CLU mRNA |
CTD |
PMID:9037392 PMID:19244175 |
|
NCBI chr15:42,626,612...42,665,858
Ensembl chr15:42,640,146...42,665,857
|
|
G |
Cmtr1 |
cap methyltransferase 1 |
increases expression |
ISO |
Vitamin E results in increased expression of CMTR1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:8,324,968...8,385,174
Ensembl chr20:8,312,792...8,368,764
|
|
G |
Cngb1 |
cyclic nucleotide gated channel subunit beta 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of CNGB1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:10,142,440...10,206,618
Ensembl chr19:10,142,496...10,206,681
|
|
G |
Cnn1 |
calponin 1 |
increases expression |
ISO |
Vitamin E results in increased expression of CNN1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:23,113,083...23,121,748
Ensembl chr 8:23,113,048...23,121,761
|
|
G |
Cnpy2 |
canopy FGF signaling regulator 2 |
decreases expression |
ISO |
Vitamin E results in decreased expression of CNPY2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:2,737,674...2,744,321
Ensembl chr 7:2,737,765...2,742,369
|
|
G |
Cnpy3 |
canopy FGF signaling regulator 3 |
increases expression |
ISO |
Vitamin E results in increased expression of CNPY3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:16,543,715...16,558,441
Ensembl chr 9:16,543,688...16,558,456
|
|
G |
Cog4 |
component of oligomeric golgi complex 4 |
multiple interactions |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of COG4 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:43,358,057...43,391,828
Ensembl chr19:43,358,057...43,391,828
|
|
G |
Col18a1 |
collagen type XVIII alpha 1 chain |
increases expression |
ISO |
Vitamin E results in increased expression of COL18A1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:12,225,202...12,332,858
Ensembl chr20:12,225,202...12,332,858
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
multiple interactions |
EXP |
[silybin co-treated with Phosphatidylcholines co-treated with Vitamin E] inhibits the reaction [Dimethylnitrosamine results in increased expression of COL1A1 mRNA] |
CTD |
PMID:16169303 |
|
NCBI chr10:82,745,801...82,762,790
Ensembl chr10:82,745,801...82,762,789
|
|
G |
Col1a2 |
collagen type I alpha 2 chain |
multiple interactions |
ISO |
Vitamin E inhibits the reaction [CYP2E1 protein results in increased expression of COL1A2 mRNA] |
CTD |
PMID:10498651 |
|
NCBI chr 4:31,534,225...31,569,152
Ensembl chr 4:31,534,225...31,569,151
|
|
G |
Col4a1 |
collagen type IV alpha 1 chain |
increases expression |
ISO |
Vitamin E results in increased expression of COL4A1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr16:83,522,162...83,632,153
Ensembl chr16:83,522,162...83,632,153
|
|
G |
Col4a3 |
collagen type IV alpha 3 chain |
decreases expression |
ISO |
Vitamin E results in decreased expression of COL4A3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:88,357,528...88,484,735
Ensembl chr 9:88,357,556...88,485,830
|
|
G |
Col6a2 |
collagen type VI alpha 2 chain |
increases expression |
ISO |
Vitamin E results in increased expression of COL6A2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:12,773,472...12,801,179
Ensembl chr20:12,773,427...12,801,180
|
|
G |
Col6a3 |
collagen type VI alpha 3 chain |
increases expression |
ISO |
Vitamin E results in increased expression of COL6A3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:97,926,784...98,004,643
Ensembl chr 9:97,926,787...98,004,546
|
|
G |
Colgalt2 |
collagen beta(1-O)galactosyltransferase 2 |
increases expression |
ISO |
Vitamin E results in increased expression of COLGALT2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr13:69,797,558...69,902,916
Ensembl chr13:69,797,880...69,901,170
|
|
G |
Commd3 |
COMM domain containing 3 |
decreases expression |
ISO |
Vitamin E results in decreased expression of COMMD3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr17:85,356,042...85,359,835
Ensembl chr17:85,356,042...85,359,833
|
|
G |
Cope |
COPI coat complex subunit epsilon |
increases expression |
ISO |
Vitamin E results in increased expression of COPE mRNA |
CTD |
PMID:19244175 |
|
NCBI chr16:20,863,141...20,873,516
Ensembl chr16:20,863,141...20,873,521
|
|
G |
Cops6 |
COP9 signalosome subunit 6 |
increases expression |
ISO |
Vitamin E results in increased expression of COPS6 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:19,303,387...19,306,226
Ensembl chr12:19,303,387...19,306,226
|
|
G |
Copz2 |
COPI coat complex subunit zeta 2 |
increases expression |
ISO |
Vitamin E results in increased expression of COPZ2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:84,718,824...84,731,880
Ensembl chr10:84,718,824...84,731,880
|
|
G |
Coq9 |
coenzyme Q9 |
increases expression |
ISO |
Vitamin E results in increased expression of COQ9 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:10,583,855...10,596,848
Ensembl chr19:10,583,857...10,596,851
|
|
G |
Cox6a1 |
cytochrome c oxidase subunit 6A1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of COX6A1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:47,024,442...47,027,495
Ensembl chr12:47,024,442...47,027,495
|
|
G |
Cpm |
carboxypeptidase M |
decreases expression |
ISO |
Vitamin E results in decreased expression of CPM mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:60,654,350...60,714,620
Ensembl chr 7:60,654,350...60,714,620
|
|
G |
Cpne1 |
copine 1 |
increases expression |
ISO |
Vitamin E results in increased expression of CPNE1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:151,617,733...151,625,448 NCBI chr 3:152,150,143...152,192,936
Ensembl chr 3:151,616,037...151,625,644 Ensembl chr 3:151,616,037...151,625,644
|
|
G |
Cpsf1 |
cleavage and polyadenylation specific factor 1 |
increases expression |
ISO |
Vitamin E results in increased expression of CPSF1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:117,661,779...117,672,373
Ensembl chr 7:117,661,661...117,672,373
|
|
G |
Cpt1a |
carnitine palmitoyltransferase 1A |
multiple interactions increases expression |
ISO |
alpha-Tocopherol inhibits the reaction [Galactosamine results in decreased expression of CPT1A mRNA]; alpha-Tocopherol promotes the reaction [NR1I2 results in increased expression of CPT1A mRNA] alpha-Tocopherol results in increased expression of CPT1A mRNA |
CTD |
PMID:17936189 |
|
NCBI chr 1:218,568,157...218,629,679
Ensembl chr 1:218,569,510...218,629,678
|
|
G |
Cr1l |
complement C3b/C4b receptor 1 like |
multiple interactions |
ISO |
Vitamin E inhibits the reaction [Endosulfan results in decreased expression of CR1L mRNA] |
CTD |
PMID:23208437 |
|
NCBI chr13:113,824,886...113,872,097
Ensembl chr13:113,824,892...113,872,097
|
|
G |
Cr2 |
complement C3d receptor 2 |
multiple interactions |
ISO |
Vitamin E inhibits the reaction [Endosulfan results in decreased expression of CR2 mRNA]; Vitamin E inhibits the reaction [Endosulfan results in decreased expression of CR2 protein] |
CTD |
PMID:23208437 |
|
NCBI chr13:113,890,274...113,927,824
Ensembl chr13:113,890,272...113,927,877
|
|
G |
Crabp2 |
cellular retinoic acid binding protein 2 |
multiple interactions |
ISO |
[Tretinoin co-treated with alpha-Tocopherol] results in increased expression of CRABP2 mRNA; [Tretinoin co-treated with alpha-Tocopherol] results in increased expression of CRABP2 protein |
CTD |
PMID:15225641 |
|
NCBI chr 2:187,322,416...187,326,794
Ensembl chr 2:184,882,969...184,883,505
|
|
G |
Creb1 |
cAMP responsive element binding protein 1 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of CREB1 mRNA [alpha-Tocopherol co-treated with Nimodipine] inhibits the reaction [Dibutyl Phthalate results in decreased phosphorylation of CREB1 protein] Vitamin E results in decreased expression of CREB1 mRNA |
CTD |
PMID:19244175 PMID:30776390 |
|
NCBI chr 9:71,229,753...71,298,994
Ensembl chr 9:71,230,108...71,293,435
|
|
G |
Creb3 |
cAMP responsive element binding protein 3 |
increases expression |
ISO |
Vitamin E results in increased expression of CREB3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:59,063,532...59,068,196
Ensembl chr 5:59,063,531...59,068,188
|
|
G |
Crebbp |
CREB binding protein |
decreases expression |
ISO |
Vitamin E results in decreased expression of CREBBP mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:11,590,994...11,721,039
Ensembl chr10:11,595,044...11,721,039
|
|
G |
Crp |
C-reactive protein |
multiple interactions decreases expression |
ISO |
[alpha-Tocopherol co-treated with gamma-Tocopherol] results in decreased expression of CRP protein; [Eicosapentaenoic Acid co-treated with Docosahexaenoic Acids co-treated with Oleic Acid co-treated with Folic Acid co-treated with Vitamin B 6 co-treated with Vitamin E] results in decreased expression of CRP protein; [Vitamin E co-treated with Ascorbic Acid co-treated with Folic Acid co-treated with Riboflavin co-treated with Vitamin B 6 co-treated with Vitamin B 12] results in decreased expression of CRP protein; [Vitamin E co-treated with Ascorbic Acid] results in decreased expression of CRP protein Vitamin E inhibits the reaction [titanium dioxide results in increased expression of CRP protein] Vitamin E results in decreased expression of CRP protein |
CTD |
PMID:16517955 PMID:17237316 PMID:18191645 PMID:20370442 PMID:30626778 |
|
NCBI chr13:91,080,448...91,081,358
Ensembl chr13:91,054,974...91,093,713
|
|
G |
Cryaa |
crystallin, alpha A |
increases expression |
EXP |
alpha-Tocopherol results in increased expression of CRYAA mRNA |
CTD |
PMID:16908007 |
|
NCBI chr20:10,438,444...10,442,189
Ensembl chr20:10,438,444...10,442,187
|
|
G |
Crybg2 |
crystallin beta-gamma domain containing 2 |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of CRYBG2 mRNA Vitamin E results in increased expression of CRYBG2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:152,289,492...152,321,539
Ensembl chr 5:152,290,084...152,321,541
|
|
G |
Csnk1a1 |
casein kinase 1, alpha 1 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of CSNK1A1 mRNA Vitamin E results in decreased expression of CSNK1A1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr18:56,887,722...56,910,610
Ensembl chr18:56,887,354...56,918,345
|
|
G |
Csnk1d |
casein kinase 1, delta |
decreases expression |
ISO |
Vitamin E results in decreased expression of CSNK1D mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:110,147,786...110,182,413
Ensembl chr10:110,148,600...110,182,408
|
|
G |
Csnk1e |
casein kinase 1, epsilon |
multiple interactions |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of CSNK1E mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:120,651,976...120,675,559
Ensembl chr 7:120,651,881...120,672,359
|
|
G |
Csnk1g2 |
casein kinase 1, gamma 2 |
decreases expression |
ISO |
Vitamin E results in decreased expression of CSNK1G2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:11,944,957...11,963,268
Ensembl chr 7:11,944,958...11,963,268
|
|
G |
Csnk1g3 |
casein kinase 1, gamma 3 |
decreases expression |
ISO |
Vitamin E results in decreased expression of CSNK1G3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr18:48,831,209...48,913,341
Ensembl chr18:48,853,418...48,911,122
|
|
G |
Csnk2a1 |
casein kinase 2 alpha 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of CSNK2A1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:147,713,808...147,760,375
Ensembl chr 3:147,713,821...147,757,862
|
|
G |
Csnk2b |
casein kinase 2 beta |
increases expression |
ISO |
Vitamin E results in increased expression of CSNK2B mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:5,108,692...5,113,675
Ensembl chr20:5,106,890...5,113,112
|
|
G |
Cspg4 |
chondroitin sulfate proteoglycan 4 |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of CSPG4 mRNA Vitamin E results in increased expression of CSPG4 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:61,532,465...61,567,510
Ensembl chr 8:61,532,465...61,567,510
|
|
G |
Cspp1 |
centrosome and spindle pole associated protein 1 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of CSPP1 mRNA Vitamin E results in decreased expression of CSPP1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:8,761,293...8,876,205
Ensembl chr 5:8,761,293...8,864,578
|
|
G |
Csrp1 |
cysteine and glycine-rich protein 1 |
increases expression |
ISO |
Vitamin E results in increased expression of CSRP1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr13:52,553,843...52,575,054
Ensembl chr13:52,553,775...52,575,051
|
|
G |
Cst3 |
cystatin C |
increases expression |
ISO |
Vitamin E results in increased expression of CST3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:143,219,671...143,223,544
Ensembl chr 3:143,219,686...143,223,615
|
|
G |
Ctbp1 |
C-terminal binding protein 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of CTBP1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:82,762,109...82,789,350
Ensembl chr14:82,762,190...82,789,319
|
|
G |
Ctbp2 |
C-terminal binding protein 2 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of CTBP2 mRNA Vitamin E results in decreased expression of CTBP2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:205,001,354...205,030,565
Ensembl chr 1:205,001,396...205,040,755
|
|
G |
Ctdnep1 |
CTD nuclear envelope phosphatase 1 |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of CTDNEP1 mRNA Vitamin E results in increased expression of CTDNEP1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:56,590,822...56,600,235
Ensembl chr10:56,591,292...56,600,232
|
|
G |
Ctdspl |
CTD small phosphatase like |
increases expression |
ISO |
Vitamin E results in increased expression of CTDSPL mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:127,065,292...127,726,248
Ensembl chr 8:127,702,534...127,726,127
|
|
G |
Ctf1 |
cardiotrophin 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of CTF1 protein |
CTD |
PMID:16507596 |
|
NCBI chr 1:199,162,319...199,168,296
Ensembl chr 1:199,163,086...199,168,296
|
|
G |
Ctnnb1 |
catenin beta 1 |
multiple interactions |
EXP ISO |
[Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Diethylhexyl Phthalate results in increased expression of and affects the localization of CTNNB1 protein]; [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [mono-(2-ethylhexyl)phthalate affects the localization of CTNNB1 protein] Vitamin E inhibits the reaction [Curcumin results in decreased expression of CTNNB1 protein] |
CTD |
PMID:29940330 PMID:30935902 |
|
NCBI chr 8:129,601,511...129,628,378
Ensembl chr 8:129,617,812...129,627,372
|
|
G |
Ctnnbl1 |
catenin, beta like 1 |
increases expression |
ISO |
Vitamin E results in increased expression of CTNNBL1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:154,212,245...154,373,170
Ensembl chr 3:154,212,202...154,373,169
|
|
G |
Ctsd |
cathepsin D |
increases expression |
EXP |
alpha-Tocopherol results in increased expression of CTSD protein |
CTD |
PMID:18942769 |
|
NCBI chr 1:215,541,570...215,553,446
Ensembl chr 1:215,541,542...215,553,451
|
|
G |
Cttn |
cortactin |
decreases expression |
ISO |
Vitamin E results in decreased expression of CTTN mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:217,602,698...217,638,196 NCBI chr 1:215,255,385...215,290,882
Ensembl chr 1:217,602,698...217,638,152 Ensembl chr 1:217,602,698...217,638,152
|
|
G |
Cuedc2 |
CUE domain containing 2 |
increases expression |
ISO |
Vitamin E results in increased expression of CUEDC2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:266,078,107...266,087,057
Ensembl chr 1:266,078,108...266,086,299
|
|
G |
Cul3 |
cullin 3 |
decreases expression |
ISO |
Vitamin E results in decreased expression of CUL3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:86,044,485...86,129,066
Ensembl chr 9:86,044,485...86,129,329
|
|
G |
Cul4a |
cullin 4A |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of CUL4A mRNA Vitamin E results in increased expression of CUL4A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr16:81,718,784...81,756,653
Ensembl chr16:81,719,028...81,756,654
|
|
G |
Cutc |
cutC copper transporter |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of CUTC mRNA Vitamin E results in decreased expression of CUTC mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:263,511,537...263,526,308
Ensembl chr 1:263,511,537...263,526,307
|
|
G |
Cux1 |
cut-like homeobox 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of CUX1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:23,150,886...23,470,095
Ensembl chr12:23,151,180...23,445,074
|
|
G |
Cwh43 |
cell wall biogenesis 43 C-terminal homolog |
decreases expression |
ISO |
Vitamin E results in decreased expression of CWH43 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:37,315,479...37,361,728
Ensembl chr14:37,315,406...37,361,798
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
multiple interactions |
EXP |
alpha-Tocopherol inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL1 mRNA] |
CTD |
PMID:24333275 |
|
NCBI chr14:18,743,678...18,745,457
Ensembl chr14:18,743,685...18,745,457
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
multiple interactions |
EXP |
alpha-Tocopherol inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL2 mRNA] |
CTD |
PMID:24333275 |
|
NCBI chr14:18,731,346...18,733,391
Ensembl chr14:18,731,378...18,733,391
|
|
G |
Cxcr1 |
C-X-C motif chemokine receptor 1 |
increases expression |
ISO |
Vitamin E results in increased expression of CXCR1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:81,466,430...81,469,299
Ensembl chr 9:81,466,332...81,469,274
|
|
G |
Cyba |
cytochrome b-245 alpha chain |
decreases expression |
ISO |
Vitamin E results in decreased expression of CYBA mRNA |
CTD |
PMID:15571180 |
|
NCBI chr19:55,249,634...55,257,824
Ensembl chr19:55,249,616...55,257,876
|
|
G |
Cycs |
cytochrome c, somatic |
multiple interactions |
ISO EXP |
Vitamin E inhibits the reaction [cinnamic aldehyde affects the localization of CYCS protein]; Vitamin E inhibits the reaction [phenethyl isothiocyanate affects the localization of CYCS protein] Vitamin E inhibits the reaction [Diazinon affects the localization of CYCS protein] |
CTD |
PMID:15566391 PMID:16054126 PMID:23523949 |
|
NCBI chr 4:80,331,226...80,333,326
Ensembl chr 4:80,331,227...80,333,326
|
|
G |
Cyfip1 |
cytoplasmic FMR1 interacting protein 1 |
increases expression |
ISO |
Vitamin E results in increased expression of CYFIP1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:114,258,773...114,347,138
Ensembl chr 1:114,258,719...114,347,137
|
|
G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
multiple interactions |
EXP |
Vitamin E inhibits the reaction [acetamiprid results in decreased expression of CYP11A mRNA]; Vitamin E inhibits the reaction [acetamiprid results in decreased expression of CYP11A protein]; Vitamin E inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased activity of CYP11A1 protein]; Vitamin E inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased expression of CYP11A1 mRNA] |
CTD |
PMID:16298753 PMID:17280759 PMID:28395332 |
|
NCBI chr 8:62,798,317...62,809,848
Ensembl chr 8:62,779,875...62,809,893
|
|
G |
Cyp11b3 |
cytochrome P450, family 11, subfamily b, polypeptide 3 |
multiple interactions decreases expression |
EXP |
Vitamin E inhibits the reaction [adrenocorticotropin zinc results in decreased expression of CYP11B2 mRNA]; Vitamin E promotes the reaction [adrenocorticotropin zinc results in decreased activity of CYP11B2 protein] Vitamin E results in decreased expression of CYP11B2 mRNA |
CTD |
PMID:10822027 PMID:28923436 |
|
NCBI chr 7:116,155,928...116,161,781
Ensembl chr 7:116,156,219...116,255,167
|
|
G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
decreases expression |
EXP |
Vitamin E results in decreased expression of CYP19A1 mRNA |
CTD |
PMID:15084515 |
|
NCBI chr 8:58,744,849...58,772,408
Ensembl chr 8:58,744,849...58,772,408
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases expression multiple interactions |
EXP |
alpha-Tocopherol results in increased expression of CYP1A1 mRNA; Vitamin E results in increased expression of CYP1A1 mRNA [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of CYP1A1 mRNA]; alpha-Tocopherol results in increased expression of and results in increased activity of CYP1A1 protein |
CTD |
PMID:15665910 PMID:22389237 PMID:28923436 |
|
NCBI chr 8:62,472,087...62,478,122
Ensembl chr 8:62,472,095...62,478,147
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
increases activity multiple interactions |
EXP ISO |
alpha-Tocopherol results in increased activity of CYP1A2 protein alpha-Tocopherol inhibits the reaction [[Dietary Fats co-treated with Fructose] results in increased expression of CYP1A2 mRNA] |
CTD |
PMID:15665910 PMID:26102010 |
|
NCBI chr 8:62,451,360...62,458,244
Ensembl chr 8:62,451,329...62,458,301
|
|
G |
Cyp2a3 |
cytochrome P450, family 2, subfamily a, polypeptide 3 |
multiple interactions |
ISO |
Vitamin E inhibits the reaction [pyrazole results in increased expression of CYP2A5 mRNA] |
CTD |
PMID:12499123 PMID:14610226 |
|
NCBI chr 1:83,653,248...83,662,118
Ensembl chr 1:83,653,234...83,766,484
|
|
G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
decreases expression |
ISO |
alpha-Tocopherol results in decreased expression of CYP2B10 mRNA |
CTD |
PMID:26102010 |
|
NCBI chr 7:99,142,431...99,183,540
Ensembl chr 7:99,142,450...99,181,783
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
decreases expression |
ISO |
alpha-Tocopherol results in decreased expression of CYP2B9 mRNA |
CTD |
PMID:26102010 |
|
NCBI chr 1:83,163,103...83,236,615
Ensembl chr 1:83,163,079...83,236,615
|
|
G |
Cyp2c79 |
cytochrome P450, family 2, subfamily c, polypeptide 79 |
multiple interactions |
ISO |
alpha-Tocopherol inhibits the reaction [[Dietary Fats co-treated with Fructose] results in increased expression of CYP2C29 protein] |
CTD |
PMID:26102010 |
|
NCBI chr 1:147,236,480...147,307,988
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
increases expression multiple interactions |
EXP ISO |
alpha-Tocopherol results in increased expression of CYP2E1 mRNA [Methionine co-treated with Thiamine co-treated with Niacinamide co-treated with alpha-Tocopherol co-treated with Zinc] inhibits the reaction [[Isoniazid co-treated with Rifampin co-treated with Ethambutol co-treated with Pyrazinamide] results in increased activity of CYP2E1 protein]; [Methionine co-treated with Thiamine co-treated with Niacinamide co-treated with alpha-Tocopherol co-treated with Zinc] inhibits the reaction [[Isoniazid co-treated with Rifampin co-treated with Ethambutol co-treated with Pyrazinamide] results in increased expression of CYP2E1 mRNA]; alpha-Tocopherol promotes the reaction [Acrylonitrile results in increased expression of CYP2E1 mRNA]; Vitamin E inhibits the reaction [decamethrin results in increased expression of CYP2E1 mRNA] Vitamin E inhibits the reaction [[CYP2E1 protein co-treated with Paraquat] results in increased expression of KLF6 protein]; Vitamin E inhibits the reaction [[CYP2E1 protein co-treated with Vitamin K 3] results in increased expression of KLF6 protein]; Vitamin E inhibits the reaction [Arachidonic Acid promotes the reaction [CYP2E1 protein results in increased expression of KLF6 mRNA]]; Vitamin E inhibits the reaction [CYP2E1 protein promotes the reaction [Arachidonic Acid results in increased expression of KLF6 mRNA alternative form]]; Vitamin E inhibits the reaction [CYP2E1 protein results in increased expression of COL1A2 mRNA] |
CTD |
PMID:10498651 PMID:22486562 PMID:25439240 PMID:26332274 PMID:27919644 PMID:28062356 |
|
NCBI chr 1:213,511,892...213,522,195
Ensembl chr 1:213,511,874...213,535,542
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
multiple interactions |
EXP |
[Methionine co-treated with Thiamine co-treated with Niacinamide co-treated with alpha-Tocopherol co-treated with Zinc] inhibits the reaction [[Isoniazid co-treated with Rifampin co-treated with Ethambutol co-treated with Pyrazinamide] results in increased expression of CYP3A2 mRNA] |
CTD |
PMID:27919644 |
|
NCBI chr12:11,641,500...11,677,818
Ensembl chr12:11,655,402...11,733,136
|
|
G |
Cyp3a62 |
cytochrome P450, family 3, subfamily a, polypeptide 62 |
decreases expression multiple interactions increases expression |
ISO |
Vitamin E results in decreased expression of CYP3A4 mRNA alpha-Tocopherol inhibits the reaction [CYP3A4 protein results in increased hydroxylation of Testosterone]; alpha-Tocopherol inhibits the reaction [Galactosamine results in decreased expression of CYP3A4 mRNA]; Galactosamine inhibits the reaction [alpha-Tocopherol results in increased expression of CYP3A4 mRNA] |
CTD |
PMID:17936189 PMID:19244175 PMID:31102695 |
|
NCBI chr12:18,679,809...18,709,397
Ensembl chr12:18,678,594...18,709,397
|
|
G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
increases expression multiple interactions decreases expression |
ISO |
alpha-Tocopherol results in increased expression of CYP3A13 mRNA; alpha-Tocopherol results in increased expression of CYP3A13 protein alpha-Tocopherol inhibits the reaction [CYP3A5 protein results in increased hydroxylation of Testosterone] Vitamin E results in decreased expression of CYP3A5 mRNA |
CTD |
PMID:19244175 PMID:26102010 PMID:31102695 |
|
NCBI chr12:19,074,288...19,114,491
Ensembl chr12:19,074,583...19,114,399
|
|
G |
Daam1 |
dishevelled associated activator of morphogenesis 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of DAAM1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:94,606,675...94,739,026
Ensembl chr 6:94,636,222...94,739,026
|
|
G |
Daam2 |
dishevelled associated activator of morphogenesis 2 |
increases expression |
ISO |
Vitamin E results in increased expression of DAAM2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:13,444,883...13,493,154
Ensembl chr 9:13,446,896...13,490,669
|
|
G |
Dact1 |
dishevelled-binding antagonist of beta-catenin 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of DACT1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:93,740,440...93,751,003
Ensembl chr 6:93,740,586...93,749,809
|
|
G |
Dad1 |
defender against cell death 1 |
multiple interactions |
EXP |
[Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of DAD1 mRNA |
CTD |
PMID:11444866 |
|
NCBI chr15:32,868,136...32,887,933
Ensembl chr15:32,868,087...32,888,095
|
|
G |
Dapk3 |
death-associated protein kinase 3 |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of DAPK3 mRNA Vitamin E results in increased expression of DAPK3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:11,392,436...11,400,855
Ensembl chr 7:11,392,437...11,400,805
|
|
G |
Dcaf8 |
DDB1 and CUL4 associated factor 8 |
increases expression |
ISO |
Vitamin E results in increased expression of DCAF8 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr13:90,532,153...90,587,542
Ensembl chr13:90,532,326...90,591,796
|
|
G |
Dcn |
decorin |
increases expression |
ISO |
Vitamin E results in increased expression of DCN mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:38,742,250...38,782,282
Ensembl chr 7:38,742,051...38,782,323
|
|
G |
Dctn3 |
dynactin subunit 3 |
increases expression |
ISO |
Vitamin E results in increased expression of DCTN3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:58,098,706...58,106,706
Ensembl chr 5:58,098,706...58,106,706
|
|
G |
Ddah2 |
dimethylarginine dimethylaminohydrolase 2 |
increases expression |
ISO |
Vitamin E results in increased expression of DDAH2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:5,049,260...5,052,573
Ensembl chr20:5,049,496...5,052,585
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
increases expression multiple interactions |
ISO EXP |
alpha-Tocopherol analog results in increased expression of DDIT3 protein alpha-Tocopherol inhibits the reaction [Cadmium Chloride results in increased expression of DDIT3 mRNA] benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [alpha-Tocopherol analog results in increased expression of DDIT3 protein]; DDIT3 mRNA affects the reaction [alpha-Tocopherol analog results in decreased expression of BCL2 protein]; salubrinal inhibits the reaction [alpha-Tocopherol analog results in increased expression of DDIT3 protein] |
CTD |
PMID:20459685 PMID:20686688 |
|
NCBI chr 7:70,578,564...70,585,074
Ensembl chr 7:70,580,198...70,585,084
|
|
G |
Ddost |
dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit |
increases expression |
ISO |
Vitamin E results in increased expression of DDOST mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:156,668,924...156,676,036
Ensembl chr 5:156,668,712...156,676,035
|
|
G |
Ddx17 |
DEAD-box helicase 17 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of DDX17 mRNA Vitamin E results in decreased expression of DDX17 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:120,761,843...120,765,012
Ensembl chr 7:120,761,826...120,780,641
|
|
G |
Ddx18 |
DEAD-box helicase 18 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of DDX18 mRNA Vitamin E results in decreased expression of DDX18 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr13:37,522,558...37,536,066
Ensembl chr13:37,522,561...37,536,066
|
|
G |
Ddx24 |
DEAD-box helicase 24 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of DDX24 mRNA Vitamin E results in decreased expression of DDX24 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:127,302,201...127,319,382
Ensembl chr 6:127,302,201...127,319,362
|
|
G |
Ddx39b |
DExD-box helicase 39B |
increases expression decreases expression |
ISO |
Vitamin E results in increased expression of DDX39B mRNA Vitamin E results in decreased expression of DDX39B mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:4,806,103...4,818,600
Ensembl chr20:4,806,108...4,818,568
|
|
G |
Ddx41 |
DEAD-box helicase 41 |
increases expression multiple interactions |
ISO |
Vitamin E results in increased expression of DDX41 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of DDX41 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr17:9,631,925...9,637,317
Ensembl chr17:9,631,925...9,637,316
|
|
G |
Dedd |
death effector domain-containing |
increases expression |
ISO |
Vitamin E results in increased expression of DEDD mRNA |
CTD |
PMID:19244175 |
|
NCBI chr13:89,706,932...89,721,825
Ensembl chr13:89,718,066...89,721,454
|
|
G |
Dennd1b |
DENN domain containing 1B |
decreases expression |
ISO |
Vitamin E results in decreased expression of DENND1B mRNA |
CTD |
PMID:19244175 |
|
NCBI chr13:56,015,813...56,242,041
Ensembl chr13:56,015,901...56,236,677
|
|
G |
Dennd2b |
DENN domain containing 2B |
increases expression |
ISO |
Vitamin E results in increased expression of DENND2B mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:174,137,120...174,290,533
Ensembl chr 1:174,137,120...174,289,647
|
|
G |
Dennd2d |
DENN domain containing 2D |
decreases expression |
ISO |
Vitamin E results in decreased expression of DENND2D mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 2:209,097,894...209,116,978
Ensembl chr 2:209,097,927...209,116,965
|
|
G |
Dennd4a |
DENN domain containing 4A |
decreases expression |
ISO |
Vitamin E results in decreased expression of DENND4A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:70,293,355...70,406,675
Ensembl chr 8:70,317,586...70,406,751
|
|
G |
Dennd5a |
DENN domain containing 5A |
increases expression |
ISO |
Vitamin E results in increased expression of DENND5A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:174,524,047...174,588,553
Ensembl chr 1:174,524,047...174,588,529
|
|
G |
Des |
desmin |
increases expression |
ISO |
Vitamin E results in increased expression of DES mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:82,556,574...82,564,288
Ensembl chr 9:82,556,573...82,564,294
|
|
G |
Dgcr8 |
DGCR8 microprocessor complex subunit |
multiple interactions |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of DGCR8 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr11:86,852,682...86,885,233
Ensembl chr11:86,852,711...86,885,224
|
|
G |
Dhcr7 |
7-dehydrocholesterol reductase |
affects expression |
EXP |
Vitamin E affects the expression of DHCR7 mRNA |
CTD |
PMID:15370891 |
|
NCBI chr 1:217,018,916...217,034,890
Ensembl chr 1:217,018,916...217,034,904
|
|
G |
Dhodh |
dihydroorotate dehydrogenase (quinone) |
decreases expression |
ISO |
Vitamin E results in decreased expression of DHODH mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:42,066,103...42,087,906
Ensembl chr19:42,066,351...42,082,012
|
|
G |
Dhps |
deoxyhypusine synthase |
increases expression multiple interactions |
ISO |
Vitamin E results in increased expression of DHPS mRNA [Selenium co-treated with Vitamin E] results in increased expression of DHPS mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:26,184,665...26,188,755
Ensembl chr19:26,184,545...26,188,832
|
|
G |
Dhrs1 |
dehydrogenase/reductase 1 |
increases expression |
ISO |
Vitamin E results in increased expression of DHRS1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr15:34,424,017...34,431,302
Ensembl chr15:34,424,016...34,431,325
|
|
G |
Dhrs4 |
dehydrogenase/reductase 4 |
increases expression |
ISO |
Vitamin E results in increased expression of DHRS4 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr15:34,155,043...34,167,073
Ensembl chr15:34,155,504...34,167,072
|
|
G |
Dhx9 |
DExH-box helicase 9 |
decreases expression |
ISO |
Vitamin E results in decreased expression of DHX9 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr13:70,885,503...70,922,278
Ensembl chr13:70,885,504...70,922,245
|
|
G |
Diablo |
diablo, IAP-binding mitochondrial protein |
affects localization multiple interactions |
ISO |
alpha-Tocopherol affects the localization of DIABLO protein Vitamin E inhibits the reaction [cinnamic aldehyde affects the localization of DIABLO protein]; Vitamin E inhibits the reaction [phenethyl isothiocyanate affects the localization of DIABLO protein] |
CTD |
PMID:15566391 PMID:15582575 PMID:16054126 |
|
NCBI chr12:38,490,230...38,503,344
Ensembl chr12:38,490,230...38,503,330
|
|
G |
Dicer1 |
dicer 1 ribonuclease III |
decreases expression |
ISO |
Vitamin E results in decreased expression of DICER1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:128,388,084...128,453,234
Ensembl chr 6:128,388,053...128,434,183
|
|
G |
Dio2 |
iodothyronine deiodinase 2 |
increases expression |
ISO |
Vitamin E results in increased expression of DIO2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:114,475,156...114,489,443
Ensembl chr 6:114,476,142...114,476,723
|
|
G |
Dlst |
dihydrolipoamide S-succinyltransferase |
increases expression |
ISO |
Vitamin E results in increased expression of DLST mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:108,936,534...108,961,322
Ensembl chr 6:108,936,664...108,959,803
|
|
G |
Dmtf1 |
cyclin D binding myb-like transcription factor 1 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of DMTF1 mRNA Vitamin E results in decreased expression of DMTF1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:21,862,297...21,902,798
Ensembl chr 4:21,862,313...21,902,762
|
|
G |
Dnaja3 |
DnaJ heat shock protein family (Hsp40) member A3 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of DNAJA3 mRNA Vitamin E results in decreased expression of DNAJA3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:11,059,701...11,085,186
Ensembl chr10:11,060,313...11,085,210
|
|
G |
Dnajb4 |
DnaJ heat shock protein family (Hsp40) member B4 |
decreases expression |
ISO |
Vitamin E results in decreased expression of DNAJB4 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 2:257,394,692...257,425,344
Ensembl chr 2:257,394,818...257,425,242
|
|
G |
Dnajc2 |
DnaJ heat shock protein family (Hsp40) member C2 |
decreases expression multiple interactions |
ISO |
Vitamin E results in decreased expression of DNAJC2 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of DNAJC2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:9,881,505...9,908,693
Ensembl chr 4:9,882,904...9,908,689
|
|
G |
Dnajc3 |
DnaJ heat shock protein family (Hsp40) member C3 |
decreases expression |
ISO |
Vitamin E results in decreased expression of DNAJC3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr15:104,186,918...104,226,236
Ensembl chr15:104,186,792...104,226,329
|
|
G |
Dnajc7 |
DnaJ heat shock protein family (Hsp40) member C7 |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of DNAJC7 mRNA Vitamin E results in increased expression of DNAJC7 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:88,498,271...88,533,730
Ensembl chr10:88,498,238...88,533,829
|
|
G |
Dnmt1 |
DNA methyltransferase 1 |
increases expression |
ISO |
Vitamin E results in increased expression of DNMT1 mRNA |
CTD |
PMID:29854080 |
|
NCBI chr 8:21,922,515...21,968,495
Ensembl chr 8:21,922,515...21,968,495
|
|
G |
Dnmt3a |
DNA methyltransferase 3 alpha |
decreases expression |
ISO |
Vitamin E results in decreased expression of DNMT3A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:28,205,375...28,346,052
Ensembl chr 6:28,235,695...28,340,577
|
|
G |
Dnph1 |
2'-deoxynucleoside 5'-phosphate N-hydrolase 1 |
increases expression |
ISO |
Vitamin E results in increased expression of DNPH1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:16,845,764...16,848,514
Ensembl chr 9:16,845,525...16,848,503
|
|
G |
Dock1 |
dedicator of cyto-kinesis 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of DOCK1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:206,900,617...207,414,852
Ensembl chr 1:206,900,617...207,414,843
|
|
G |
Dohh |
deoxyhypusine hydroxylase |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of DOHH mRNA Vitamin E results in increased expression of DOHH mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:11,191,127...11,195,971
Ensembl chr 7:11,191,131...11,195,866
|
|
G |
Dok1 |
docking protein 1 |
increases expression |
ISO |
Vitamin E results in increased expression of DOK1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:113,864,211...113,866,695
Ensembl chr 4:113,864,215...113,866,674
|
|
G |
Dpt |
dermatopontin |
increases expression |
ISO |
Vitamin E results in increased expression of DPT mRNA |
CTD |
PMID:19244175 |
|
NCBI chr13:83,073,307...83,102,404
Ensembl chr13:83,073,544...83,102,401
|
|
G |
Dpysl3 |
dihydropyrimidinase-like 3 |
increases expression |
ISO |
Vitamin E results in increased expression of DPYSL3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr18:37,716,371...37,819,347
Ensembl chr18:37,716,143...37,819,097
|
|
G |
Dr1 |
down-regulator of transcription 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of DR1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:2,463,651...2,475,004
Ensembl chr14:2,463,643...2,474,780
|
|
G |
Drg2 |
developmentally regulated GTP binding protein 2 |
increases expression |
ISO |
Vitamin E results in increased expression of DRG2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:46,818,412...46,831,308
Ensembl chr10:46,818,525...46,830,739
|
|
G |
Dsc2 |
desmocollin 2 |
decreases expression multiple interactions |
ISO |
Vitamin E results in decreased expression of DSC2 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of DSC2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr18:11,826,705...11,858,801
Ensembl chr18:11,826,706...11,858,754
|
|
G |
Dxo |
decapping exoribonuclease |
increases expression |
ISO |
Vitamin E results in increased expression of DXO mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:4,517,307...4,519,391
Ensembl chr20:4,517,307...4,519,389
|
|
G |
Dync1h1 |
dynein cytoplasmic 1 heavy chain 1 |
increases expression |
ISO |
Vitamin E results in increased expression of DYNC1H1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:134,958,854...135,085,769
Ensembl chr 6:134,958,854...135,085,769
|
|
G |
E2f6 |
E2F transcription factor 6 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of E2F6 mRNA Vitamin E results in decreased expression of E2F6 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:42,092,513...42,108,692
Ensembl chr 6:42,092,467...42,108,702
|
|
G |
Echdc2 |
enoyl CoA hydratase domain containing 2 |
decreases expression |
ISO |
Vitamin E results in decreased expression of ECHDC2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:127,770,570...127,789,568
Ensembl chr 5:127,770,570...127,789,567
|
|
G |
Ecsit |
ECSIT signaling integrator |
increases expression multiple interactions |
ISO |
Vitamin E results in increased expression of ECSIT mRNA [Selenium co-treated with Vitamin E] results in increased expression of ECSIT mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:23,085,598...23,099,064
Ensembl chr 8:23,085,590...23,099,042
|
|
G |
Eda |
ectodysplasin-A |
decreases expression |
ISO |
Vitamin E results in decreased expression of EDA mRNA |
CTD |
PMID:19244175 |
|
NCBI chr X:69,730,123...70,222,693
Ensembl chr X:69,730,242...70,220,329
|
|
G |
Edem3 |
ER degradation enhancing alpha-mannosidase like protein 3 |
decreases expression |
ISO |
Vitamin E results in decreased expression of EDEM3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr13:69,135,095...69,197,708
Ensembl chr13:69,135,128...69,199,511
|
|
G |
Edf1 |
endothelial differentiation-related factor 1 |
increases expression |
ISO |
Vitamin E results in increased expression of EDF1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:2,781,169...2,785,474
Ensembl chr 3:2,781,169...2,785,474
|
|
G |
Ednra |
endothelin receptor type A |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of EDNRA mRNA Vitamin E results in decreased expression of EDNRA mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:33,928,356...33,991,703
Ensembl chr19:33,928,356...33,991,703
|
|
G |
Eef1a2 |
eukaryotic translation elongation factor 1 alpha 2 |
increases expression multiple interactions |
ISO |
Vitamin E results in increased expression of EEF1A2 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of EEF1A2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:176,657,104...176,666,282
Ensembl chr 3:176,657,107...176,666,282
|
|
G |
Eef1d |
eukaryotic translation elongation factor 1 delta |
increases expression |
ISO |
Vitamin E results in increased expression of EEF1D mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:116,928,264...116,942,981
Ensembl chr 7:116,928,265...116,936,674
|
|
G |
Eef2 |
eukaryotic translation elongation factor 2 |
multiple interactions increases expression |
EXP |
Vitamin E analog inhibits the reaction [cumene hydroperoxide results in decreased expression of EEF2 protein] Vitamin E analog results in increased expression of EEF2 protein |
CTD |
PMID:17510559 |
|
NCBI chr 7:11,401,501...11,406,771
Ensembl chr 7:11,401,501...11,406,771
|
|
G |
Efcab14 |
EF-hand calcium binding domain 14 |
increases expression |
ISO |
Vitamin E results in increased expression of EFCAB14 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:134,594,012...134,632,168
Ensembl chr 5:134,593,517...134,633,935
|
|
G |
Efemp2 |
EGF containing fibulin extracellular matrix protein 2 |
increases expression |
ISO |
Vitamin E results in increased expression of EFEMP2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:220,853,695...220,861,420
Ensembl chr 1:220,854,403...220,861,420
|
|
G |
Efhc1 |
EF-hand domain containing 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of EFHC1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:27,068,505...27,107,713
Ensembl chr 9:27,068,443...27,107,709
|
|
G |
Efhd2 |
EF-hand domain family, member D2 |
increases expression |
ISO |
Vitamin E results in increased expression of EFHD2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:160,407,777...160,423,811
Ensembl chr 5:160,407,778...160,423,811
|
|
G |
Egfr |
epidermal growth factor receptor |
decreases expression |
ISO |
Vitamin E results in decreased expression of EGFR mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:99,919,485...100,104,136
Ensembl chr14:99,919,485...100,098,796
|
|
G |
Egln2 |
egl-9 family hypoxia-inducible factor 2 |
increases expression |
ISO |
Vitamin E results in increased expression of EGLN2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:83,969,456...83,977,665
Ensembl chr 1:83,969,457...83,977,236
|
|
G |
Egr1 |
early growth response 1 |
decreases expression multiple interactions |
ISO EXP |
Vitamin E results in decreased expression of EGR1 mRNA [Selenium deficiency co-treated with Vitamin E deficiency] results in increased expression of EGR1 mRNA |
CTD |
PMID:11444866 PMID:19244175 |
|
NCBI chr18:27,657,903...27,660,101
Ensembl chr18:27,657,628...27,661,429
|
|
G |
Ehbp1 |
EH domain binding protein 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of EHBP1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:106,871,426...107,160,224
Ensembl chr14:106,871,430...107,160,334
|
|
G |
Ehd2 |
EH-domain containing 2 |
increases expression |
ISO |
Vitamin E results in increased expression of EHD2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:77,847,599...77,865,870
Ensembl chr 1:77,847,600...77,865,870
|
|
G |
Eif2a |
eukaryotic translation initiation factor 2A |
increases phosphorylation multiple interactions |
ISO |
alpha-Tocopherol analog results in increased phosphorylation of EIF2A protein benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [alpha-Tocopherol analog results in increased phosphorylation of EIF2A protein]; salubrinal inhibits the reaction [alpha-Tocopherol analog results in increased phosphorylation of EIF2A protein] |
CTD |
PMID:20686688 |
|
NCBI chr 2:148,722,343...148,755,781
Ensembl chr 2:148,722,231...148,755,520
|
|
G |
Eif2ak2 |
eukaryotic translation initiation factor 2-alpha kinase 2 |
decreases expression |
ISO |
Vitamin E results in decreased expression of EIF2AK2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:1,428,845...1,466,193
Ensembl chr 6:1,428,834...1,466,201
|
|
G |
Eif2b2 |
eukaryotic translation initiation factor 2B subunit beta |
increases expression |
ISO |
Vitamin E results in increased expression of EIF2B2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:109,044,830...109,051,254
Ensembl chr 6:109,043,880...109,051,253
|
|
G |
Eif3a |
eukaryotic translation initiation factor 3, subunit A |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of EIF3A mRNA Vitamin E results in decreased expression of EIF3A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:282,139,809...282,170,017
Ensembl chr 1:282,139,823...282,170,017
|
|
G |
Eif3b |
eukaryotic translation initiation factor 3, subunit B |
increases expression |
ISO |
Vitamin E results in increased expression of EIF3B mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:16,285,730...16,310,190
Ensembl chr12:16,285,733...16,310,190
|
|
G |
Eif3k |
eukaryotic translation initiation factor 3, subunit K |
increases expression |
ISO |
Vitamin E results in increased expression of EIF3K mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:87,927,142...87,937,033
Ensembl chr 1:87,927,141...87,937,516
|
|
G |
Eif4a1 |
eukaryotic translation initiation factor 4A1 |
increases expression |
ISO |
Vitamin E results in increased expression of EIF4A1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:56,271,257...56,276,764
Ensembl chr10:56,271,257...56,276,764
|
|
G |
Eif4ebp2 |
eukaryotic translation initiation factor 4E binding protein 2 |
increases expression |
ISO |
Vitamin E results in increased expression of EIF4EBP2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:31,055,292...31,072,469
Ensembl chr20:31,055,789...31,072,469
|
|
G |
Eif4g1 |
eukaryotic translation initiation factor 4 gamma, 1 |
multiple interactions increases expression decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of EIF4G1 mRNA Vitamin E results in increased expression of EIF4G1 mRNA Vitamin E results in decreased expression of EIF4G1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr11:83,907,659...83,927,683
Ensembl chr11:83,908,109...83,926,524
|
|
G |
Eif5 |
eukaryotic translation initiation factor 5 |
decreases expression |
ISO |
Vitamin E results in decreased expression of EIF5 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:136,002,983...136,011,409
Ensembl chr 6:136,004,214...136,011,406
|
|
G |
Eif5a |
eukaryotic translation initiation factor 5A |
multiple interactions increases expression decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of EIF5A mRNA Vitamin E results in increased expression of EIF5A mRNA Vitamin E results in decreased expression of EIF5A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:56,527,075...56,531,615
Ensembl chr10:56,527,085...56,531,483
|
|
G |
Eif5b |
eukaryotic translation initiation factor 5B |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of IF2 mRNA Vitamin E results in decreased expression of IF2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:44,658,724...44,713,518
Ensembl chr 9:44,681,494...44,713,199
|
|
G |
Eif6 |
eukaryotic translation initiation factor 6 |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of EIF6 mRNA Vitamin E results in increased expression of EIF6 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:151,356,867...151,363,201
Ensembl chr 3:151,356,868...151,363,115
|
|
G |
Elf1 |
E74 like ETS transcription factor 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of ELF1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr15:61,772,544...61,868,442
Ensembl chr15:61,826,711...61,868,343
|
|
G |
Elk1 |
ETS transcription factor ELK1 |
increases phosphorylation |
ISO |
Vitamin E results in increased phosphorylation of ELK1 protein |
CTD |
PMID:11522656 |
|
NCBI chr X:1,287,875...1,304,822
Ensembl chr X:1,297,099...1,304,822
|
|
G |
Eloa |
elongin A |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of ELOA mRNA Vitamin E results in decreased expression of ELOA mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:154,348,167...154,363,324
Ensembl chr 5:154,347,391...154,363,329
|
|
G |
Emc6 |
ER membrane protein complex subunit 6 |
increases expression |
ISO |
Vitamin E results in increased expression of EMC6 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:59,741,772...59,743,338
Ensembl chr10:59,741,772...59,743,315
|
|
G |
Emc9 |
ER membrane protein complex subunit 9 |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of EMC9 mRNA Vitamin E results in increased expression of EMC9 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr15:34,258,940...34,263,156
Ensembl chr15:34,256,374...34,263,224
|
|
G |
Emilin1 |
elastin microfibril interfacer 1 |
increases expression |
ISO |
Vitamin E results in increased expression of EMILIN1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:26,821,249...26,829,013
Ensembl chr 6:26,821,255...26,828,972
|
|
G |
Eml2 |
EMAP like 2 |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of EML2 mRNA Vitamin E results in increased expression of EML2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:80,087,684...80,118,784
Ensembl chr 1:80,087,684...80,119,012
|
|
G |
Emp3 |
epithelial membrane protein 3 |
increases expression |
ISO |
Vitamin E results in increased expression of EMP3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:101,900,731...101,903,948
Ensembl chr 1:101,900,733...101,903,910
|
|
G |
Emsy |
EMSY transcriptional repressor, BRCA2 interacting |
decreases expression |
ISO |
Vitamin E results in decreased expression of EMSY mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:163,541,071...163,618,576
Ensembl chr 1:163,545,326...163,611,299
|
|
G |
Endog |
endonuclease G |
increases expression |
ISO |
Vitamin E results in increased expression of ENDOG mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:8,741,833...8,744,414
Ensembl chr 3:8,741,766...8,744,592
|
|
G |
Eno1 |
enolase 1 |
increases expression |
ISO |
Vitamin E results in increased expression of ENO1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:167,288,223...167,299,610
Ensembl chr 5:167,288,223...167,299,609
|
|
G |
Eno2 |
enolase 2 |
increases expression |
ISO |
Vitamin E results in increased expression of ENO2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:157,285,192...157,294,090
Ensembl chr 4:157,285,179...157,294,047
|
|
G |
Entpd1 |
ectonucleoside triphosphate diphosphohydrolase 1 |
increases expression |
ISO |
Vitamin E results in increased expression of ENTPD1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:259,692,020...259,818,922
Ensembl chr 1:259,739,955...259,819,494
|
|
G |
Entpd5 |
ectonucleoside triphosphate diphosphohydrolase 5 |
decreases expression |
ISO |
Vitamin E results in decreased expression of ENTPD5 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:108,087,677...108,123,811
Ensembl chr 6:108,087,418...108,120,579
|
|
G |
Epb41l2 |
erythrocyte membrane protein band 4.1-like 2 |
increases expression |
ISO |
Vitamin E results in increased expression of EPB41L2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:20,881,820...21,067,713
Ensembl chr 1:20,893,995...20,962,526
|
|
G |
Epn2 |
epsin 2 |
increases expression |
ISO |
Vitamin E results in increased expression of EPN2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:47,795,496...47,857,373
Ensembl chr10:47,795,524...47,857,326
|
|
G |
Erbb2 |
erb-b2 receptor tyrosine kinase 2 |
multiple interactions |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of ERBB2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:86,367,596...86,391,728
Ensembl chr10:86,367,596...86,391,728
|
|
G |
Ercc1 |
ERCC excision repair 1, endonuclease non-catalytic subunit |
increases expression |
ISO |
Vitamin E results in increased expression of ERCC1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:80,256,973...80,268,198
Ensembl chr 1:80,256,973...80,268,198
|
|
G |
Ercc3 |
ERCC excision repair 3, TFIIH core complex helicase subunit |
increases expression |
ISO |
Vitamin E results in increased expression of ERCC3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr18:25,037,668...25,068,380
Ensembl chr18:25,037,625...25,068,389
|
|
G |
Esr1 |
estrogen receptor 1 |
multiple interactions |
EXP |
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of ESR1 mRNA]; [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of ESR1 protein] |
CTD |
PMID:22389237 |
|
NCBI chr 1:41,192,029...41,594,799
Ensembl chr 1:41,192,824...41,594,796
|
|
G |
Esr2 |
estrogen receptor 2 |
multiple interactions |
EXP |
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of ESR2 mRNA] |
CTD |
PMID:22389237 |
|
NCBI chr 6:99,163,953...99,214,711
Ensembl chr 6:99,164,357...99,214,251
|
|
G |
Esrp2 |
epithelial splicing regulatory protein 2 |
decreases expression multiple interactions |
ISO |
Vitamin E results in decreased expression of ESRP2 mRNA [Selenium co-treated with Vitamin E] results in increased expression of ESRP2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:38,113,412...38,120,578
Ensembl chr19:38,113,412...38,120,578
|
|
G |
Ess2 |
ess-2 splicing factor homolog |
increases expression |
ISO |
Vitamin E results in increased expression of ESS2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr11:87,224,371...87,234,329
Ensembl chr11:87,224,421...87,233,326
|
|
G |
Ets2 |
ETS proto-oncogene 2, transcription factor |
decreases expression |
ISO |
Vitamin E results in decreased expression of ETS2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr11:36,075,709...36,092,495
Ensembl chr11:36,075,709...36,092,495
|
|
G |
Evi5 |
ecotropic viral integration site 5 |
decreases expression |
ISO |
Vitamin E results in decreased expression of EVI5 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:2,892,738...3,038,237
Ensembl chr14:2,892,753...3,038,237
|
|
G |
Evl |
Enah/Vasp-like |
increases expression |
ISO |
Vitamin E results in increased expression of EVL mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:132,470,283...132,590,242
Ensembl chr 6:132,510,757...132,590,241
|
|
G |
Ewsr1 |
EWS RNA-binding protein 1 |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of EWSR1 mRNA Vitamin E results in increased expression of EWSR1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:85,322,105...85,350,826
Ensembl chr14:85,322,296...85,350,948
|
|
G |
Exoc3 |
exocyst complex component 3 |
increases expression |
ISO |
Vitamin E results in increased expression of SEC6 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:31,700,953...31,731,726
Ensembl chr 1:31,700,953...31,731,815
|
|
G |
Exosc4 |
exosome component 4 |
increases expression |
ISO |
Vitamin E results in increased expression of EXOSC4 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:117,390,302...117,393,044
Ensembl chr 7:117,390,285...117,393,719
|
|
G |
Ext1 |
exostosin glycosyltransferase 1 |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of EXT1 mRNA Vitamin E results in increased expression of EXT1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:92,605,008...92,881,392
Ensembl chr 7:92,605,728...92,882,068
|
|
G |
Eya2 |
EYA transcriptional coactivator and phosphatase 2 |
increases expression |
ISO |
Vitamin E results in increased expression of EYA2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:162,285,275...162,470,642
Ensembl chr 3:162,346,490...162,470,065
|
|
G |
Ezh1 |
enhancer of zeste 1 polycomb repressive complex 2 subunit |
increases expression |
ISO |
Vitamin E results in increased expression of EZH1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:89,104,026...89,139,978
Ensembl chr10:89,104,027...89,130,339
|
|
G |
Ezr |
ezrin |
decreases expression multiple interactions |
ISO |
Vitamin E results in decreased expression of EZR mRNA [Selenium co-treated with Vitamin E] results in decreased expression of EZR mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:47,287,872...47,331,412
Ensembl chr 1:47,287,874...47,331,412
|
|
G |
F10 |
coagulation factor X |
increases expression |
ISO |
Vitamin E results in increased expression of F10 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr16:81,803,169...81,822,476
Ensembl chr16:81,803,110...81,822,716
|
|
G |
F2 |
coagulation factor II |
multiple interactions |
ISO |
Vitamin E results in decreased expression of and results in decreased activity of F2 protein |
CTD |
PMID:10216089 |
|
NCBI chr 3:80,529,468...80,542,993
Ensembl chr 3:80,529,428...80,543,031
|
|
G |
F2r |
coagulation factor II (thrombin) receptor |
decreases expression multiple interactions |
ISO |
Vitamin E results in decreased expression of F2R mRNA [Selenium co-treated with Vitamin E] results in increased expression of F2R mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 2:26,118,760...26,135,340
Ensembl chr 2:26,118,760...26,135,340
|
|
G |
F3 |
coagulation factor III, tissue factor |
multiple interactions |
ISO |
Vitamin E inhibits the reaction [Copper results in increased activity of F3 protein]; Vitamin E inhibits the reaction [Norepinephrine results in increased expression of F3 mRNA]; Vitamin E results in decreased expression of and results in decreased activity of F3 protein |
CTD |
PMID:7600656 PMID:10216089 PMID:23114885 |
|
NCBI chr 2:225,310,686...225,322,281
Ensembl chr 2:225,310,624...225,322,272
|
|
G |
Fabp3 |
fatty acid binding protein 3 |
increases expression |
ISO |
Vitamin E results in increased expression of FABP3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:148,528,854...148,535,597
Ensembl chr 5:148,528,725...148,535,565
|
|
G |
Faim |
Fas apoptotic inhibitory molecule |
increases expression |
ISO |
Vitamin E results in increased expression of FAIM mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:107,225,119...107,247,228
Ensembl chr 8:107,225,212...107,241,224 Ensembl chr 8:107,225,212...107,241,224
|
|
G |
Fam107a |
family with sequence similarity 107, member A |
increases expression |
ISO |
Vitamin E results in increased expression of FAM107A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr15:18,399,145...18,415,959
Ensembl chr15:18,399,515...18,415,965
|
|
G |
Fam111a |
FAM111 trypsin like peptidase A |
decreases expression multiple interactions |
ISO |
Vitamin E results in decreased expression of FAM111A mRNA [Selenium co-treated with Vitamin E] results in decreased expression of FAM111A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:229,003,778...229,019,532
Ensembl chr 1:229,003,961...229,019,527
|
|
G |
Fam149a |
family with sequence similarity 149, member A |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of FAM149A mRNA Vitamin E results in decreased expression of FAM149A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr16:50,049,816...50,105,962
Ensembl chr16:50,049,828...50,107,856
|
|
G |
Fam174c |
family with sequence similarity 174 member C |
decreases expression |
ISO |
Vitamin E results in decreased expression of FAM174C mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:12,398,200...12,399,910
Ensembl chr 7:12,398,200...12,399,910
|
|
G |
Fam222b |
family with sequence similarity 222, member B |
decreases expression |
ISO |
Vitamin E results in decreased expression of FAM222B mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:65,351,245...65,416,869
Ensembl chr10:65,351,245...65,416,869
|
|
G |
Fam3a |
FAM3 metabolism regulating signaling molecule A |
multiple interactions |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of FAM3A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr X:156,319,687...156,328,974
Ensembl chr X:156,319,687...156,328,309
|
|
G |
Fam53b |
family with sequence similarity 53, member B |
increases expression |
ISO |
Vitamin E results in increased expression of FAM53B mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:204,714,468...204,805,738
Ensembl chr 1:204,714,473...204,817,080
|
|
G |
Fam89b |
family with sequence similarity 89, member B |
increases expression |
ISO |
Vitamin E results in increased expression of FAM89B mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:221,085,894...221,087,449
Ensembl chr 1:221,085,895...221,087,449
|
|
G |
Farsa |
phenylalanyl-tRNA synthetase subunit alpha |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of FARSA mRNA Vitamin E results in increased expression of FARSA mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:25,969,255...25,978,777
Ensembl chr19:25,969,255...25,978,776
|
|
G |
Faslg |
Fas ligand |
increases expression |
EXP |
alpha-Tocopherol results in increased expression of FASLG mRNA |
CTD |
PMID:26332274 |
|
NCBI chr13:79,696,811...79,717,581
Ensembl chr13:79,698,445...79,705,705
|
|
G |
Fastkd3 |
FAST kinase domains 3 |
decreases expression |
ISO |
Vitamin E results in decreased expression of FASTKD3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:37,734,400...37,742,932
Ensembl chr 1:37,734,403...37,742,932
|
|
G |
Fat4 |
FAT atypical cadherin 4 |
decreases expression |
ISO |
Vitamin E results in decreased expression of FAT4 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 2:125,751,818...125,879,398
Ensembl chr 2:125,752,130...125,879,387
|
|
G |
Fbl |
fibrillarin |
decreases expression |
EXP |
alpha-Tocopherol deficiency results in decreased expression of FBL protein |
CTD |
PMID:15247049 |
|
NCBI chr 1:85,103,519...85,112,619
Ensembl chr 1:85,103,519...85,112,619
|
|
G |
Fbln1 |
fibulin 1 |
increases expression |
ISO |
Vitamin E results in increased expression of FBLN1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:126,096,793...126,176,468
Ensembl chr 7:126,096,793...126,176,468
|
|
G |
Fbxl7 |
F-box and leucine-rich repeat protein 7 |
increases expression |
ISO |
Vitamin E results in increased expression of FBXL7 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 2:79,067,907...79,439,987
Ensembl chr 2:79,067,915...79,078,258
|
|
G |
Fbxo17 |
F-box protein 17 |
increases expression |
ISO |
Vitamin E results in increased expression of FBXO17 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:86,903,762...86,919,238
Ensembl chr 1:86,914,137...86,919,236
|
|
G |
Fbxo28 |
F-box protein 28 |
multiple interactions |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of FBXO28 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr13:100,715,257...100,740,728
Ensembl chr13:100,715,260...100,740,728
|
|
G |
Fbxo31 |
F-box protein 31 |
increases expression |
ISO |
Vitamin E results in increased expression of FBXO31 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:53,487,610...53,625,673
Ensembl chr19:53,487,613...53,625,673
|
|
G |
Fbxw2 |
F-box and WD repeat domain containing 2 |
increases expression |
ISO |
Vitamin E results in increased expression of FBXW2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:13,871,513...13,897,033
Ensembl chr 3:13,871,517...13,896,838
|
|
G |
Fech |
ferrochelatase |
decreases expression |
ISO |
Vitamin E results in decreased expression of FECH mRNA |
CTD |
PMID:19244175 |
|
NCBI chr18:59,941,992...59,975,192
Ensembl chr18:59,941,992...59,975,192
|
|
G |
Fermt1 |
FERM domain containing kindlin 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of FERMT1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:125,566,744...125,607,864
Ensembl chr 3:125,566,643...125,607,735
|
|
G |
Fgg |
fibrinogen gamma chain |
multiple interactions |
EXP |
[Selenium deficiency co-treated with Vitamin E deficiency] results in increased expression of FGG mRNA |
CTD |
PMID:11444866 |
|
NCBI chr 2:181,987,080...181,994,523
Ensembl chr 2:181,987,217...181,994,514
|
|
G |
Fibp |
FGF1 intracellular binding protein |
increases expression |
ISO |
Vitamin E results in increased expression of FIBP mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:220,840,078...220,844,412
Ensembl chr 1:220,840,118...220,844,405
|
|
G |
Fig4 |
FIG4 phosphoinositide 5-phosphatase |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of FIG4 mRNA Vitamin E results in decreased expression of FIG4 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:45,922,806...46,044,754
Ensembl chr20:45,922,806...46,044,738
|
|
G |
Fis1 |
fission, mitochondrial 1 |
increases expression |
ISO |
Vitamin E results in increased expression of FIS1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:22,750,485...22,765,324
Ensembl chr12:22,750,485...22,765,308
|
|
G |
Fkbp1a |
FKBP prolyl isomerase 1A |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of FKBP1A mRNA Vitamin E results in increased expression of FKBP1A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:147,042,944...147,062,725
Ensembl chr 3:147,042,944...147,062,724
|
|
G |
Flii |
FLII, actin remodeling protein |
increases expression |
ISO |
Vitamin E results in increased expression of FLII mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:46,955,460...46,969,468
Ensembl chr10:46,955,487...46,969,406
|
|
G |
Flna |
filamin A |
increases expression |
ISO |
Vitamin E results in increased expression of FLNA mRNA |
CTD |
PMID:19244175 |
|
NCBI chr X:156,460,785...156,487,245
Ensembl chr X:156,463,953...156,487,245
|
|
G |
Flot1 |
flotillin 1 |
increases expression |
ISO |
Vitamin E results in increased expression of FLOT1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:3,427,890...3,438,418
Ensembl chr20:3,427,880...3,438,396
|
|
G |
Flrt3 |
fibronectin leucine rich transmembrane protein 3 |
decreases expression |
ISO |
Vitamin E results in decreased expression of FLRT3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:134,684,446...134,696,586
Ensembl chr 3:134,683,065...134,696,654
|
|
G |
Fmo1 |
flavin containing dimethylaniline monoxygenase 1 |
increases expression |
EXP |
alpha-Tocopherol results in increased expression of FMO1 mRNA |
CTD |
PMID:16908007 |
|
NCBI chr13:80,712,885...80,745,095
Ensembl chr13:80,712,882...80,745,347
|
|
G |
Fmo5 |
flavin containing dimethylaniline monoxygenase 5 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of FMO5 mRNA Vitamin E results in decreased expression of FMO5 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 2:199,796,870...199,823,927
Ensembl chr 2:199,796,881...199,823,927
|
|
G |
Fn1 |
fibronectin 1 |
multiple interactions |
ISO |
alpha-Tocopherol inhibits the reaction [Glucose results in increased expression of and results in increased secretion of FN1 protein] |
CTD |
PMID:9225831 |
|
NCBI chr 9:78,900,111...78,969,018
Ensembl chr 9:78,900,103...78,969,078
|
|
G |
Fnbp1 |
formin binding protein 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of FNBP1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:9,865,657...9,936,333
Ensembl chr 3:9,861,237...9,936,405
|
|
G |
Fnbp4 |
formin binding protein 4 |
decreases expression |
ISO |
Vitamin E results in decreased expression of FNBP4 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:79,570,610...79,610,122
Ensembl chr 3:79,570,625...79,610,454
|
|
G |
Folh1 |
folate hydrolase 1 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of FOLH1 mRNA Vitamin E results in decreased expression of FOLH1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:150,323,768...150,395,415
Ensembl chr 1:150,323,768...150,395,415
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
ISO |
Vitamin E promotes the reaction [Alcohols results in increased expression of FOS mRNA] |
CTD |
PMID:18814483 |
|
NCBI chr 6:109,300,433...109,303,299
Ensembl chr 6:109,300,433...109,303,299
|
|
G |
Foxa2 |
forkhead box A2 |
multiple interactions |
EXP ISO |
Vitamin E inhibits the reaction [nitrofen results in decreased expression of FOXA2 protein] Vitamin E inhibits the reaction [nitrofen results in decreased expression of FOXA2 mRNA] |
CTD |
PMID:16490937 PMID:16863852 |
|
NCBI chr 3:142,383,084...142,387,493
Ensembl chr 3:142,383,278...142,387,481
|
|
G |
Foxe1 |
forkhead box E1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of FOXE1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:61,954,549...61,957,357
Ensembl chr 5:61,954,549...61,957,357
|
|
G |
Foxf2 |
forkhead box F2 |
decreases expression |
ISO |
Vitamin E results in decreased expression of FOXF2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr17:34,150,417...34,156,450
|
|
G |
Foxm1 |
forkhead box M1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of FOXM1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:161,685,236...161,697,633
Ensembl chr 4:161,685,258...161,696,305
|
|
G |
Foxo1 |
forkhead box O1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of FOXO1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 2:141,451,234...141,527,016
Ensembl chr 2:141,451,234...141,527,016
|
|
G |
Frat1 |
FRAT regulator of WNT signaling pathway 1 |
increases expression |
ISO |
Vitamin E results in increased expression of FRAT1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:261,071,965...261,075,244
|
|
G |
Fshb |
follicle stimulating hormone subunit beta |
multiple interactions |
EXP |
Vitamin E inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased expression of FSHB protein]; Vitamin E inhibits the reaction [chromium hexavalent ion results in increased expression of FSHB protein]; Vitamin E inhibits the reaction [cypermethrin results in decreased expression of FSHB protein]; Vitamin E inhibits the reaction [Petroleum results in increased expression of FSHB protein]; Vitamin E inhibits the reaction [Potassium Dichromate results in increased expression of FSHB protein] |
CTD |
PMID:17280759 PMID:20079796 PMID:24759048 PMID:25046308 |
|
NCBI chr 3:98,088,321...98,092,131
Ensembl chr 3:98,088,324...98,092,131
|
|
G |
Fst |
follistatin |
increases expression |
ISO |
Vitamin E results in increased expression of FST mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 2:46,537,589...46,544,813
Ensembl chr 2:46,538,700...46,544,457
|
|
G |
Ftsj1 |
FtsJ RNA 2'-O-methyltransferase 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of FTSJ1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr X:14,993,685...15,006,010
Ensembl chr X:14,994,016...15,002,074
|
|
G |
Fus |
FUS RNA binding protein |
increases expression |
ISO |
Vitamin E results in increased expression of FUS mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:199,412,805...199,426,705
Ensembl chr 1:199,412,834...199,426,702
|
|
G |
Fxr1 |
FMR1 autosomal homolog 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of FXR1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 2:120,529,716...120,570,356
Ensembl chr 2:120,512,899...120,570,355
|
|
G |
Fxr2 |
FMR1 autosomal homolog 2 |
increases expression |
ISO |
Vitamin E results in increased expression of FXR2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:56,237,814...56,257,877
Ensembl chr10:56,237,755...56,257,890
|
|
G |
Fxyd6 |
FXYD domain-containing ion transport regulator 6 |
increases expression |
ISO |
Vitamin E results in increased expression of FXYD6 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:49,676,520...49,703,419
Ensembl chr 8:49,676,540...49,703,419
|
|
G |
Fyn |
FYN proto-oncogene, Src family tyrosine kinase |
multiple interactions |
ISO |
alpha-Tocopherol inhibits the reaction [bis(2-hydroxy-2-ethylbutanoato)oxochromate(V) results in increased phosphorylation of FYN protein]; alpha-Tocopherol inhibits the reaction [Potassium Dichromate results in increased phosphorylation of FYN protein] |
CTD |
PMID:14572611 |
|
NCBI chr20:44,436,354...44,630,316
Ensembl chr20:44,436,403...44,630,317
|
|
G |
Fzr1 |
fizzy and cell division cycle 20 related 1 |
increases expression multiple interactions |
ISO |
Vitamin E results in increased expression of FZR1 mRNA [Selenium co-treated with Vitamin E] results in increased expression of FZR1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:11,201,690...11,213,614
Ensembl chr 7:11,201,690...11,213,613
|
|
G |
G0s2 |
G0/G1switch 2 |
increases expression |
ISO |
Vitamin E results in increased expression of G0S2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr13:112,004,140...112,005,052
Ensembl chr13:112,004,140...112,005,052
|
|
G |
G6pd |
glucose-6-phosphate dehydrogenase |
multiple interactions |
ISO |
Vitamin E inhibits the reaction [sodium arsenite results in decreased activity of G6PD protein] |
CTD |
PMID:19635623 |
|
NCBI chr X:156,274,800...156,293,935
Ensembl chr X:156,274,800...156,293,926
|
|
G |
Gab2 |
GRB2-associated binding protein 2 |
increases expression |
ISO |
Vitamin E results in increased expression of GAB2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:162,082,876...162,283,379
Ensembl chr 1:162,083,030...162,279,727
|
|
G |
Gabpb2 |
GA binding protein transcription factor subunit beta 2 |
decreases expression |
ISO |
Vitamin E results in decreased expression of GABPB2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 2:196,357,030...196,392,514
Ensembl chr 2:196,359,243...196,377,883
|
|
G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
increases expression decreases expression multiple interactions |
EXP ISO |
alpha-Tocopherol results in increased expression of GADD45A mRNA Vitamin E results in decreased expression of GADD45A mRNA [Selenium co-treated with Vitamin E] results in increased expression of GADD45A mRNA |
CTD |
PMID:19244175 PMID:26332274 |
|
NCBI chr 4:97,782,512...97,784,814
Ensembl chr 4:97,782,512...97,784,842
|
|
G |
Gak |
cyclin G associated kinase |
decreases expression |
ISO |
Vitamin E results in decreased expression of GAK mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:2,100,104...2,174,332
Ensembl chr14:2,100,106...2,174,318
|
|
G |
Galnt1 |
polypeptide N-acetylgalactosaminyltransferase 1 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of GALNT1 mRNA Vitamin E results in decreased expression of GALNT1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr18:16,141,062...16,187,271
Ensembl chr18:16,146,447...16,185,496
|
|
G |
Galnt10 |
polypeptide N-acetylgalactosaminyltransferase 10 |
decreases expression |
ISO |
Vitamin E results in decreased expression of GALNT10 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:43,067,316...43,208,992
Ensembl chr10:43,067,299...43,210,427
|
|
G |
Galnt3 |
polypeptide N-acetylgalactosaminyltransferase 3 |
decreases expression |
ISO |
Vitamin E results in decreased expression of GALNT3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:52,174,469...52,212,395
Ensembl chr 3:52,175,547...52,212,412
|
|
G |
Galr3 |
galanin receptor 3 |
increases expression |
ISO |
Vitamin E results in increased expression of GALR3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:120,271,451...120,276,243
Ensembl chr 7:120,273,117...120,275,581
|
|
G |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
increases expression |
ISO |
Vitamin E results in increased expression of GAPDH mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:157,676,336...157,680,322
Ensembl chr 4:157,676,595...157,679,962
|
|
G |
Gas8 |
growth arrest specific 8 |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of GAS8 mRNA Vitamin E results in increased expression of GAS8 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:56,316,367...56,335,873
Ensembl chr19:56,316,268...56,335,870
|
|
G |
Gata4 |
GATA binding protein 4 |
affects expression |
EXP |
Vitamin E affects the expression of GATA4 mRNA |
CTD |
PMID:15370891 |
|
NCBI chr15:46,386,703...46,458,679
Ensembl chr15:46,386,712...46,432,965
|
|
G |
Gatad1 |
GATA zinc finger domain containing 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of GATAD1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:27,647,005...27,658,533
Ensembl chr 4:27,647,335...27,657,167
|
|
G |
Gatd3a |
glutamine amidotransferase like class 1 domain containing 3A |
increases expression |
ISO |
Vitamin E results in increased expression of GATD3A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:11,244,353...11,252,450
Ensembl chr20:11,244,353...11,252,449
|
|
G |
Gbp1 |
guanylate binding protein 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of GBP1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 2:248,343,334...248,423,402
Ensembl chr 2:248,398,917...248,409,570
|
|
G |
Gcfc2 |
GC-rich sequence DNA-binding factor 2 |
decreases expression |
ISO |
Vitamin E results in decreased expression of GCFC2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:112,662,556...112,700,505
Ensembl chr 4:112,662,609...112,699,711
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
multiple interactions affects expression |
ISO EXP |
[alpha-Tocopherol co-treated with Paraquat] results in increased expression of GCLC mRNA [Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of GCLC mRNA; Vitamin E affects the reaction [[REL binds to GCLC promoter] which affects the expression of GCLC mRNA] Vitamin E affects the expression of GCLC mRNA; Vitamin E affects the expression of GCLC protein Vitamin E inhibits the reaction [Alcohols results in increased expression of GCLC mRNA] |
CTD |
PMID:11444866 PMID:16298738 PMID:18814483 PMID:24530478 |
|
NCBI chr 8:85,059,051...85,097,471
Ensembl chr 8:85,059,051...85,097,468
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
multiple interactions affects expression |
ISO EXP |
[alpha-Tocopherol co-treated with Paraquat] results in increased expression of GCLM mRNA Vitamin E affects the expression of GCLM mRNA [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of GCLM mRNA]; Vitamin E affects the reaction [[REL binds to GCLM promoter] which affects the expression of GCLM mRNA] |
CTD |
PMID:16298738 PMID:20447326 PMID:22389237 PMID:24530478 |
|
NCBI chr 2:225,827,504...225,847,876
Ensembl chr 2:225,827,504...225,847,874
|
|
G |
Gdap1l1 |
ganglioside-induced differentiation-associated protein 1-like 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of GDAP1L1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:159,823,791...159,843,260
Ensembl chr 3:159,823,878...159,842,278
|
|
G |
Gdi1 |
GDP dissociation inhibitor 1 |
increases expression |
ISO |
Vitamin E results in increased expression of GDI1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr X:156,400,734...156,407,396
Ensembl chr X:156,400,736...156,407,404
|
|
G |
Gfap |
glial fibrillary acidic protein |
increases expression multiple interactions |
EXP |
alpha-Tocopherol results in increased expression of GFAP protein Vitamin E inhibits the reaction [Aluminum results in increased expression of GFAP protein] |
CTD |
PMID:16545059 PMID:18942769 |
|
NCBI chr10:90,990,762...90,999,435
Ensembl chr10:90,990,762...90,999,506
|
|
G |
Gfod1 |
glucose-fructose oxidoreductase domain containing 1 |
increases expression |
ISO |
Vitamin E results in increased expression of GFOD1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr17:23,818,370...23,924,393
Ensembl chr17:23,823,632...23,923,792
|
|
G |
Gfus |
GDP-L-fucose synthase |
increases expression |
ISO |
Vitamin E results in increased expression of GFUS mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:116,958,427...116,963,281
Ensembl chr 7:116,958,392...116,963,295
|
|
G |
Ggps1 |
geranylgeranyl diphosphate synthase 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of GGPS1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr17:53,956,185...53,971,039
Ensembl chr17:53,956,203...53,971,443
|
|
G |
Ggt1 |
gamma-glutamyltransferase 1 |
multiple interactions |
ISO EXP |
[Selenium co-treated with Vitamin E] results in increased expression of GGT1 mRNA Vitamin E inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased activity of GGT1 protein] |
CTD |
PMID:16298753 PMID:19244175 |
|
NCBI chr20:14,019,723...14,045,781
Ensembl chr20:14,019,723...14,025,068
|
|
G |
Gigyf2 |
GRB10 interacting GYF protein 2 |
decreases expression |
ISO |
Vitamin E results in decreased expression of GIGYF2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:94,425,191...94,550,431
Ensembl chr 9:94,425,252...94,550,431
|
|
G |
Gimap5 |
GTPase, IMAP family member 5 |
increases expression |
ISO |
Vitamin E results in increased expression of GIMAP5 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:78,377,228...78,386,683
Ensembl chr 4:78,378,144...78,385,577
|
|
G |
Gipc1 |
GIPC PDZ domain containing family, member 1 |
increases expression multiple interactions |
ISO |
Vitamin E results in increased expression of GIPC1 mRNA [Selenium co-treated with Vitamin E] results in increased expression of GIPC1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:24,786,604...24,798,231
Ensembl chr19:24,786,628...24,798,233
|
|
G |
Gja1 |
gap junction protein, alpha 1 |
multiple interactions |
EXP |
[Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of GJA1 protein]; [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of GJA1 protein] |
CTD |
PMID:29940330 |
|
NCBI chr20:37,876,650...37,889,097
Ensembl chr20:37,876,650...37,889,089
|
|
G |
Glg1 |
golgi glycoprotein 1 |
decreases expression increases expression |
ISO |
Vitamin E results in decreased expression of GLG1 mRNA Vitamin E results in increased expression of GLG1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:42,983,879...43,088,074
Ensembl chr19:42,983,869...43,090,841
|
|
G |
Gli2 |
GLI family zinc finger 2 |
increases expression |
ISO |
Vitamin E results in increased expression of GLI2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr13:34,829,021...35,049,172
Ensembl chr13:34,829,139...35,048,444
|
|
G |
Glmn |
glomulin, FKBP associated protein |
decreases expression |
ISO |
Vitamin E results in decreased expression of GLMN mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:3,204,390...3,247,703
Ensembl chr14:3,204,390...3,247,695
|
|
G |
Gmppa |
GDP-mannose pyrophosphorylase A |
increases expression |
ISO |
Vitamin E results in increased expression of GMPPA mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:82,632,267...82,639,811
Ensembl chr 9:82,632,230...82,639,821
|
|
G |
Gnai2 |
G protein subunit alpha i2 |
multiple interactions |
EXP |
alpha-Tocopherol inhibits the reaction [Glucose results in decreased expression of GNAI2 protein] |
CTD |
PMID:18441196 |
|
NCBI chr 8:116,370,730...116,391,337
Ensembl chr 8:116,370,744...116,391,307
|
|
G |
Gnai3 |
G protein subunit alpha i3 |
multiple interactions |
EXP |
alpha-Tocopherol inhibits the reaction [Glucose results in decreased expression of GNAI3 protein] |
CTD |
PMID:18441196 |
|
NCBI chr 2:210,896,779...210,934,733
Ensembl chr 2:210,896,656...210,934,749
|
|
G |
Gnas |
GNAS complex locus |
multiple interactions |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of GNAS mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:172,374,957...172,434,988
Ensembl chr 3:172,374,957...172,428,483 Ensembl chr 3:172,374,957...172,428,483
|
|
G |
Gnaz |
G protein subunit alpha z |
increases expression |
ISO |
Vitamin E results in increased expression of GNAZ mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:14,593,072...14,644,020
Ensembl chr20:14,593,819...14,620,019
|
|
G |
Gng4 |
G protein subunit gamma 4 |
decreases expression |
ISO |
Vitamin E results in decreased expression of GNG4 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr17:90,266,571...90,316,278
Ensembl chr17:90,266,794...90,315,492
|
|
G |
Golga3 |
golgin A3 |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of GOLGA3 mRNA Vitamin E results in increased expression of GOLGA3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:52,510,509...52,558,606
Ensembl chr12:52,512,970...52,558,606
|
|
G |
Gosr1 |
golgi SNAP receptor complex member 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of GOSR1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:63,405,526...63,442,257
Ensembl chr10:63,405,586...63,442,250
|
|
G |
Gp6 |
glycoprotein VI |
decreases expression |
ISO |
Vitamin E results in decreased expression of GP6 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:72,994,977...73,064,639
Ensembl chr 1:73,040,901...73,064,641
|
|
G |
Gpatch8 |
G patch domain containing 8 |
decreases expression |
ISO |
Vitamin E results in decreased expression of GPATCH8 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:90,421,443...90,501,996
Ensembl chr10:90,421,442...90,501,819
|
|
G |
Gpi |
glucose-6-phosphate isomerase |
increases expression |
ISO |
Vitamin E results in increased expression of GPI mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:90,063,411...90,091,287
Ensembl chr 1:90,063,411...90,091,287
|
|
G |
Gpkow |
G patch domain and KOW motifs |
increases expression |
ISO |
Vitamin E results in increased expression of GPKOW mRNA |
CTD |
PMID:19244175 |
|
NCBI chr X:15,636,567...15,651,332
Ensembl chr X:15,636,563...15,651,332
|
|
G |
Gpn3 |
GPN-loop GTPase 3 |
decreases expression |
ISO |
Vitamin E results in decreased expression of GPN3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:39,670,746...39,679,364
Ensembl chr12:39,670,453...39,679,510
|
|
G |
Gpr107 |
G protein-coupled receptor 107 |
increases expression |
ISO |
Vitamin E results in increased expression of GPR107 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:10,632,876...10,694,654
Ensembl chr 3:10,632,896...10,694,649
|
|
G |
Gprin2 |
G protein regulated inducer of neurite outgrowth 2 |
decreases expression multiple interactions |
ISO |
Vitamin E results in decreased expression of GPRIN2 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of GPRIN2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr16:10,524,880...10,534,705
Ensembl chr16:10,527,697...10,529,061
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
multiple interactions |
EXP |
[Quercetin co-treated with Vitamin E] inhibits the reaction [Cyclosporine results in increased activity of GPT protein]; alpha-Tocopherol inhibits the reaction [beryllium nitrate results in increased activity of GPT protein]; Vitamin E inhibits the reaction [Cyclophosphamide results in increased expression of GPT protein]; Vitamin E inhibits the reaction [Cyclosporine results in increased activity of GPT protein]; Vitamin E inhibits the reaction [Food Additives results in increased activity of GPT protein] |
CTD |
PMID:16758767 PMID:17429802 PMID:17927767 PMID:25779342 |
|
NCBI chr 7:117,759,083...117,761,932
Ensembl chr 7:117,759,083...117,761,931
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
multiple interactions |
ISO EXP |
[Ascorbic Acid co-treated with Vitamin E] results in increased expression of GPX1 mRNA; [Vitamin A co-treated with Ascorbic Acid co-treated with Vitamin E] results in increased expression of GPX1 protein; Vitamin E inhibits the reaction [Aluminum results in decreased activity of GPX1 protein] [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Diethylhexyl Phthalate results in increased expression of GPX1 protein]; [Curcumin co-treated with Vitamin E] inhibits the reaction [Thyroxine results in increased expression of GPX1 protein]; [Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of GPX1 mRNA; Vitamin E inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased activity of GPX1 protein]; Vitamin E inhibits the reaction [Endosulfan results in increased activity of GPX1 protein]; Vitamin E inhibits the reaction [Thyroxine results in decreased expression of GPX1 mRNA] |
CTD |
PMID:11444866 PMID:15337585 PMID:16298753 PMID:17179735 PMID:17709913 PMID:19914224 PMID:22207723 PMID:29663635 |
|
NCBI chr 8:117,117,430...117,118,528
Ensembl chr 8:117,117,430...117,118,522
|
|
G |
Gpx2 |
glutathione peroxidase 2 |
multiple interactions |
EXP |
Vitamin E inhibits the reaction [phoxim results in increased expression of GPX2 mRNA] |
CTD |
PMID:30003487 |
|
NCBI chr 6:99,839,960...99,843,245
Ensembl chr 6:99,839,960...99,843,245
|
|
G |
Gpx3 |
glutathione peroxidase 3 |
increases expression |
ISO |
Vitamin E results in increased expression of GPX3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:40,247,436...40,255,423
Ensembl chr10:40,247,436...40,255,422
|
|
G |
Gpx4 |
glutathione peroxidase 4 |
multiple interactions |
ISO |
alpha-Tocopherol inhibits the reaction [Sodium Selenite results in increased expression of GPX4 mRNA] |
CTD |
PMID:14642406 |
|
NCBI chr 7:12,516,357...12,519,154
Ensembl chr 7:12,516,352...12,519,154
|
|
G |
Grhpr |
glyoxylate and hydroxypyruvate reductase |
increases expression |
ISO |
Vitamin E results in increased expression of GRHPR mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:60,528,981...60,538,410
Ensembl chr 5:60,528,997...60,538,375
|
|
G |
Gria2 |
glutamate ionotropic receptor AMPA type subunit 2 |
decreases expression |
ISO |
Vitamin E results in decreased expression of GRIA2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 2:179,584,302...179,704,629
Ensembl chr 2:179,584,308...179,704,629
|
|
G |
Grina |
glutamate ionotropic receptor NMDA type subunit associated protein 1 |
multiple interactions |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of GRINA mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:117,304,742...117,307,916
Ensembl chr 7:117,304,742...117,307,916
|
|
G |
Grk3 |
G protein-coupled receptor kinase 3 |
decreases expression |
ISO |
Vitamin E results in decreased expression of GRK3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:49,626,871...49,750,389
Ensembl chr12:49,626,871...49,746,272
|
|
G |
Grn |
granulin precursor |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of GRN mRNA Vitamin E results in increased expression of GRN mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:90,377,103...90,383,207
Ensembl chr10:90,376,933...90,383,205
|
|
G |
Gsk3a |
glycogen synthase kinase 3 alpha |
increases expression |
ISO |
Vitamin E results in increased expression of GSK3A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:82,097,244...82,108,238
Ensembl chr 1:82,097,247...82,108,203
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of GSK3B mRNA Vitamin E results in decreased expression of GSK3B mRNA Vitamin E inhibits the reaction [wortmannin results in decreased expression of GSK3B protein modified form] |
CTD |
PMID:15842767 PMID:19244175 |
|
NCBI chr11:65,060,884...65,208,842
Ensembl chr11:65,066,235...65,209,268
|
|
G |
Gsn |
gelsolin |
increases expression |
ISO |
Vitamin E results in increased expression of GSN mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:14,456,106...14,508,922
Ensembl chr 3:14,467,330...14,508,911
|
|
G |
Gsr |
glutathione-disulfide reductase |
multiple interactions |
ISO EXP |
Vitamin E inhibits the reaction [Cadmium results in decreased activity of GSR protein]; Vitamin E inhibits the reaction [Ethanol results in decreased activity of GSR protein] [Curcumin co-treated with Vitamin E] inhibits the reaction [Thyroxine results in decreased expression of GSR mRNA]; [Vitamin E co-treated with coenzyme Q10] inhibits the reaction [Cadmium Chloride results in decreased activity of GSR protein]; [Vitamin E co-treated with coenzyme Q10] results in increased activity of GSR protein; alpha-Tocopherol inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased activity of GSR protein]; Vitamin E inhibits the reaction [Cadmium Chloride results in decreased activity of GSR protein]; Vitamin E inhibits the reaction [Cadmium results in increased activity of GSR protein]; Vitamin E inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased activity of GSR protein]; Vitamin E inhibits the reaction [Diethylnitrosamine results in decreased activity of GSR protein]; Vitamin E inhibits the reaction [Methoxychlor results in decreased activity of GSR protein]; Vitamin E inhibits the reaction [Tetrachlorodibenzodioxin results in decreased activity of GSR protein]; Vitamin E inhibits the reaction [Thyroxine results in decreased expression of GSR mRNA] |
CTD |
PMID:11955947 PMID:12355564 PMID:14535831 PMID:16144695 PMID:16298753 PMID:16979807 PMID:17262218 PMID:19914224 PMID:19958828 PMID:21086752 |
|
NCBI chr16:62,197,617...62,239,987
Ensembl chr16:62,197,617...62,241,361
|
|
G |
Gstk1 |
glutathione S-transferase kappa 1 |
increases expression |
ISO |
Vitamin E results in increased expression of GSTK1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:71,621,777...71,626,096
Ensembl chr 4:71,621,729...71,626,107
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
multiple interactions |
EXP |
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of GSTM1 mRNA] |
CTD |
PMID:22389237 |
|
NCBI chr 2:210,803,869...210,809,461
Ensembl chr 2:210,803,869...210,809,306
|
|
G |
Gstm3l |
glutathione S-transferase mu 3-like |
increases expression |
ISO |
Vitamin E results in increased expression of GSTM5 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 2:210,761,729...210,766,501
Ensembl chr 2:210,761,729...210,766,501
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
increases expression multiple interactions |
ISO |
Vitamin E results in increased expression of GSTP1 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of GSTP1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:219,291,679...219,294,147
Ensembl chr 1:219,291,679...219,294,147
|
|
G |
Gstt1 |
glutathione S-transferase theta 1 |
increases expression |
EXP |
alpha-Tocopherol results in increased expression of GSTT1 protein |
CTD |
PMID:9855024 |
|
NCBI chr20:13,799,102...13,816,527
Ensembl chr20:13,799,102...13,816,526
|
|
G |
Gtf2f1 |
general transcription factor IIF subunit 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of GTF2F1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:10,032,806...10,042,392
Ensembl chr 9:10,033,011...10,042,418
|
|
G |
Gtf2ird1 |
GTF2I repeat domain containing 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of GTF2IRD1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:25,264,052...25,370,947
Ensembl chr12:25,264,192...25,371,001
|
|
G |
Gtpbp8 |
GTP-binding protein 8 (putative) |
decreases expression multiple interactions |
ISO |
Vitamin E results in decreased expression of GTPBP8 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of GTPBP8 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr11:60,906,990...60,916,958
Ensembl chr11:60,907,015...60,916,842
|
|
G |
Gusb |
glucuronidase, beta |
multiple interactions |
ISO |
alpha-Tocopherol inhibits the reaction [cumene hydroperoxide results in decreased uptake of GUSB protein]; alpha-Tocopherol inhibits the reaction [cumene hydroperoxide results in increased secretion of GUSB protein] |
CTD |
PMID:19135433 |
|
NCBI chr12:30,202,066...30,215,583
Ensembl chr12:30,198,822...30,227,771
|
|
G |
H3f3a |
H3.3 histone A |
decreases expression |
ISO |
Vitamin E results in decreased expression of H3-3A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr13:99,091,246...99,102,828
Ensembl chr13:99,091,763...99,101,208
|
|
G |
H6pd |
hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) |
increases expression multiple interactions |
ISO |
Vitamin E results in increased expression of H6PD mRNA [Selenium co-treated with Vitamin E] results in decreased expression of H6PD mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:166,994,683...167,030,441
Ensembl chr 5:166,998,881...167,030,441
|
|
G |
Hadha |
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha |
decreases expression |
ISO |
Vitamin E results in decreased expression of HADHA mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:27,589,840...27,628,921
Ensembl chr 6:27,589,657...27,629,175
|
|
G |
Hagh |
hydroxyacyl glutathione hydrolase |
increases expression |
ISO |
Vitamin E results in increased expression of HAGH mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:14,215,913...14,230,506
Ensembl chr10:14,216,155...14,230,515
|
|
G |
Hal |
histidine ammonia lyase |
increases expression |
EXP |
alpha-Tocopherol results in increased expression of HAL mRNA |
CTD |
PMID:16908007 |
|
NCBI chr 7:34,326,087...34,356,413
Ensembl chr 7:34,326,087...34,356,413
|
|
G |
Hamp |
hepcidin antimicrobial peptide |
multiple interactions |
ISO |
Vitamin E inhibits the reaction [Ethanol results in decreased expression of HAMP mRNA] |
CTD |
PMID:16737972 |
|
NCBI chr 1:89,368,021...89,369,960
Ensembl chr 1:89,368,021...89,369,960
|
|
G |
Hars1 |
histidyl-tRNA synthetase 1 |
increases expression |
ISO |
Vitamin E results in increased expression of HARS1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr18:29,611,545...29,629,087
Ensembl chr18:29,611,547...29,629,087
|
|
G |
Haus3 |
HAUS augmin-like complex, subunit 3 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of HAUS3 mRNA Vitamin E results in decreased expression of HAUS3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:81,837,772...81,857,458
Ensembl chr14:81,837,809...81,856,830
|
|
G |
Haus4 |
HAUS augmin-like complex, subunit 4 |
increases expression |
ISO |
Vitamin E results in increased expression of HAUS4 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr15:33,182,139...33,193,880
Ensembl chr15:33,182,128...33,193,537
|
|
G |
Hba-a2 |
hemoglobin alpha, adult chain 2 |
decreases expression |
ISO |
Vitamin E results in decreased expression of HBA1 protein |
CTD |
PMID:1991440 |
|
NCBI chr10:15,589,364...15,590,207
Ensembl chr10:15,589,364...15,590,220
|
|
G |
Hcfc1 |
host cell factor C1 |
increases expression |
ISO |
Vitamin E results in increased expression of HCFC1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr X:156,812,012...156,837,227
Ensembl chr X:156,812,064...156,837,227
|
|
G |
Hdac1 |
histone deacetylase 1 |
increases expression |
ISO |
Vitamin E results in increased expression of HDAC1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:147,716,664...147,743,723
Ensembl chr 5:147,716,664...147,743,723
|
|
G |
Hdac5 |
histone deacetylase 5 |
increases expression |
ISO |
Vitamin E results in increased expression of HDAC5 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:90,140,183...90,169,853
Ensembl chr10:90,140,183...90,151,042
|
|
G |
Hemk1 |
HemK methyltransferase family member 1 |
increases expression |
ISO |
Vitamin E results in increased expression of HEMK1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:116,081,858...116,092,872
Ensembl chr 8:116,082,005...116,092,763
|
|
G |
Hes1 |
hes family bHLH transcription factor 1 |
decreases expression multiple interactions |
ISO EXP |
Vitamin E results in decreased expression of HES1 mRNA [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of HES1 protein] [Selenium co-treated with Vitamin E] results in increased expression of HES1 mRNA |
CTD |
PMID:19244175 PMID:29663635 |
|
NCBI chr11:74,312,837...74,315,249
Ensembl chr11:74,312,806...74,315,248
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
decreases expression |
ISO |
Vitamin E results in decreased expression of HIF1A protein |
CTD |
PMID:16507596 |
|
NCBI chr 6:96,810,868...96,856,303
Ensembl chr 6:96,810,907...96,856,052
|
|
G |
Hif1an |
hypoxia inducible factor 1 subunit alpha inhibitor |
increases expression |
ISO |
Vitamin E results in increased expression of HIF1AN mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:264,309,214...264,319,269
Ensembl chr 1:264,309,214...264,319,267
|
|
G |
Higd2a |
HIG1 hypoxia inducible domain family, member 2A |
increases expression |
ISO |
Vitamin E results in increased expression of HIGD2A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr17:10,558,714...10,559,638
Ensembl chr17:10,558,714...10,559,627
|
|
G |
Hipk2 |
homeodomain interacting protein kinase 2 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of HIPK2 mRNA Vitamin E results in decreased expression of HIPK2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:66,438,390...66,625,183
Ensembl chr 4:66,445,266...66,624,912
|
|
G |
Hmces |
5-hydroxymethylcytosine binding, ES cell specific |
increases expression |
ISO |
Vitamin E results in increased expression of HMCES mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:119,841,088...119,864,115
Ensembl chr 4:119,815,139...119,864,114
|
|
G |
Hmgb1 |
high mobility group box 1 |
decreases expression multiple interactions |
ISO |
Vitamin E results in decreased expression of HMGB1 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of HMGB1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:7,082,529...7,090,246
Ensembl chr16:37,500,017...37,502,237
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
multiple interactions |
EXP |
[Quercetin co-treated with alpha-Tocopherol] inhibits the reaction [Cadmium results in increased activity of HMGCR protein]; [Quercetin co-treated with alpha-Tocopherol] inhibits the reaction [Isoproterenol results in increased activity of HMGCR protein] |
CTD |
PMID:19595682 PMID:21535577 |
|
NCBI chr 2:27,480,224...27,500,654
Ensembl chr 2:27,480,226...27,500,654
|
|
G |
Hmgxb4 |
HMG-box containing 4 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of HMGXB4 mRNA Vitamin E results in decreased expression of HMGXB4 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:14,352,644...14,390,499
Ensembl chr19:14,352,411...14,390,478
|
|
G |
Hmox1 |
heme oxygenase 1 |
affects expression multiple interactions increases expression |
ISO EXP |
alpha-Tocopherol affects the expression of HMOX1 mRNA alpha-Tocopherol inhibits the reaction [benzo(a)pyrene-7,8-dione results in increased expression of HMOX1 protein]; Vitamin E inhibits the reaction [Polychlorinated Biphenyls analog results in increased expression of HMOX1 protein] Vitamin E results in increased expression of HMOX1 mRNA [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of HMOX1 mRNA]; [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of HMOX1 protein]; [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Diethylhexyl Phthalate results in increased expression of HMOX1 protein]; alpha-Tocopherol inhibits the reaction [Paraquat results in increased activity of HMOX1 protein] |
CTD |
PMID:8743975 PMID:12180188 PMID:15571180 PMID:22053912 PMID:22389237 PMID:24361488 PMID:29663635 PMID:29940330 PMID:30513525 |
|
NCBI chr19:14,508,634...14,515,455
Ensembl chr19:14,508,616...14,515,456
|
|
G |
Hnmt |
histamine N-methyltransferase |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of HNMT mRNA Vitamin E results in decreased expression of HNMT mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:905,111...937,038
Ensembl chr 3:904,765...937,102
|
|
G |
Hnrnpm |
heterogeneous nuclear ribonucleoprotein M |
increases expression |
ISO |
Vitamin E results in increased expression of HNRNPM mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:18,516,253...18,554,536
Ensembl chr 7:18,516,512...18,554,227
|
|
G |
Hnrnpr |
heterogeneous nuclear ribonucleoprotein R |
decreases expression |
ISO |
Vitamin E results in decreased expression of HNRNPR mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:154,668,194...154,699,967
Ensembl chr 5:154,668,179...154,699,966
|
|
G |
Homer1 |
homer scaffold protein 1 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of HOMER1 mRNA Vitamin E results in decreased expression of HOMER1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 2:22,909,550...23,012,303
Ensembl chr 2:22,909,569...23,009,678
|
|
G |
Hook1 |
hook microtubule-tethering protein 1 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of HOOK1 mRNA Vitamin E results in decreased expression of HOOK1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:114,940,053...115,000,691
Ensembl chr 5:114,940,053...115,000,691
|
|
G |
Hoxa11 |
homeobox A11 |
increases expression |
ISO |
Vitamin E results in increased expression of HOXA11 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:82,296,888...82,301,419
Ensembl chr 4:82,298,152...82,300,503 Ensembl chr 4:82,298,152...82,300,503
|
|
G |
Hoxa7 |
homeobox A7 |
decreases expression |
ISO |
Vitamin E results in decreased expression of HOXA7 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:82,184,299...82,187,890
Ensembl chr 4:82,183,196...82,186,190
|
|
G |
Hp |
haptoglobin |
affects activity multiple interactions |
ISO |
alpha-Tocopherol affects the activity of HP protein polymorphism Ascorbic Acid inhibits the reaction [alpha-Tocopherol affects the activity of HP protein polymorphism] |
CTD |
PMID:19769483 |
|
NCBI chr19:42,096,255...42,100,805
Ensembl chr19:42,097,995...42,100,804
|
|
G |
Hpcal1 |
hippocalcin-like 1 |
increases expression multiple interactions |
ISO |
Vitamin E results in increased expression of HPCAL1 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of HPCAL1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:43,001,920...43,109,083
Ensembl chr 6:43,001,948...43,109,071
|
|
G |
Hprt1 |
hypoxanthine phosphoribosyltransferase 1 |
multiple interactions |
EXP |
Vitamin E inhibits the reaction [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased mutagenesis of HPRT1 gene] |
CTD |
PMID:12467141 |
|
NCBI chr X:158,196,640...158,228,815
Ensembl chr X:158,197,149...158,228,749
|
|
G |
Hras |
HRas proto-oncogene, GTPase |
multiple interactions increases expression |
ISO |
Vitamin E inhibits the reaction [Urethane promotes the reaction [RAF1 protein binds to HRAS protein]] Vitamin E results in increased expression of HRAS mRNA [Selenium co-treated with Vitamin E] results in increased expression of HRAS mRNA |
CTD |
PMID:11062179 PMID:19244175 |
|
NCBI chr 1:214,178,404...214,181,841
Ensembl chr 1:214,178,407...214,181,686
|
|
G |
Hsd11b1 |
hydroxysteroid 11-beta dehydrogenase 1 |
increases expression |
ISO |
Vitamin E results in increased expression of HSD11B1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr13:111,946,626...111,996,536
Ensembl chr13:111,926,442...111,972,603
|
|
G |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
multiple interactions |
EXP |
[Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of HSD11B2 mRNA |
CTD |
PMID:11444866 |
|
NCBI chr19:37,476,083...37,481,326
Ensembl chr19:37,476,095...37,481,307
|
|
G |
Hsd17b3 |
hydroxysteroid (17-beta) dehydrogenase 3 |
multiple interactions |
EXP |
alpha-Tocopherol inhibits the reaction [Mercuric Chloride results in decreased expression of HSD17B3 mRNA]; Vitamin E inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased expression of HSD17B3 mRNA] |
CTD |
PMID:17280759 PMID:32134168 |
|
NCBI chr17:1,579,319...1,610,745
Ensembl chr17:1,579,319...1,610,745
|
|
G |
Hsd17b8 |
hydroxysteroid (17-beta) dehydrogenase 8 |
increases expression |
ISO |
Vitamin E results in increased expression of HSD17B8 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:3,817,212...3,819,316
Ensembl chr20:3,817,179...3,819,235
|
|
G |
Hsd3b1 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
multiple interactions |
EXP |
Vitamin E inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased expression of HSD3B1 mRNA] |
CTD |
PMID:17280759 |
|
|
|
G |
Hsd3b2 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 |
multiple interactions |
EXP |
alpha-Tocopherol inhibits the reaction [Mercuric Chloride results in decreased expression of HSD3B2 mRNA] |
CTD |
PMID:32134168 |
|
NCBI chr 2:200,712,895...200,722,429
Ensembl chr 2:202,341,422...202,350,929
|
|
G |
Hsp90aa1 |
heat shock protein 90 alpha family class A member 1 |
decreases expression multiple interactions |
ISO |
Vitamin E results in decreased expression of HSP90AA1 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of HSP90AA1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:135,107,262...135,112,793
Ensembl chr 6:135,107,271...135,112,775
|
|
G |
Hsp90ab1 |
heat shock protein 90 alpha family class B member 1 |
increases expression |
ISO |
Vitamin E results in increased expression of HSP90AB1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:17,817,791...17,823,163
Ensembl chr 9:17,817,721...17,823,243
|
|
G |
Hsp90b1 |
heat shock protein 90 beta family member 1 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of HSP90B1 mRNA Vitamin E results in decreased expression of HSP90B1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:27,226,570...27,240,533
Ensembl chr 7:27,226,569...27,240,533
|
|
G |
Hspa1a |
heat shock protein family A (Hsp70) member 1A |
increases expression |
ISO |
Vitamin E results in increased expression of HSPA1A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:4,875,834...4,881,751
Ensembl chr20:4,877,324...4,879,779
|
|
G |
Hspa1b |
heat shock protein family A (Hsp70) member 1B |
increases expression |
EXP |
alpha-Tocopherol results in increased expression of HSPA1B mRNA |
CTD |
PMID:16908007 |
|
NCBI chr20:4,877,638...4,880,112
Ensembl chr20:2,699,712...2,701,815
|
|
G |
Hspa4 |
heat shock protein family A (Hsp70) member 4 |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of HSPA4 mRNA Vitamin E results in increased expression of HSPA4 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:38,601,624...38,642,397
Ensembl chr10:38,601,624...38,642,397
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
multiple interactions |
ISO |
Vitamin E inhibits the reaction [pyrazole results in increased expression of HSPA5 protein] |
CTD |
PMID:18068688 |
|
NCBI chr 3:13,838,304...13,842,763
Ensembl chr 3:13,838,304...13,842,762
|
|
G |
Hspa9 |
heat shock protein family A (Hsp70) member 9 |
decreases expression multiple interactions |
ISO |
Vitamin E results in decreased expression of HSPA9 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of HSPA9 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr18:27,731,072...27,749,235
Ensembl chr18:27,731,072...27,749,235
|
|
G |
Hspb1 |
heat shock protein family B (small) member 1 |
increases expression |
ISO |
Vitamin E results in increased expression of HSPB1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:23,839,390...23,841,051
Ensembl chr12:23,839,399...23,841,049
|
|
G |
Htra1 |
HtrA serine peptidase 1 |
increases expression |
ISO |
Vitamin E results in increased expression of HTRA1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:201,499,067...201,548,508
Ensembl chr 1:201,499,028...201,548,513
|
|
G |
Htra2 |
HtrA serine peptidase 2 |
multiple interactions |
ISO |
Vitamin E inhibits the reaction [cinnamic aldehyde affects the localization of HTRA2 protein] |
CTD |
PMID:15566391 |
|
NCBI chr 4:113,883,671...113,886,833
Ensembl chr 4:113,883,670...113,886,994
|
|
G |
Iars1 |
isoleucyl-tRNA synthetase 1 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of IARS1 mRNA Vitamin E results in decreased expression of IARS1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr17:15,356,016...15,402,680
Ensembl chr17:15,355,529...15,402,649
|
|
G |
Ica1 |
islet cell autoantigen 1 |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of ICA1 mRNA Vitamin E results in increased expression of ICA1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:34,635,509...34,780,187
Ensembl chr 4:34,635,506...34,780,193
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
multiple interactions |
ISO |
[Ascorbic Acid co-treated with Lycopene co-treated with alpha-Tocopherol] inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA]; [Vitamin E co-treated with Bezafibrate] results in decreased expression of ICAM1 protein modified form; alpha-Tocopherol inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA]; alpha-Tocopherol inhibits the reaction [Vehicle Emissions results in increased expression of ICAM1 protein]; Vitamin E inhibits the reaction [Norepinephrine results in increased expression of ICAM1 mRNA]; Vitamin E inhibits the reaction [Simvastatin results in decreased expression of ICAM1 protein modified form] |
CTD |
PMID:14602771 PMID:22313677 PMID:23114885 PMID:25551565 |
|
NCBI chr 8:22,035,287...22,047,049
Ensembl chr 8:22,035,256...22,047,059
|
|
G |
Id2 |
inhibitor of DNA binding 2 |
decreases expression |
ISO |
Vitamin E results in decreased expression of ID2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:44,360,077...44,361,908
Ensembl chr 6:44,348,501...44,363,915
|
|
G |
Idh3b |
isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit beta |
increases expression |
ISO |
Vitamin E results in increased expression of IDH3B mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:122,808,564...122,813,638
Ensembl chr 3:122,808,564...122,813,583
|
|
G |
Idh3g |
isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit gamma |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of IDH3G mRNA Vitamin E results in increased expression of IDH3G mRNA |
CTD |
PMID:19244175 |
|
NCBI chr X:156,999,803...157,008,735
Ensembl chr X:156,999,826...157,008,733
|
|
G |
Ids |
iduronate 2-sulfatase |
increases expression |
ISO |
Vitamin E results in increased expression of IDS mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:69,447,971...69,466,708
Ensembl chr 8:69,449,801...69,466,618
|
|
G |
Idua |
alpha-L-iduronidase |
increases expression multiple interactions |
ISO |
Vitamin E results in increased expression of IDUA mRNA [Selenium co-treated with Vitamin E] results in increased expression of IDUA mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:2,041,828...2,056,762
Ensembl chr14:2,042,411...2,056,762
|
|
G |
Iffo1 |
intermediate filament family orphan 1 |
increases expression |
ISO |
Vitamin E results in increased expression of IFFO1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:157,659,115...157,676,335
Ensembl chr 4:157,659,147...157,676,331
|
|
G |
Ifi35 |
interferon-induced protein 35 |
increases expression |
ISO |
Vitamin E results in increased expression of IFI35 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:89,358,376...89,366,628
Ensembl chr10:89,358,376...89,366,626
|
|
G |
Ifitm2 |
interferon induced transmembrane protein 2 |
increases expression |
ISO |
Vitamin E results in increased expression of IFITM2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:213,750,219...213,751,399
Ensembl chr 1:213,750,192...213,751,405
|
|
G |
Ifitm3 |
interferon induced transmembrane protein 3 |
increases expression |
ISO |
Vitamin E results in increased expression of IFITM3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:213,810,712...213,811,821
Ensembl chr 1:213,810,696...213,811,901
|
|
G |
Ifng |
interferon gamma |
multiple interactions decreases expression |
ISO EXP |
Vitamin E inhibits the reaction [Ethanol results in increased activity of IFNG protein] [alpha-Tocopherol co-treated with Lipopolysaccharides] results in increased expression of IFNG mRNA; alpha-Tocopherol results in decreased susceptibility to [IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4]; Vitamin E inhibits the reaction [APP protein modified form promotes the reaction [[IFNG protein co-treated with Lipopolysaccharides] results in increased expression of NOS2 protein]] Vitamin E results in decreased expression of IFNG protein |
CTD |
PMID:14624943 PMID:15223066 PMID:16307444 PMID:21086752 PMID:24333275 |
|
NCBI chr 7:61,337,383...61,341,419
Ensembl chr 7:61,337,381...61,341,419
|
|
G |
Ift74 |
intraflagellar transport 74 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of IFT74 mRNA Vitamin E results in decreased expression of IFT74 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:113,579,065...113,682,485
Ensembl chr 5:113,592,919...113,682,484
|
|
G |
Ift81 |
intraflagellar transport 81 |
decreases expression |
ISO |
Vitamin E results in decreased expression of IFT81 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:39,420,161...39,507,412
Ensembl chr12:39,423,596...39,506,890
|
|
G |
Igf1r |
insulin-like growth factor 1 receptor |
multiple interactions decreases expression |
ISO EXP |
Rutin results in increased susceptibility to [Vitamin E results in decreased expression of IGF1R protein] Vitamin E inhibits the reaction [Thyroxine results in increased expression of IGF1R protein] Vitamin E results in decreased expression of IGF1R mRNA; Vitamin E results in decreased expression of IGF1R protein |
CTD |
PMID:17447016 PMID:19244175 PMID:20015448 |
|
NCBI chr 1:128,924,921...129,213,816
Ensembl chr 1:128,924,966...129,206,516
|
|
G |
Igf2bp2 |
insulin-like growth factor 2 mRNA binding protein 2 |
decreases expression |
ISO |
Vitamin E results in decreased expression of IGF2BP2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr11:82,466,071...82,621,105
Ensembl chr11:82,466,071...82,621,079
|
|
G |
Igf2r |
insulin-like growth factor 2 receptor |
decreases expression |
ISO |
Vitamin E results in decreased expression of IGF2R mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:48,176,095...48,264,482
Ensembl chr 1:48,176,106...48,264,477
|
|
G |
Igfbp2 |
insulin-like growth factor binding protein 2 |
increases expression |
ISO |
Vitamin E results in increased expression of IGFBP2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:80,118,029...80,144,804
Ensembl chr 9:80,118,029...80,144,789
|
|
G |
Igfbp4 |
insulin-like growth factor binding protein 4 |
increases expression |
ISO |
Vitamin E results in increased expression of IGFBP4 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:86,950,555...86,962,563
Ensembl chr10:86,950,557...86,962,578
|
|
G |
Igfbp5 |
insulin-like growth factor binding protein 5 |
multiple interactions |
EXP |
[alpha-Tocopherol co-treated with beta Carotene co-treated with Ascorbic Acid co-treated with Zinc co-treated with Sodium Selenite] results in decreased expression of IGFBP5 mRNA |
CTD |
PMID:23859036 |
|
NCBI chr 9:80,154,230...80,166,813
Ensembl chr 9:80,150,211...80,167,033
|
|
G |
Igfbp6 |
insulin-like growth factor binding protein 6 |
increases expression |
ISO |
Vitamin E results in increased expression of IGFBP6 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:143,749,385...143,754,018
Ensembl chr 7:143,749,221...143,754,054
|
|
G |
Ik |
IK cytokine |
increases expression |
ISO |
Vitamin E results in increased expression of IK mRNA |
CTD |
PMID:19244175 |
|
NCBI chr18:29,587,901...29,602,705
Ensembl chr18:29,587,901...29,608,338
|
|
G |
Il10 |
interleukin 10 |
multiple interactions |
ISO EXP |
[Ascorbic Acid co-treated with lycopene co-treated with alpha-Tocopherol] promotes the reaction [TNF protein results in increased expression of and results in increased secretion of IL10 protein]; alpha-Tocopherol promotes the reaction [TNF protein results in increased expression of and results in increased secretion of IL10 protein] [alpha-Tocopherol co-treated with Lipopolysaccharides] results in increased expression of IL10 mRNA; [Vanadium co-treated with Selenium co-treated with Vitamin E co-treated with Chromium] inhibits the reaction [Streptozocin results in decreased expression of IL10 protein] Vitamin E inhibits the reaction [Ethanol results in increased activity of IL10 protein] |
CTD |
PMID:15862027 PMID:21086752 PMID:24333275 PMID:25551565 |
|
NCBI chr13:47,738,933...47,743,392
Ensembl chr13:47,739,526...47,743,392
|
|
G |
Il13ra1 |
interleukin 13 receptor subunit alpha 1 |
increases expression |
ISO |
Vitamin E results in increased expression of IL13RA1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr X:122,724,081...122,783,801
Ensembl chr X:122,724,129...122,781,479
|
|
G |
Il1a |
interleukin 1 alpha |
multiple interactions |
EXP |
alpha-Tocopherol inhibits the reaction [Hexachlorocyclohexane results in increased expression of IL1A mRNA]; alpha-Tocopherol inhibits the reaction [Hexachlorocyclohexane results in increased expression of IL1A protein] |
CTD |
PMID:15025948 |
|
NCBI chr 3:121,824,712...121,836,122
Ensembl chr 3:121,825,412...121,836,086
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions increases expression |
ISO EXP |
alpha-Tocopherol inhibits the reaction [cumene hydroperoxide results in increased secretion of IL1B protein]; alpha-Tocopherol inhibits the reaction [Dibutyl Phthalate results in increased expression of IL1B protein]; alpha-Tocopherol inhibits the reaction [Vitamin E deficiency results in increased expression of IL1B mRNA]; Quercetin inhibits the reaction [Vitamin E deficiency results in increased expression of IL1B mRNA] alpha-Tocopherol inhibits the reaction [Acrylonitrile results in increased expression of IL1B mRNA]; Vitamin E inhibits the reaction [[IL1B protein co-treated with TNF protein] results in increased chemical synthesis of Nitric Oxide]; Vitamin E inhibits the reaction [[IL1B protein co-treated with TNF protein] results in increased expression of NOS2 protein]; Vitamin E inhibits the reaction [Aluminum results in increased expression of IL1B protein]; Vitamin E inhibits the reaction [Vehicle Emissions results in increased expression of IL1B mRNA] |
CTD |
PMID:15223066 PMID:16545059 PMID:18234736 PMID:19135433 PMID:19735175 PMID:26332274 PMID:31712109 |
|
NCBI chr 3:121,876,256...121,882,637
Ensembl chr 3:121,876,263...121,882,726
|
|
G |
Il2 |
interleukin 2 |
multiple interactions |
EXP |
Vitamin E inhibits the reaction [Formaldehyde results in increased expression of IL2 protein] |
CTD |
PMID:16937016 |
|
NCBI chr 2:123,847,150...123,851,854
Ensembl chr 2:123,847,150...123,851,854
|
|
G |
Il4 |
interleukin 4 |
decreases expression multiple interactions |
ISO EXP |
Vitamin E results in decreased expression of IL4 protein [Vanadium co-treated with Selenium co-treated with Vitamin E co-treated with Chromium] results in increased expression of IL4 protein |
CTD |
PMID:14624943 PMID:15862027 |
|
NCBI chr10:38,963,979...38,969,531
Ensembl chr10:38,963,979...38,969,531
|
|
G |
Il4r |
interleukin 4 receptor |
increases expression multiple interactions |
ISO |
Vitamin E results in increased expression of IL4R mRNA [Selenium co-treated with Vitamin E] results in decreased expression of IL4R mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:196,942,343...196,967,221
Ensembl chr 1:196,942,364...196,967,220
|
|
G |
Il5 |
interleukin 5 |
multiple interactions |
ISO |
[Vitamin E co-treated with Quercetin co-treated with kaempferol co-treated with 3,4-dihydroxyphenylethanol] results in decreased expression of IL5 mRNA |
CTD |
PMID:16797527 |
|
NCBI chr10:39,066,716...39,069,587
Ensembl chr10:39,066,716...39,069,587
|
|
G |
Il6 |
interleukin 6 |
multiple interactions decreases expression |
ISO EXP |
[Vitamin E co-treated with Quercetin co-treated with kaempferol co-treated with 3,4-dihydroxyphenylethanol] results in decreased expression of IL6 mRNA; alpha-Tocopherol inhibits the reaction [2,2',4,4'-tetrabromodiphenyl ether results in increased expression of and results in increased secretion of IL6 protein] alpha-Tocopherol inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein] alpha-Tocopherol inhibits the reaction [Mercuric Chloride results in increased expression of IL6 protein]; Vitamin E inhibits the reaction [phoxim results in decreased expression of IL6 mRNA]; Vitamin E inhibits the reaction [Vehicle Emissions results in increased expression of IL6 mRNA]; Vitamin E inhibits the reaction [Vehicle Emissions results in increased expression of IL6 protein] Vitamin E results in decreased expression of IL6 protein |
CTD |
PMID:15630180 PMID:16797527 PMID:18234736 PMID:20370442 PMID:24296301 PMID:30003487 PMID:32134168 |
|
NCBI chr 4:3,043,231...3,047,807
Ensembl chr 4:3,043,231...3,047,807
|
|
G |
Ilf3 |
interleukin enhancer binding factor 3 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of ILF3 mRNA Vitamin E results in decreased expression of ILF3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:22,402,877...22,440,984
Ensembl chr 8:22,402,890...22,440,885
|
|
G |
Ilk |
integrin-linked kinase |
increases expression |
ISO |
Vitamin E results in increased expression of ILK mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:170,578,941...170,585,192
Ensembl chr 1:170,578,889...170,585,189
|
|
G |
Inpp5k |
inositol polyphosphate-5-phosphatase K |
increases expression |
ISO |
Vitamin E results in increased expression of INPP5K mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:63,775,639...63,796,879
Ensembl chr10:63,776,378...63,795,899
|
|
G |
Insr |
insulin receptor |
multiple interactions |
EXP |
[Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Diethylhexyl Phthalate results in increased expression of INSR mRNA] |
CTD |
PMID:21911000 |
|
NCBI chr12:1,682,527...1,816,414
Ensembl chr12:1,680,957...1,816,414
|
|
G |
|